<html lang="en" class="pb-page js" data-request-id="94d6c9e08714a4d7-GRU"><head data-pb-dropzone="head"><style type="text/css" nonce="94d6c9e08714a4d7-GRU">@font-face {font-family: "Source Sans Pro";src: url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.ttf) format("truetype"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.woff) format("woff"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.otf) format("opentype"),url(https://consent.trustarc.com/get?name=SourceSansPro-Regular.eot) format("embedded-opentype");}.truste_cursor_pointer {cursor: pointer;}.truste_border_none {border: none;}.truste_accessible_link {font-family: "Source Sans Pro", sans-serif;color: #1D4ED8;font-size: 14px;font-weight: 600;text-decoration: underline;}.truste_accessible_link:hover {color: #1D4ED8;text-decoration: none !important;}.truste_accessible_link:focus-visible {outline: none;border-radius: 4px;box-shadow: 0 0 0 1px #FFFFFF, 0 0 0 4px #3699F1;}</style><script src="https://ssl-cdn.janraincapture.com/widget_data/flow.js:7h8bznq6j7bvyvzqcrwvyp8dfb:en-US:20240514181256512029:standard" type="text/javascript"></script><script src="https://cssjs.nejm.org/akamai/capture:login" type="text/javascript"></script><script src="https://ssl-widget-cdn.rpxnow.com/translations/login/en-US" type="text/javascript"></script><script type="text/javascript" id="janrainAuthWidget" src="https://cssjs.nejm.org/akamai/mms-prod.js"></script><script type="text/javascript" src="https://www.nejm.org/IWgeTwbOqGmAzqNqWj-_ThHBfGZonMlXlVC0rknmhuRJJ4yIr3mDAOmj9Pjtljqm6ef4FjFYaO33dtXxbNucaw=="></script>
            

<meta charset="UTF-8">






    
        
            
        
    
        
            
        
    
        
            
        
    
        
            
        
    
        
    
        
    
        
            
                
                
<title>Population Immunity and Covid-19 Severity with Omicron Variant in South Africa | New England Journal of Medicine</title>





                
            
        
    







    
        
            
        
    
        
            
        
    
        
            
                
                



                
            
        
    
        
            
        
    
        
    
        
    
        
            
        
    











    








    

    
    

    
    
    
    
        
            
                <link rel="stylesheet" type="text/css" href="/wro/1125813~article-metrics.css">
            
            
            
        
    

    
    
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_nejm_1-994b0160d1eb33dc79517ef0295aab1b.ico" type="image/x-icon">
        
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_16-4aa032aa775940f725817b7ff42f0e2c.png" type="image/png" sizes="16x16">
        
        
            <link rel="icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_32-0a94fa44823476ffa0bb15bdb320fb34.png" type="image/png" sizes="32x32">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_152-d6c3522864a8e483996b7e9c132c901a.png" sizes="152x152">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_180-f2538afc53a365d4cd3f10ab73c56aad.png" sizes="180x180">
        
        
            <link rel="apple-touch-icon" href="/products/mms-nextgen/mms/releasedAssets/images/favicon/fav_167-8e888012bbdd31a00c3e54bc5b8ca5b6.png" sizes="167x167">
        
    

    
    
            <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/build-5b89b331018866a4a965.css" media="all">
        <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/print-5b89b331018866a4a965.css" media="print">
           <link rel="stylesheet" href="/products/mms-nextgen/mms/releasedAssets/css/build-article-5b89b331018866a4a965.css" media="all" id="article-style-sheet">
    
        <script nonce="94d6c9e08714a4d7-GRU">
        try {
            document.documentElement.classList.add('js');
        } catch (e) {
        }
    </script>
     
    

















    
        
            
                
                
                
                    
                    <!-- TrustArc Scripts -->
<script async="async" src="https://consent.trustarc.com/notice?domain=nejm.com&amp;c=teconsent&amp;js=nj&amp;noticeType=bb&amp;gtm=1&amp;text=true&amp;pcookie" crossorigin="" id="truste_0.8268627020791525"></script>
<script src="https://consent.trustarc.com/autoblockasset/core.min.js?domain=nejm.com"></script>
<script src="https://consent.trustarc.com/autoblockoptout?domain=nejm.com"></script>
<!-- /TrustArc Scripts -->
<!-- BlueConic Scripts -->
<script src="https://bc.nejm.org/script.js"></script>
    <!-- /BlueConic Scripts -->
<!-- Printing Meta Tags -->
    <meta name="topics" content="Viral Infections|Vaccines|Coronavirus">
<meta name="articleCategory" content="Research">
<meta name="articleType" content="Original Article">
<meta name="Specialties" content="Infectious Disease"><script type="text/javascript">var mmsData = {"access":{"isFreeCountry":"n"},"ad":{"category":"article"},"imageChallenge":{"id":null},"article":{"doi":"10.1056/NEJMoa2119658","title":"Population Immunity and Covid-19 Severity with Omicron Variant in South Africa","category":"Research","type":"Original Article","topics":"Viral Infections|Vaccines|Coronavirus","specialties":"Infectious Disease","seriesTitle":"","viewType":"Full","age":"2Years-1990","issueDate":"2022-04-07T00:00Z","isFree":"y","broadTopics":"","perspectiveTopics":"","granularTopics":"","methodologicalArea":"","isOnlineFirst":"n","isCurrentIssue":"n","metaTags":"\u003cmeta name\u003d\"topics\" content\u003d\"Viral Infections|Vaccines|Coronavirus\"/\u003e\n\u003cmeta name\u003d\"articleCategory\" content\u003d\"Research\"/\u003e\n\u003cmeta name\u003d\"articleType\" content\u003d\"Original Article\"/\u003e\n\u003cmeta name\u003d\"Specialties\" content\u003d\"Infectious Disease\"/\u003e"},"page":{"activity":"showFullText","url":"www.nejm.org/doi/full/10.1056/NEJMoa2119658","viewType":"desktop","journal":"NEJM"},"user":{"ucid":null,"audienceSegment":null,"specialtyGroupCode":null,"meterCountRemaining":null,"totalMeterCount":null},"object":{"type":"Visual Abstract","title":"Population Immunity and Covid-19 Severity with Omicron Variant","doi":"10.1056/NEJMdo006521","issueDate":"2022-04-07T00:00Z","age":"6Months-1990","isFree":"y","topics":"Viral Infections|Vaccines|Coronavirus","viewType":"Full","specialties":"Infectious Disease"}};</script>
    <script type="text/javascript">var mmsDataAdd = {"user":{"customerType":"null","accessInstitutionID":"null"}};</script>
    <!-- Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- placeholder id=null, description=Adobe-Target-Prehiding-Snippet --><!--
  Adobe Target - Prehiding Snippet
  v2.0.0
-->
<script nonce="94d6c9e08714a4d7-GRU">
function tgtNoFlicker(e,n,t,o,i,c,l,r){function d(){return n.getElementsByTagName("head")[0]}function a(e,t){if(e){var o=n.getElementById(t);o&&e.removeChild(o)}}function f(e,o){!function(e,t,o){if(e){var i=n.createElement("style");i.id=t,i.innerHTML=o,e.appendChild(i)}}(d(),t,e),setTimeout(function(){a(d(),t)},o)}var m;n.location.href.indexOf(c)>-1?f(l,r):f(o,i),n.location.href.indexOf("mboxDisable")>-1?(a(d(),t),console.log("[TARGET] - Disabled, removing prehiding style")):(m=function(e){e&&(a(d(),t),console.log("[TARGET] - Blocked, removing prehiding style"))},fetch("//cdn.tt.omtrdc.net/cdn/target-vec.js",{method:"HEAD",mode:"no-cors"}).then(e=>m(!1)).catch(e=>m(!0)))}

tgtNoFlicker(window, document, 'at-body-style', 'div[data-location-name="Anonymous Module"], div[data-location-name="Anonymous Banner"], main > div.page-body > div > div > div > div.col-md-2-3.o-col.o-col--primary > div[class*="u-hide"], main > div.page-body > div > div > div > div.col-md-1-3.o-col.o-col--secondary > aside, header > h1#mainContent, a.m-article__link[href*="/10.1056/NEJMoa2116747"] > span.m-article__blurb > p, li.g-nejm-group__user-tool-secondary {opacity: 0 !important}', 3000);

tgtNoFlicker(window, document, 'at-mbox-style', '.N-ad-global-top-right, #N-ad-myNEJM-contextual-top, .N-ad-recentArticles, #N-ad-article-rightRail-1, #N-ad-siteWide-rightRail-1, #N-ad-imageChallenge-rightRail-2 {opacity: 0 !important}', 3000);
</script><!-- /Prehiding snippet for Adobe Target with asynchronous Launch deployment -->
    <!-- Launch Header Embed Code -->
    <script src="//assets.adobedtm.com/launch-ENcd6450fae3ae4870becbe6a2b01ab2e1.min.js" async="" type="ta-blocked" data-ta-blocked="1"></script>
    <!-- /Launch Header Embed Code -->

                    
                
            
        
    
        
            
                
                
                
                    
                    <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="New England Journal of Medicine"><meta name="dc.Title" content="Population Immunity and Covid-19 Severity with Omicron Variant in South Africa"><meta name="dc.Creator" content="Shabir A. Madhi"><meta name="dc.Creator" content="Gaurav Kwatra"><meta name="dc.Creator" content="Jonathan E. Myers"><meta name="dc.Creator" content="Waasila Jassat"><meta name="dc.Creator" content="Nisha Dhar"><meta name="dc.Creator" content="Christian K. Mukendi"><meta name="dc.Creator" content="Amit J. Nana"><meta name="dc.Creator" content="Lucille Blumberg"><meta name="dc.Creator" content="Richard Welch"><meta name="dc.Creator" content="Nicoletta Ngorima-Mabhena"><meta name="dc.Creator" content="Portia C. Mutevedzi"><meta name="dc.Description" content="The B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified on November 25, 2021, in Gauteng province, South Africa. Data regarding the sero..."><meta name="Description" content="The B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified on November 25, 2021, in Gauteng province, South Africa. Data regarding the sero..."><meta name="dc.Publisher" content="Massachusetts Medical Society"><meta name="dc.Date" scheme="WTN8601" content="2022-04-07"><meta name="dc.Type" content="research-article"><meta name="dc.Format" content="text/HTML"><meta name="dc.Identifier" scheme="doi" content="10.1056/NEJMoa2119658"><meta name="dc.Identifier" scheme="publisher-id" content="NJ202204073861406"><meta name="dc.Language" content="EN"><meta name="dc.Relation" content="10.1056/NEJMe2201812"><meta name="dc.Relation" content="YXQYoa2119658"><meta name="dc.Coverage" content="world"><meta name="dc.Rights" content="Copyright Â© 2022 Massachusetts Medical Society. All rights reserved.">




<link rel="meta" type="application/atom+xml" href="https://doi.org/10.1056%2FNEJMoa2119658">
<link rel="meta" type="application/rdf+json" href="https://doi.org/10.1056%2FNEJMoa2119658">
<link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1056%2FNEJMoa2119658">


                    
                
            
        
    
        
            
                
                
                
                
                
            
        
    
        
            
                
                
                
                    
                    





<meta name="robots" content="noarchive">





    





    
    
        
        <meta name="twitter:title" content="Population Immunity and Covid-19 Severity with Omicron Variant in South Africa | NEJM">
        <meta property="og:title" content="Population Immunity and Covid-19 Severity with Omicron Variant in South Africa | NEJM">
    


    <meta property="og:type" content="article">


    
    
        <meta property="og:url" content="https://www.nejm.org/doi/full/10.1056/NEJMoa2119658">
    
    


    
    
        <meta property="og:image" content="https://www.nejm.org/cms/asset/4ef19b00-4065-4054-a454-07c112cf4901/nejmoa2119658_f1.jpg">
        <meta name="twitter:image" content="https://www.nejm.org/cms/asset/4ef19b00-4065-4054-a454-07c112cf4901/nejmoa2119658_f1.jpg">
    



    <meta property="og:site_name" content="The New England Journal of Medicine">


    
    
        
        <meta property="og:description" content="The B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) was first identified on November 25, 2021, in Gauteng province, South
Africa. Data regarding the sero...">
        <meta name="twitter:description" content="The B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) was first identified on November 25, 2021, in Gauteng province, South
Africa. Data regarding the sero...">
    


    
    
        <meta property="og:image:width" content="1656">
    


    
    
        <meta property="og:image:height" content="2465">
    


    <meta name="twitter:card" content="summary">


    <meta name="twitter:site" content="@NEJM">


<meta name="viewport" content="width=device-width,initial-scale=1"><meta name="citation_fulltext_world_readable" content="">
    <meta name="publication_doi" content="10.1056/NEJMoa2119658">


    















                    
                
            
        
    
        
    
        
    
        
            
                
                
                
                
                
            
        
    




<meta name="format-detection" content="telephone=no">

<meta http-equiv="X-UA-Compatible" content="IE=edge">
    




    
        
        
        <link rel="canonical" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2119658">
    
    







<meta name="pbContext" content=";requestedJournal:journal:nejm;page:string:Article/Chapter View;article:article:doi\:10.1056/NEJMoa2119658;ctype:string:Journal Content;wgroup:string:MMS NextGen Website Group;issue:issue:doi\:10.1056/nejm_2022.386.issue-14;pageGroup:string:Publication Pages;subPage:string:Full Text;website:website:mms-site;journal:journal:nejms">
        <script id="altmetric-embed-js" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-288192a491f0ad9cc434f05ea175659426f5ab0cfd6befb3f3592f96bb90b0d1.js"></script><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-933-8e181dff8b36ea01dc4c.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-34-6ea546d794fb7a1cea52.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-743-ddd329e1530654ec0846.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-305-9eee37798fdfe5196307.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-388-bb098c62445f518c0b46.css"><link rel="stylesheet" type="text/css" href="https://cssjs.nejm.org/custreg-556-8e58ca05fb5497e541ef.css"><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/0-dfd243c732a07d3608f6.js"></script><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/7-10d355ba95f7ec1fddf2.js"></script><script charset="utf-8" src="https://www.nejm.org/products/mms-nextgen/mms/releasedAssets/js/11-04bf2a0da30146b4a5d0.js"></script><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><link rel="preconnect" href="https://use.typekit.net"><meta http-equiv="P3P" content="CP=&quot;NOI DSP ADM OUR IND OTC&quot;"><link rel="stylesheet" href="https://quilt-cdn.janrain.com/HEAD/providers.css" type="text/css"><link id="altmetric-embed-css" rel="stylesheet" type="text/css" href="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed-59614f5c46b49b21eeef3bb28c4fb38d1e7069e8d014752fcb66e84942556802.css"></head>
    

    



    
        
        
        
            <body class="pb-ui website-mms-site loaded">
            






    
    
        





    
    
        
        
    
    
    







<input type="hidden" id="isRoMode" name="isRoMode" value="false">

        <div id="pb-page-content" data-ng-non-bindable="">
                
            <div data-pb-dropzone="main" data-pb-dropzone-name="Main">
                
                    
                        



        
        <header data-sticky="false" class="ng-header js_stickyAd"><a href="#mainContent" class="ng-skipToMainContent">Skip to main content</a><div class="ng-header_topAd"><div class="ng-header_topAd-content d-flex justify-content-center align-items-center">



        
        <div id="DTM_Position_Topbanner" class="ad">
 <!--emptycomment-->
</div>
</div></div><div class="ng-header_journal-navbar"><div class="ng-header_journal-navbar-content"><div class="container-fluid"><div class="row"><div class="ng-header_journal-navbar_left col-lg-8 col-sm-12 pr-lg-0 d-flex align-items-center"><div data-location="nejm_group_product_nav" class="ng-header_journalNavMenu">



        
        <nav data-location="nejm_group_product_nav" role="navigation" class="ng-journalNavMenu">
<ul class="ng-journalNavMenu_list">
<li class="ng-journalNavMenu_list-item"><a href="/" class="ng-journalNavMenu_mainLink active" aria-current="page" aria-label="The New England Journal of Medicine selected item"><span class="ng-journalNavMenu_mainLink-text d-lg-block d-none">The New England Journal of Medicine</span><span class="ng-journalNavMenu_mainLink-text d-lg-none d-block">NEJM</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://evidence.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Evidence</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://ai.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> AI</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://catalyst.nejm.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Catalyst</span></a></li>
<li class="ng-journalNavMenu_list-item"><a href="https://www.jwatch.org/" class="ng-journalNavMenu_mainLink"><span class="ng-journalNavMenu_mainLink-text"><span class="ng-journalNavMenu_mainLink-text-firstWord">NEJM</span> Journal Watch</span></a></li>
</ul>
</nav>

</div></div><div class="ng-header_journal-navbar_right col-lg-4 pl-lg-0 d-none d-xl-flex align-items-center justify-content-end"><div class="ng-header_loginBar d-xl-flex align-items-lg-center">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2119658" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div></div><div class="ng-header_instBanner d-none d-lg-block"></div><div class="ng-header_logoBar"><div class="container-fluid"><div class="row"><div data-location="logo" class="ng-header_logoBar_left col-lg-4 col-6 d-flex align-items-center justify-content-start"><a href="/" title="The New England Journal of Medicine homepage" class="ng-header_logo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-logo-166667e91992a5212bc723b03e45d39f.svg" alt="The New England Journal of Medicine homepage" width="366" height="58" class="ng-header_logo-image"></a></div><div class="ng-header_logoBar_right ng-header_navBar col-lg-8 col-sm-12 p-lg-0 align-items-center justify-content-end"><div class="ng-header_navBar-content"><div class="container-fluid"><div class="row"><div class="ng-header_instBanner-md col-12 d-block d-lg-none"></div><div class="ng-header_loginBar-md col-12 d-block d-xl-none">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2119658" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div><div class="ng-header_navBar_left col-lg-8 col-sm-12 d-flex align-items-center"><div class="ng-header_stickyLogo mr-32"><a href="/" title="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-small-logo-070df7a3f4d8cfa2e71c3c45bb4b172f.svg" alt="The New England Journal of Medicine homepage" class="ng-header_stickyLogo-image"></a></div><div class="ng-header_mainMenu">









    
    
        <div data-widget-def="menuWidget" data-widget-id="97fb3983-db63-4b0b-97dd-d9bb7929fce1" data-location="main_nav">
        



        
        <nav class="ng-menu"><ul class="ng-menu_list ng-simple-menu"><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/toc/nejm/current" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">current issue</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/toc/nejm/current" class="ng-simple-menu_list-link">VIEW CURRENT ISSUE</a></li><li class="ng-simple-menu_list-item"><a href="/toc/nejm/recently-published" class="ng-simple-menu_list-link">BROWSE RECENTLY PUBLISHED</a></li><li class="ng-simple-menu_list-item"><a href="/loi/nejm" class="ng-simple-menu_list-link">BROWSE ALL ISSUES</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/medical-specialties" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">SPECIALTIES</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/browse/specialty/cardiology" class="ng-simple-menu_list-link">Cardiology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/clinical-medicine" class="ng-simple-menu_list-link">Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/endocrinology" class="ng-simple-menu_list-link">Endocrinology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/gastroenterology" class="ng-simple-menu_list-link">Gastroenterology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/hematology-oncology" class="ng-simple-menu_list-link">Hematology/Oncology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/infectious-disease" class="ng-simple-menu_list-link">Infectious Disease</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/nephrology" class="ng-simple-menu_list-link">Nephrology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/neurology-neurosurgery" class="ng-simple-menu_list-link">Neurology/Neurosurgery</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/obstetrics-gynecology" class="ng-simple-menu_list-link">Obstetrics/Gynecology</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/pediatrics" class="ng-simple-menu_list-link">Pediatrics</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/pulmonary-critical-care" class="ng-simple-menu_list-link">Pulmonary/Critical Care</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/surgery" class="ng-simple-menu_list-link">Surgery</a></li><li class="ng-simple-menu_list-item"><a href="/medical-specialties" class="ng-simple-menu_list-link">View All Specialties</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/topics" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">TOPICS</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/ai-in-medicine" class="ng-simple-menu_list-link">AI in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/climate-change" class="ng-simple-menu_list-link">Climate Change</a></li><li class="ng-simple-menu_list-item"><a href="/coronavirus" class="ng-simple-menu_list-link">Coronavirus</a></li><li class="ng-simple-menu_list-item"><a href="/equity" class="ng-simple-menu_list-link">Efforts toward Equity</a></li><li class="ng-simple-menu_list-item"><a href="/firearm-injury-prevention" class="ng-simple-menu_list-link">Firearm Injury Prevention</a></li><li class="ng-simple-menu_list-item"><a href="/nam" class="ng-simple-menu_list-link">From the National Academy of Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/fundamentals-of-medical-ethics" class="ng-simple-menu_list-link">Fundamentals of Medical Ethics</a></li><li class="ng-simple-menu_list-item"><a href="/gray-matters" class="ng-simple-menu_list-link">Gray Matters</a></li><li class="ng-simple-menu_list-item"><a href="/browse/specialty/health-policy" class="ng-simple-menu_list-link">Health Policy</a></li><li class="ng-simple-menu_list-item"><a href="/medicine-and-society" class="ng-simple-menu_list-link">Medicine and Society</a></li><li class="ng-simple-menu_list-item"><a href="/nutrition-in-medicine" class="ng-simple-menu_list-link">Nutrition in Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/outbreaks" class="ng-simple-menu_list-link">Outbreaks Center</a></li><li class="ng-simple-menu_list-item"><a href="/race-and-medicine" class="ng-simple-menu_list-link">Race and Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/recognizing-historical-injustices" class="ng-simple-menu_list-link">Recognizing Historical Injustices and the Journal</a></li><li class="ng-simple-menu_list-item"><a href="/tobacco-use-reduction" class="ng-simple-menu_list-link">Tobacco Use Reduction</a></li><li class="ng-simple-menu_list-item"><a href="/topics" class="ng-simple-menu_list-link">View All Topics</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/multimedia" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">MULTIMEDIA</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/rss-feed" class="ng-simple-menu_list-link">Podcasts</a></li><li class="ng-simple-menu_list-item"><a href="/double-take" class="ng-simple-menu_list-link">Double Takes</a></li><li class="ng-simple-menu_list-item"><a href="https://illustrated-glossary.nejm.org/" class="ng-simple-menu_list-link">Illustrated Glossary</a></li><li class="ng-simple-menu_list-item"><a href="/image-challenge" class="ng-simple-menu_list-link">Image Challenge</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/images-in-clinical-medicine" class="ng-simple-menu_list-link">Images in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/interactive-medical-case" class="ng-simple-menu_list-link">Interactive Medical Cases</a></li><li class="ng-simple-menu_list-item"><a href="/plain-language-research-summaries" class="ng-simple-menu_list-link">Plain Language/Research Summaries</a></li><li class="ng-simple-menu_list-item"><a href="/multimedia/quick-take-video" class="ng-simple-menu_list-link">Quick Takes</a></li><li class="ng-simple-menu_list-item"><a href="/browse/nejm-media-type/videos-in-clinical-medicine" class="ng-simple-menu_list-link">Videos in Clinical Medicine</a></li><li class="ng-simple-menu_list-item"><a href="/multimedia" class="ng-simple-menu_list-link">View All Multimedia</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item hasChildren"><a href="/learning" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">LEARNING/CME</span><span class="ng-simple-menu_mainLink-arrowIcon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-down"></use></svg></span></span></a><div class="ng-simple-menu_dropblock"><div class="ng-simple-menu_dropblock-cont"><div class="ng-simple-menu_list"><ul class="ng-simple-menu_list-items"><li class="ng-simple-menu_list-item"><a href="/continuing-medical-education" class="ng-simple-menu_list-link">Weekly CME</a></li><li class="ng-simple-menu_list-item"><a href="/cme-ce/obesity" class="ng-simple-menu_list-link">Obesity CME/CE</a></li><li class="ng-simple-menu_list-item"><a href="/learning" class="ng-simple-menu_list-link">VIEW ALL LEARNING/CME</a></li></ul></div></div></div></li><li class="ng-menu_list-item ng-simple-menu_item"><a href="/author-center/home" class="ng-simple-menu_mainLink"><span class="ng-simple-menu_mainLink-text">AUTHOR CENTER</span></a></li></ul></nav>

        </div>
    

</div><button aria-label="Search" class="ng-header_searchBtn searchBtnNav d-block ml-24"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button></div><div class="ng-header_loginBar ng-header_loginBar-sticky col-4">



        
        <div data-location="authstring_nav" class="ng-header_loginBar-menu"><span class="ng-simple-menu_mainLink-icon signIn newIcon-2"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#user2"></use></svg></span></span><span class="ng-header_loginBar-signIn"><a href="/sign-in?uri=/doi/full/10.1056/NEJMoa2119658" class="ng-header_loginBar-signIn-link">Sign In</a></span><span class="ng-header_loginBar-separator">|</span><span class="ng-header_loginBar-createAcc"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC1" class="ng-header_loginBar-createAcc-link ro-mode_disabled">Create Account</a></span></div><div data-location="authstring_nav" class="ng-header_loginBar-subscribe pl-xl-16"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS1" class="ng-header_loginBar-subscribe-btn ng-btn_primary ro-mode_disabled">Subscribe</a></div>
</div></div></div></div></div><div class="ng-header_logoBar_right-lg col-lg-8 col-6 d-flex align-items-center justify-content-end d-xl-none"><button aria-label="Search" class="ng-header_searchBtn d-flex justify-content-end"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button><div class="ng-header_openCloseBtns d-flex align-items-center justify-content-end"><button aria-label="Open" class="ng-header_openBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#burger"></use></svg></span></button><button aria-label="Close" class="ng-header_closeBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></button></div></div><div class="ng-header_quickSearch col-12"><div class="ng-header_quickSearch-content">



        
        <div class="ng-quick-search js-ng-quick-search"><form action="/search" method="get" class="ng-quick-search_form js-form"><div class="ng-quick-search_inputArea js-inputArea"><input type="search" name="q" placeholder="Enter keyword, author, title or citation" autocomplete="off" value="" required="required" class="ng-quick-search_allField ng-large-text-input js-allField js-allField-def-tmpl ui-autocomplete-input"><button type="submit" aria-label="Search Button" class="ng-quick-search_iconBtn d-xl-none d-block js-submitBtn"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#search"></use></svg></span></button><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" style="display: none;"></ul></div><div class="ng-quick-search_btnsArea d-none d-xl-flex align-items-center justify-content-end"><a href="/search/advanced" class="ng-quick-search_advSearchLink ng-btn_link js-advancedSearchLink">Advanced Search</a><button type="submit" class="ng-quick-search_textBtn ng-btn_secondary ng-btn_iconRight js-submitBtn"><span class="ng-btn_text">SEARCH</span><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-right"></use></svg></span></button></div></form></div>
</div></div></div></div></div></header><div class="ng-header_overlay"></div><div class="ng-header_after">









    
    
        <div data-widget-def="literatumAd" data-widget-id="4931ddbd-d46e-4597-b4fd-92549e9847ca" id="ad-global-banner-FULLx64-1">
        



        
        



    

    

    
        
    



        </div>
    

</div>

                    
                        



        
        <div>









    
    
        <main data-widget-def="axelPublicationContent" data-widget-id="fcdb5261-d6a2-4a9c-81d5-3a3e2304e9c1" id="mainContent">
        



        
        <div class="article-tools__savePopup"><div class="ng-save"><input type="hidden" value="/action/getSavedTags" class="getKeywordsServiceUrl"><input type="hidden" value="/action/mmsSaveItemsService?itemType=article" class="saveServiceUrl"><input type="hidden" value="article" class="saveType"><input type="hidden" value="10.1056/NEJMoa2119658" class="inputDoi"><input type="hidden" value="S.A. Madhi and Others" class="inputAuthor"><input type="hidden" value="N Engl J Med 2022;386:1314-1326" class="inputCitation"><input type="hidden" value="02-23-2022" class="inputEPubDate"><input type="hidden" value="April 2022" class="inputCoverDate"><input type="hidden" value="Original Article" class="inputContentType"><input type="hidden" value="Population Immunity and Covid-19 Severity with Omicron Variant in South Africa" class="inputArticleTitle"><input type="hidden" value="/browse/nejm-article-type/original-article" class="inputContentTypeUrl"><button type="button" id="saveArticleShowPopupBtn" aria-hidden="true" tabindex="-1" class="ng-save-btn ng-btn_secondary isLoggedOut">Save</button></div></div><div class="article-tools__articleAlertPopup"><div id="articleAlertModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="articleAlertModalTitle" class="ng-modal_title modal-title">Create an E-mail Alert for This Article</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><div class="ng-do-media_popup modal-lg"><div id="doPopup" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body"></div></div></div></div></div><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/mms-nextgen/mms/releasedAssets/css/build-article-5b89b331018866a4a965.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" data-type="research-article" vocab="http://schema.org/" typeof="ScholarlyArticle" lang="en" dir="ltr"><header data-extent="frontmatter" data-location="header_article"><div class="core-container"><div data-article-access="free" data-article-access-type="free" class="meta-panel"><div class="meta-panel__left-content"><div class="meta-panel__type"><a href="/browse/nejm-article-type/original-article">Original Article</a></div></div><div class="meta-panel__right-content"><div class="meta-panel__share">









    
    
        <div data-widget-def="UX3share" data-widget-id="eee5f139-16f2-48f8-97ea-1b114367da16" data-location="share_tools_article">
        



        
        <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js" nonce="94d6c9e08714a4d7-GRU"></script><div class="share"><div class="share__block share__inline-links"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="d-flex list-unstyled a2a a2a_kit a2a_default_style mb-0 a2a_kit_size_32" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Facebook" data-interactiontype="social" class="share__link a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-facebook"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="X (formerly Twitter)" data-interactiontype="social" class="share__link a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-twitter"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Linked In" data-interactiontype="social" class="share__link a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-linkedin"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Email" data-interactiontype="content_email_click" class="share__link a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-email"></use></svg></span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" data-interactiontype="social" class="share__link a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><span class="icon-component " style="height: 24px; width: 24px"><svg aria-hidden="true" style="height: 24px; width: 24px"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#social-bluesky"></use></svg></span></a></li></ul></div></div>

        </div>
    

</div></div></div><h1 property="name">Population Immunity and Covid-19 Severity with Omicron Variant in South Africa</h1><div class="core-relations my-3"></div><div class="contributors"><span class="authors"><span class="heading">Authors</span>: <span role="list"><span property="author" typeof="Person" role="listitem"><span property="givenName">Shabir A.</span> <span property="familyName">Madhi</span>, <span property="honorificSuffix">Ph.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-7629-0636" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-7629-0636</a></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Gaurav</span> <span property="familyName">Kwatra</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Jonathan E.</span> <span property="familyName">Myers</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Waasila</span> <span property="familyName">Jassat</span>, <span property="honorificSuffix">M.Med.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Nisha</span> <span property="familyName">Dhar</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Christian K.</span> <span property="familyName">Mukendi</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Amit J.</span> <span property="familyName">Nana</span>, <span property="honorificSuffix">B.Sc.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Lucille</span> <span property="familyName">Blumberg</span>, <span property="honorificSuffix">M.Med.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Richard</span> <span property="familyName">Welch</span>, <span property="honorificSuffix">B.Sc.</span></span>, <span property="author" typeof="Person" role="listitem"><span property="givenName">Nicoletta</span> <span property="familyName">Ngorima-Mabhena</span>, <span property="honorificSuffix">M.B., Ch.B.</span></span>, and <span property="author" typeof="Person" role="listitem"><span property="givenName">Portia C.</span> <span property="familyName">Mutevedzi</span>, <span property="honorificSuffix">Ph.D.</span></span></span></span><a href="#tab-contributors" class="to-authors-affiliations" data-id="article-authors-viewall">Author Info &amp; Affiliations</a></div><div class="core-self-citation"><div class="core-date-published">Published <span property="datePublished">February 23, 2022</span></div><div property="isPartOf" typeof="Periodical"><span property="name">N Engl J Med</span> 2022<span property="isPartOf" typeof="PublicationVolume">;<span property="volumeNumber">386</span></span>:<span property="pageStart">1314</span>-<span property="pageEnd">1326</span></div><div class="doi">DOI: 10.1056/NEJMoa2119658</div><div class="core-enumeration"><a href="/toc/nejm/386/14"><span property="isPartOf" typeof="PublicationVolume">VOL. <span property="volumeNumber">386</span></span> <span property="isPartOf" typeof="PublicationIssue">NO. <span property="issueNumber">14</span></span></a></div><div><a href="#tab-information">Copyright Â© 2022</a></div></div><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__metrics info-panel__item"></div></div><div data-location="tools_article" class="info-panel__right-content"><div class="info-panel__article_tools info-panel__item">



        
        <div data-permission="/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3DShabir%2BA.%2BMadhi%252C%2BGaurav%2BKwatra%252C%2BJonathan%2BE.%2BMyers%252C%2Bet%2Bal%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D386%26issueNum%3D14%26contentID%3D10.1056%252FNEJMoa2119658%26title%3DPopulation%2BImmunity%2Band%2BCovid-19%2BSeverity%2Bwith%2BOmicron%2BVariant%2Bin%2BSouth%2BAfrica%26publicationDate%3D04%252F07%252F2022" class="article-tools"><button id="articleToolsAlertBtn" data-url="/action/addCitationAlert?doi=10.1056%2FNEJMoa2119658" data-toggle="" data-target="#articleAlertModal" aria-label="Sign in or create account to add an article alert" data-interactiontype="article_alert" class="article-tools__citation btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to add an article alert"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#alerts"></use></svg></span></span></button><button id="articleToolsSaveBtn" data-toggle="modal" data-target="#saveArticle" aria-label="Sign in or create account to save this article" data-interactiontype="article_tools_save_click" class="article-tools__favorite btn btn--slim isLoggedOut"><span title="" data-toggle="tooltip" class="d-inline-block" data-original-title="Sign in or create account to save this article"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#bookmarkFilled"></use></svg></span></span></button><a href="/servlet/linkout?type=rightslink&amp;url=publisherName%3Dmassmed%26author%3DShabir%2BA.%2BMadhi%252C%2BGaurav%2BKwatra%252C%2BJonathan%2BE.%2BMyers%252C%2Bet%2Bal%26publication%3Dnejm%26orderBeanReset%3Dtrue%26volumeNum%3D386%26issueNum%3D14%26contentID%3D10.1056%252FNEJMoa2119658%26title%3DPopulation%2BImmunity%2Band%2BCovid-19%2BSeverity%2Bwith%2BOmicron%2BVariant%2Bin%2BSouth%2BAfrica%26publicationDate%3D04%252F07%252F2022" target="_blank" title="" data-toggle="tooltip" aria-label="Permissions" data-interactiontype="article_tools_permissions_click" class="article-tools__permissions btn btn--slim" data-original-title="Permissions"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#permissions"></use></svg></span></a><a href="/about-nejm/reprints" title="" data-toggle="tooltip" aria-label="Reprints" data-interactiontype="article_tools_reprints_click" class="article-tools__reprints btn btn--slim" data-original-title="Reprints"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#reprints"></use></svg></span></a><a href="/cms/asset/459a89d7-7559-4e40-b653-5e9469e23640/nejmoa2119658.pptx" target="_blank" title="" data-toggle="tooltip" aria-label="Download Slides" data-interactiontype="article_tools_slide_set_download" data-multimedia-type="Article Slideset" data-multimedia-filename="nejmoa2119658.pptx" class="article-tools__downloadSlides btn btn--slim" data-original-title="Download Slides"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#download"></use></svg></span></a><div class="article-tools__permissionsPopup"><div id="permissionsModal" tabindex="-1" role="dialog" aria-labelledby="exampleModalCenterTitle" aria-hidden="true" class="ng-modal modal"><div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered"><div class="ng-modal_content modal-content"><div class="ng-modal_header modal-header"><h5 id="permissionsModalTitle" class="ng-modal_title modal-title">Permissions</h5><button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#close"></use></svg></span></span></button></div><div class="ng-modal_body modal-body">For permission requests, please contact NEJM Reprints at <a href="mailto:reprints@nejm.org">reprints@nejm.org</a></div></div></div></div></div></div>
</div><div class="info-panel__citations info-panel__item"><a href="#tab-citations" class="btn btn--slim" aria-label="View Citations" data-toggle="tooltip" data-original-title="View Citations" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><i aria-hidden="true" class="icon-format_quote"></i></a></div><div class="info-panel__formats info-panel__item"><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2119658" class="btn btn--pdf btn--slim" aria-label="View PDF" data-toggle="tooltip" data-original-title="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa2119658" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2119658.pdf"><i aria-hidden="true" class="icon-PDF"></i></a></div></div></div></div></header><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Contents</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><ul><li><a href="#summary-abstract" aria-current="true">Abstract</a></li><li><a href="#sec-1" aria-current="false">Methods</a></li><li><a href="#sec-2" aria-current="false">Results</a></li><li><a href="#sec-3" aria-current="false">Discussion</a></li><li class="bordered"><a href="#backnotes" aria-current="false">Notes</a></li><li><a href="#supplementary-materials" aria-current="false">Supplementary Material</a></li><li><a href="#bibliography" aria-current="false">References</a></li></ul></nav></div><nav id="article_collateral_menu"><ul data-core-nav="collateral" class="collateral-pill" style="margin-top: 0px;"><li><a href="#core-collateral-info" data-id="article-nav-menubar-info" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Information &amp; Authors"><i aria-hidden="true" class="icon-info"></i><span class="sr-only">Information &amp; Authors</span></a></li><li><a href="#core-collateral-metrics" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Metrics &amp; Citations"><i aria-hidden="true" class="icon-timeline"></i><span class="sr-only">Metrics &amp; Citations</span></a></li><li><a href="#core-collateral-fulltext-options" data-id="article-nav-menubar-metrics" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="View Options"><i aria-hidden="true" class="icon-eye"></i><span class="sr-only">View Options</span></a></li><li><a href="#core-collateral-references" data-id="article-nav-menubar-references" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="References"><i aria-hidden="true" class="icon-references"></i><span class="sr-only">References</span></a></li><li><a href="#core-collateral-media" data-id="article-nav-menubar-media" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Media"><i aria-hidden="true" class="icon-photo"></i><span class="sr-only">Media</span></a></li><li><a href="#core-collateral-tables" data-id="article-nav-menubar-tables" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Tables"><i aria-hidden="true" class="icon-tables"></i><span class="sr-only">Tables</span></a></li><li><a href="#core-collateral-share" data-id="article-nav-menubar-share" title="" tabindex="0" data-toggle="tooltip" data-placement="left" data-offset="4px, 16px" data-original-title="Share"><i aria-hidden="true" class="icon-share"></i><span class="sr-only">Share</span></a></li></ul></nav></div></div><div data-core-wrapper="content"><div id="abstracts" data-extent="frontmatter" data-location="articleTab_article"><div class="core-container"><section id="summary-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Abstract</h2><section id="abs-sec-1"><h3>Background</h3><div role="paragraph">The B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified on November 25, 2021, in Gauteng province, South Africa. Data regarding the seroprevalence of SARS-CoV-2 IgG in Gauteng before the fourth wave of coronavirus disease 2019 (Covid-19), in which the omicron variant was dominant, are needed.</div></section><section id="abs-sec-2"><h3>Methods</h3><div role="paragraph">We conducted a seroepidemiologic survey from October 22 to December 9, 2021, in Gauteng to determine the seroprevalence of SARS-CoV-2 IgG. Households included in a previous seroepidemiologic survey (conducted from November 2020 to January 2021) were contacted; to account for changes in the survey population, there was a 10% increase in the households contacted, with the use of the same sampling framework. Dried-blood-spot samples were tested for IgG against SARS-CoV-2 spike protein and nucleocapsid protein with the use of quantitative assays. We also evaluated Covid-19 epidemiologic trends in Gauteng, including cases, hospitalizations, recorded deaths, and excess deaths from the start of the pandemic through January 12, 2022.</div></section><section id="abs-sec-3"><h3>Results</h3><div role="paragraph">Samples were obtained from 7010 participants, of whom 1319 (18.8%) had received a Covid-19 vaccine. The seroprevalence of SARS-CoV-2 IgG ranged from 56.2% (95% confidence interval [CI], 52.6 to 59.7) among children younger than 12 years of age to 79.7% (95% CI, 77.6 to 81.5) among adults older than 50 years of age. Vaccinated participants were more likely to be seropositive for SARS-CoV-2 than unvaccinated participants (93.1% vs. 68.4%). Epidemiologic data showed that the incidence of SARS-CoV-2 infection increased and subsequently declined more rapidly during the fourth wave than it had during the three previous waves. The incidence of infection was decoupled from the incidences of hospitalization, recorded death, and excess death during the fourth wave, as compared with the proportions seen during previous waves.</div></section><section id="abs-sec-4"><h3>Conclusions</h3><div role="paragraph">Widespread underlying SARS-CoV-2 seropositivity was observed in Gauteng before the omicron-dominant wave of Covid-19. Epidemiologic data showed a decoupling of hospitalizations and deaths from infections while omicron was circulating. (Funded by the Bill and Melinda Gates Foundation.)</div></section></section><div class="core-digital-object visual-abstract">
<div class="ng-page_separator pt-24"></div>
<div class="ng-do-media">
    <button data-toggle="modal" data-target="#doPopup" class="ng-do-media_btn" modal-size="lg"></button>
    <div data-ajaxurl="/do/10.1056/NEJMdo006521/full/?ajaxRequest=true" class="ng-do-media_item">
        <div class="ng-do-media_item-left">
            <a href="#" class="ng-do-media_item-img-link" data-interactiontype="multimedia_click" data-multimedia-type="Visual Abstract" data-multimedia-contentid="10.1056/NEJMdo006521" data-multimedia-filename="NEJMdo006521_600x400.jpg">
                <img src="/cms/asset/0cc7fa72-86a5-42f1-861a-fffdf0ce082f/media/NEJMdo006521_300x200.jpg" class="ng-do-media_item-img">
                <span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#tooltip-visual"></use></svg></span>
            </a>
        </div>
        <div class="ng-do-media_item-right">
            <div class="ng-do-media_item-type">
                <a href="/browse/nejm-media-type/visual-abstract" class="ng-do-media_item-type-link">Visual Abstract</a>
            </div>
            <h6 class="ng-do-media_item-title">
                <a href="#" class="ng-do-media_item-title-link" data-interactiontype="multimedia_click" data-multimedia-type="Visual Abstract" data-multimedia-contentid="10.1056/NEJMdo006521" data-multimedia-filename="NEJMdo006521_600x400.jpg">Population Immunity and Covid-19 Severity with Omicron Variant</a>
            </h6>
        </div>
    </div>
</div>

</div></div></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text" data-location="articleTab_article"><div class="core-container"><div role="paragraph">The B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified on November 25, 2021, in Gauteng province, South Africa.<sup><a href="#core-r1" role="doc-biblioref" data-xml-rid="r1" id="body-ref-r1" href-manipulated="true" aria-label="Reference 1">1</a></sup> The World Health Organization designated omicron as a variant of concern because of its predicted high transmissibility and its potential to evade immunity from neutralizing antibodies induced by vaccination or natural infection with wild-type virus.<sup><a href="#core-r2" role="doc-biblioref" data-xml-rid="r2" id="body-ref-r2" href-manipulated="true" aria-label="Reference 2">2</a></sup> The omicron variant contains mutations that indicate that it could be more infectious, more transmissible, and possibly better able to evade innate immunity and neutralizing antibody activity than wild-type virus.<sup><a href="#core-r3" role="doc-biblioref" data-xml-rid="r3 r4 r5" id="body-ref-r5" href-manipulated="true">3-5</a></sup> In addition to having at least 32 mutations affecting the spike protein,<sup><a href="#core-r6" role="doc-biblioref" data-xml-rid="r6" id="body-ref-r6" href-manipulated="true" aria-label="Reference 6">6</a></sup> the omicron variant harbors 3 mutations involving the membrane protein and 6 involving the nucleocapsid protein, whereas the antibody-evasive B.1.351 (beta) variant has only 7 spike-protein mutations and 1 nucleocapsid-protein mutation.<sup><a href="#core-r7" role="doc-biblioref" data-xml-rid="r7" id="body-ref-r7-1" href-manipulated="true" aria-label="Reference 7">7</a></sup></div><div role="paragraph">The omicron variant outcompeted the B.1.617.2 (delta) variant in Gauteng and was responsible for 98.4% of new cases sequenced in South Africa in December 2021.<sup><a href="#core-r8" role="doc-biblioref" data-xml-rid="r8" id="body-ref-r8" href-manipulated="true" aria-label="Reference 8">8</a></sup> This fourth wave of coronavirus disease 2019 (Covid-19) arose in the context of the rollout of Covid-19 vaccines, which began on May 17, 2021, in South Africa. We previously conducted a population-wide seroepidemiologic survey in Gauteng that was completed on January 22, 2021.<sup><a href="#core-r9" role="doc-biblioref" data-xml-rid="r9" id="body-ref-r9-1" href-manipulated="true" aria-label="Reference 9">9</a></sup> We found that 19.1% of the population was seropositive for SARS-CoV-2, as assessed by the detection of IgG against the receptor-binding domain; the seroprevalence ranged from 5% to 43% across provincial subdistricts.<sup><a href="#core-r9" role="doc-biblioref" data-xml-rid="r9" id="body-ref-r9-2" href-manipulated="true" aria-label="Reference 9">9</a></sup> After that survey was completed, South Africa faced a third wave of Covid-19, from approximately April 7 to November 1, that was largely due to the delta variant, which outcompeted the beta variant.<sup><a href="#core-r10" role="doc-biblioref" data-xml-rid="r10" id="body-ref-r10" href-manipulated="true" aria-label="Reference 10">10</a></sup></div><div role="paragraph">We report the results of a follow-up seroepidemiologic survey in Gauteng that was completed on December 9, 2021, and thus provides seroprevalence data largely from before the fourth wave of Covid-19. Furthermore, we report data regarding Covid-19 epidemiologic trends in Gauteng, including cases, hospitalizations, recorded deaths, and excess deaths from the start of the pandemic through January 12, 2022.</div><section id="sec-1" data-type="methods"><h2>Methods</h2><section id="sec-1-1"><h3>Study Setting</h3><div role="paragraph">Gauteng is divided into five health districts (Johannesburg, Ekurhuleni, Sedibeng, Tshwane, and West Rand) that comprise 26 subdistricts.<sup><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11" id="body-ref-r11-1" href-manipulated="true" aria-label="Reference 11">11</a></sup> Gauteng constitutes 1.5% of the landmass in South Africa but contains 26% of the population (15.5 of 59.6 million persons).<sup><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11" id="body-ref-r11-2" href-manipulated="true" aria-label="Reference 11">11</a></sup> The overall population density in Gauteng is 737 persons per square kilometer, with the value ranging from 3400 in Johannesburg, where 36.9% of the population lives, to 200 in West Rand, where 6.2% of the population lives (Table S1 in the <a href="#ap1">Supplementary Appendix</a>, available with the full text of this article at NEJM.org).</div></section><section id="sec-1-2"><h3>Study Survey</h3><div role="paragraph">This survey included the same households that were sampled during our previous survey, which was undertaken from November 4, 2020, to January 22, 2021.<sup><a href="#core-r9" role="doc-biblioref" data-xml-rid="r9" id="body-ref-r9-3" href-manipulated="true" aria-label="Reference 9">9</a></sup> The previous survey was started 9 weeks after the onset of the second wave of Covid-19 in Gauteng, which was dominated by the beta variant. Details regarding the previous survey, including the sampling framework used, have been published<sup><a href="#core-r9" role="doc-biblioref" data-xml-rid="r9" id="body-ref-r9-4" href-manipulated="true" aria-label="Reference 9">9</a></sup> and are summarized in the Supplementary Methods section of the <a href="#ap1">Supplementary Appendix</a>.</div><div role="paragraph">This survey was conducted from October 22 to December 9, 2021. To account for possible nonparticipation, out-migration, and death since the previous survey, there was a 10% increase in the households that were sampled; the additional households were sampled in the same clusters used previously. The survey was powered to evaluate seropositivity for SARS-CoV-2 at the district and subdistrict levels. Demographic and epidemiologic data were collected with the use of an electronic questionnaire.<sup><a href="#core-r9" role="doc-biblioref" data-xml-rid="r9" id="body-ref-r9-5" href-manipulated="true" aria-label="Reference 9">9</a></sup> Details regarding the questionnaire are provided in the <a href="#ap1">Supplementary Appendix</a>.</div><div role="paragraph">The Human Research Ethics Committee at the University of the Witwatersrand granted a waiver for ethics approval of the survey, which was performed at the behest of the Gauteng Department of Health as part of public health surveillance. Nevertheless, all participants provided written informed consent; those who were approached to participate were free to decline participation. The authors designed the study, collected and analyzed the data, and vouch for the completeness and accuracy of the data and the fidelity of the study to the protocol. The authors wrote the manuscript; no one who is not an author contributed to the writing of the manuscript.</div></section><section id="sec-1-3"><h3>Serologic Analysis</h3><div role="paragraph">Dried-blood-spot samples were obtained from participants and tested for IgG against SARS-CoV-2 spike protein and nucleocapsid protein with the use of quantitative assays on the Luminex platform. Anti-nucleocapsid IgG was included to identify persons who were seropositive from natural infection rather than vaccination. Details regarding the serologic assays have been published<sup><a href="#core-r12" role="doc-biblioref" data-xml-rid="r12 r13" id="body-ref-r13" href-manipulated="true">12,13</a></sup> and are summarized in the <a href="#ap1">Supplementary Appendix</a>.</div></section><section id="sec-1-4"><h3>Covid-19 Data Sources</h3><div role="paragraph">Data regarding daily cases, hospitalizations, and recorded deaths were sourced from the South African National Institute for Communicable Diseases daily databases, including the DATCOV database, through January 12, 2022.<sup><a href="#core-r14" role="doc-biblioref" data-xml-rid="r14 r15" id="body-ref-r15" href-manipulated="true">14,15</a></sup> Data regarding weekly excess deaths attributable to Covid-19 were defined by and sourced from the South African Medical Research Council through January 8, 2022.<sup><a href="#core-r16" role="doc-biblioref" data-xml-rid="r16" id="body-ref-r16-1" href-manipulated="true" aria-label="Reference 16">16</a></sup> We analyzed these epidemiologic data for Gauteng and its five health districts, both overall and with stratification according to age group and sex when granular data were available.</div><div role="paragraph">Cases included asymptomatic and symptomatic infections with SARS-CoV-2 confirmed by either a nucleic acid amplification assay or a rapid antigen test. Hospitalizations included admissions for SARS-CoV-2 infection, as well as admissions for other illnesses in which SARS-CoV-2 infection was incidentally identified on routine screening at the time of admission. Definitions of recorded death and excess death attributable to Covid-19 are provided in the <a href="#ap1">Supplementary Appendix</a>.</div></section><section id="sec-1-5"><h3>Statistical Analysis</h3><div role="paragraph">The sample-size justification and the methods for repeated random sampling of households that were used in our previous survey have been published<sup><a href="#core-r9" role="doc-biblioref" data-xml-rid="r9" id="body-ref-r9-6" href-manipulated="true" aria-label="Reference 9">9</a></sup> and are summarized in the <a href="#ap1">Supplementary Appendix</a>, together with the methods for analyses of associations with seropositivity, which were performed with the use of generalized linear models with log link to estimate risk ratios. These were unadjusted, univariable analyses for each risk factor. Data regarding daily cases, hospitalizations, and recorded deaths and weekly excess deaths were converted to incidences with the use of population denominators from Statistics South Africa mid-2020 projections for South Africa and its provinces.<sup><a href="#core-r11" role="doc-biblioref" data-xml-rid="r11" id="body-ref-r11-3" href-manipulated="true" aria-label="Reference 11">11</a></sup></div></section></section><section id="sec-2" data-type="results"><h2>Results</h2><section id="sec-2-1"><h3>Participants</h3><div role="paragraph">We obtained samples that were adequate for serostatus evaluation from 7010 of 7498 participants from 3047 households (<a href="#f1">Figure 1</a>); 83% of the samples had been obtained by November 25, 2021, when the omicron variant was first identified (Fig. S1). Demographic and household characteristics, known underlying medical conditions and participant-reported human immunodeficiency virus status, and vaccination status of the survey participants are shown in <a href="#t1">Table 1</a>. The degree to which the survey population was representative of the general population of Gauteng and of South Africa is described in Table S2. Vaccination in Gauteng according to district, age, and vaccine is summarized in Table S3. As of November 25, 2021, of the total population of 12,191,569 persons 12 years of age or older (who were eligible for vaccination), 4,386,646 (36.0%) had received at least one dose of BNT162b2 or Ad26.COV2.S, and 2,452,017 (20.1%) had received two doses. Of the 2,416,045 persons older than 50 years of age, 1,074,303 (44.5%) had received two doses of BNT162b2.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 1</div><nav><a href="#f1" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119658_f1.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f1" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119658_f1.jpg"><img src="/cms/10.1056/NEJMoa2119658/asset/4ef19b00-4065-4054-a454-07c112cf4901/assets/images/large/nejmoa2119658_f1.jpg" height="2465" width="1656" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Survey Participants.</div><div class="notes"><div role="doc-footnote">This survey (conducted from October 22 to December 9, 2021) included the same households that were sampled during our previous survey (conducted from November 4, 2020, to January 22, 2021).<sup><a href="#core-r9" role="doc-biblioref" data-xml-rid="r9" id="body-ref-r9-7" href-manipulated="true" aria-label="Reference 9">9</a></sup> To account for possible nonparticipation, out-migration, and death since the previous survey, there was a 10% increase in the households that were sampled; the additional households were sampled in the same clusters used previously.</div></div></figcaption></figure></div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Table 1</div><nav><a href="#t1" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119658_t1.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="t1" class="table"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#t1" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119658_t1.jpg"><img src="/cms/10.1056/NEJMoa2119658/asset/3bf78d71-c370-4922-84f3-7faff734fcf9/assets/images/large/nejmoa2119658_t1.jpg" height="3438" width="1334" loading="lazy"></a></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Variable</th><th class="txxx-borders">Overall</th><th class="txxx-borders" colspan="2"><span>Seroprevalence</span></th><th class="txxr-borders">Association with Seropositivity<a href="#t1fn2" role="doc-noteref">â </a></th></tr><tr class="head3" data-type="row head3" data-xml-valign="top"><td class="xxlx-borders hanging03">&nbsp;</td><th class="xxxx-borders">no. (%)</th><th class="xxxx-borders">no.</th><th class="xxxx-borders">% (95% CI)</th><th class="xxxr-borders">risk ratio (95% CI)</th></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging03 shading" data-xml-align="left">All participants<a href="#t1fn3" role="doc-noteref">â¡</a></td><td class="xxxx-borders shading">7010 (100)</td><td class="xxxx-borders shading">5123</td><td class="xxxx-borders shading">73.1 (72.0â74.1)</td><td class="xxxr-borders shading">â</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Sex</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Male</td><td class="xxxx-borders shading">2941 (42.0)</td><td class="xxxx-borders shading">1998</td><td class="xxxx-borders shading">67.9 (66.2â69.6)</td><td class="xxxr-borders shading">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Female</td><td class="xxxx-borders">4065 (58.0)</td><td class="xxxx-borders">3125</td><td class="xxxx-borders">76.9 (75.5â78.1)</td><td class="xxxr-borders">1.13 (1.10â1.17)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Not reported</td><td class="xxxx-borders shading">4 (&lt;0.1)</td><td class="xxxx-borders shading">â</td><td class="xxxx-borders shading">â</td><td class="xxxr-borders shading">â</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Age group<a href="#t1fn4" role="doc-noteref">Â§</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">&lt;12 yr</td><td class="xxxx-borders shading">753 (10.7)</td><td class="xxxx-borders shading">423</td><td class="xxxx-borders shading">56.2 (52.6â59.7)</td><td class="xxxr-borders shading">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">12 to 17 yr</td><td class="xxxx-borders">622 (8.9)</td><td class="xxxx-borders">459</td><td class="xxxx-borders">73.8 (70.2â77.1)</td><td class="xxxr-borders">1.31 (1.21â1.42)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">18 to 50 yr</td><td class="xxxx-borders shading">4047 (57.7)</td><td class="xxxx-borders shading">2977</td><td class="xxxx-borders shading">73.6 (72.2â74.9)</td><td class="xxxr-borders shading">1.30 (1.23â1.40)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">&gt;50 yr</td><td class="xxxx-borders">1588 (22.7)</td><td class="xxxx-borders">1264</td><td class="xxxx-borders">79.7 (77.6â81.5)</td><td class="xxxr-borders">1.42 (1.32â1.52)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">Vaccination status<a href="#t1fn4" role="doc-noteref">Â§</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Unvaccinated</td><td class="xxxx-borders">5691 (81.2)</td><td class="xxxx-borders">3895</td><td class="xxxx-borders">68.4 (67.2â69.6)</td><td class="xxxr-borders">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Vaccinated</td><td class="xxxx-borders shading">1319 (18.8)</td><td class="xxxx-borders shading">1228</td><td class="xxxx-borders shading">93.1 (91.6â94.3)</td><td class="xxxr-borders shading">1.36 (1.33â1.39)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Vaccination status according to age group<a href="#t1fn4" role="doc-noteref">Â§</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging13 shading">Unvaccinated</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23" data-xml-align="left">&lt;12 yr</td><td class="xxxx-borders">753 (10.7)</td><td class="xxxx-borders">423</td><td class="xxxx-borders">55.8 (52.2â59.4)</td><td class="xxxr-borders">0.81 (0.76â0.86)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23 shading" data-xml-align="left">12 to 17 yr</td><td class="xxxx-borders shading">603 (8.6)</td><td class="xxxx-borders shading">443</td><td class="xxxx-borders shading">73.5 (69.8â76.8)</td><td class="xxxr-borders shading">1.06 (1.00â1.11)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23" data-xml-align="left">18 to 50 yr</td><td class="xxxx-borders">3356 (47.9)</td><td class="xxxx-borders">2334</td><td class="xxxx-borders">69.5 (68.0â71.1)</td><td class="xxxr-borders">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23 shading" data-xml-align="left">&gt;50 yr</td><td class="xxxx-borders shading">979 (14.0)</td><td class="xxxx-borders shading">695</td><td class="xxxx-borders shading">71.0 (68.1â73.7)</td><td class="xxxr-borders shading">1.02 (0.97â1.07)</td></tr><tr data-type="row"><td class="xxlx-borders hanging13">Vaccinated</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23 shading" data-xml-align="left">&lt;12 yr</td><td class="xxxx-borders shading">0</td><td class="xxxx-borders shading">0</td><td class="xxxx-borders shading">â</td><td class="xxxr-borders shading">â</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23" data-xml-align="left">12 to 17 yr</td><td class="xxxx-borders">19 (0.3)</td><td class="xxxx-borders">16</td><td class="xxxx-borders">84.2 (60.8â94.8)</td><td class="xxxr-borders">1.21 (1.00â1.47)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23 shading" data-xml-align="left">18 to 50 yr</td><td class="xxxx-borders shading">691 (9.9)</td><td class="xxxx-borders shading">643</td><td class="xxxx-borders shading">93.1 (90.9â94.7)</td><td class="xxxr-borders shading">1.33 (1.30â1.38)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23" data-xml-align="left">&gt;50 yr</td><td class="xxxx-borders">609 (8.7)</td><td class="xxxx-borders">569</td><td class="xxxx-borders">93.4 (91.2â95.1)</td><td class="xxxr-borders">1.34 (1.30â1.39)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">Previous Covid-19 testing</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Never tested</td><td class="xxxx-borders">5956 (85.0)</td><td class="xxxx-borders">4271</td><td class="xxxx-borders">71.7 (70.6â72.8)</td><td class="xxxr-borders">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Tested positive</td><td class="xxxx-borders shading">195 (2.8)</td><td class="xxxx-borders shading">172</td><td class="xxxx-borders shading">88.2 (82.9â92.0)</td><td class="xxxr-borders shading">1.23 (1.17â1.30)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Tested negative</td><td class="xxxx-borders">859 (12.3)</td><td class="xxxx-borders">680</td><td class="xxxx-borders">79.3 (76.3â81.8)</td><td class="xxxr-borders">1.10 (1.06â1.15)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging03 shading" data-xml-align="left">Household members per room<a href="#t1fn5" role="doc-noteref">Â¶</a></td><td class="xxxx-borders shading">1 (0.5â1.5)</td><td class="xxxx-borders shading">â</td><td class="xxxx-borders shading">â</td><td class="xxxr-borders shading">1.01 (1.00â1.02)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Occupation</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Unemployed</td><td class="xxxx-borders shading">4102 (58.5)</td><td class="xxxx-borders shading">3014</td><td class="xxxx-borders shading">73.5 (72.1â74.8)</td><td class="xxxr-borders shading">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Production</td><td class="xxxx-borders">381 (5.4)</td><td class="xxxx-borders">279</td><td class="xxxx-borders">73.2 (68.6â77.4)</td><td class="xxxr-borders">1.00 (0.94â1.06)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Education, public transportation, or retail</td><td class="xxxx-borders shading">661 (9.4)</td><td class="xxxx-borders shading">509</td><td class="xxxx-borders shading">77.0 (73.6â80.1)</td><td class="xxxr-borders shading">1.05 (1.00â1.10)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Health care</td><td class="xxxx-borders">73 (1.0)</td><td class="xxxx-borders">63</td><td class="xxxx-borders">86.3 (76.4â92.5)</td><td class="xxxr-borders">1.17 (1.07â1.29)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Office work or other</td><td class="xxxx-borders shading">353 (5.0)</td><td class="xxxx-borders shading">277</td><td class="xxxx-borders shading">78.5 (73.9â82.4)</td><td class="xxxr-borders shading">1.06 (1.01â1.13)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Student</td><td class="xxxx-borders">1440 (20.5)</td><td class="xxxx-borders">981</td><td class="xxxx-borders">68.1 (65.7â70.5)</td><td class="xxxr-borders">0.93 (0.89â0.96)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">Smoking status<a href="#t1fn6" role="doc-noteref">â</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">None</td><td class="xxxx-borders">4168 (59.5)</td><td class="xxxx-borders">3234</td><td class="xxxx-borders">77.6 (76.3â78.8)</td><td class="xxxr-borders">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Daily</td><td class="xxxx-borders shading">1125 (16.1)</td><td class="xxxx-borders shading">748</td><td class="xxxx-borders shading">66.5 (63.7â69.2)</td><td class="xxxr-borders shading">0.86 (0.82â0.90)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Once or twice a week</td><td class="xxxx-borders">244 (3.5)</td><td class="xxxx-borders">181</td><td class="xxxx-borders">74.2 (68.3â79.3)</td><td class="xxxr-borders">0.96 (0.89â1.03)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Occasionally</td><td class="xxxx-borders shading">203 (2.9)</td><td class="xxxx-borders shading">157</td><td class="xxxx-borders shading">77.3 (71.1â82.6)</td><td class="xxxr-borders shading">1.00 (0.92â1.08)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Coexisting conditions</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">None</td><td class="xxxx-borders shading">4731 (67.5)</td><td class="xxxx-borders shading">3507</td><td class="xxxx-borders shading">74.1 (72.9â75.4)</td><td class="xxxr-borders shading">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">â¥1</td><td class="xxxx-borders">2279 (32.5)</td><td class="xxxx-borders">1616</td><td class="xxxx-borders">70.9 (69.0â72.7)</td><td class="xxxr-borders">0.96 (0.93â0.99)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">HIV status</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Negative</td><td class="xxxx-borders">6460 (92.2)</td><td class="xxxx-borders">4727</td><td class="xxxx-borders">73.2 (72.1â74.2)</td><td class="xxxr-borders">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Positive</td><td class="xxxx-borders shading">550 (7.8)</td><td class="xxxx-borders shading">396</td><td class="xxxx-borders shading">72.0 (68.1â75.6)</td><td class="xxxr-borders shading">0.98 (0.93â1.04)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Dwelling type<a href="#t1fn7" role="doc-noteref">**</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Formal standalone house</td><td class="xxxx-borders shading">4700 (67.0)</td><td class="xxxx-borders shading">3488</td><td class="xxxx-borders shading">74.2 (72.9â75.4)</td><td class="xxxr-borders shading">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Informal settlement</td><td class="xxxx-borders">1147 (16.4)</td><td class="xxxx-borders">761</td><td class="xxxx-borders">66.3 (63.6â69.0)</td><td class="xxxr-borders">0.89 (0.86â0.93)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Block of flats or high-rise building</td><td class="xxxx-borders shading">423 (6.0)</td><td class="xxxx-borders shading">329</td><td class="xxxx-borders shading">77.8 (73.6â81.5)</td><td class="xxxr-borders shading">1.05 (0.99â1.11)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Subsidized low-income housing</td><td class="xxxx-borders">666 (9.5)</td><td class="xxxx-borders">494</td><td class="xxxx-borders">74.3 (70.8â77.4)</td><td class="xxxr-borders">1.00 (0.95â1.05)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Other</td><td class="xxxx-borders shading">74 (1.1)</td><td class="xxxx-borders shading">51</td><td class="xxxx-borders shading">68.9 (57.5â78.4)</td><td class="xxxr-borders shading">0.93 (0.80â1.08)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">District</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Johannesburg</td><td class="xxxx-borders shading">2468 (35.2)</td><td class="xxxx-borders shading">1880</td><td class="xxxx-borders shading">76.2 (74.5â77.8)</td><td class="xxxr-borders shading">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Ekurhuleni</td><td class="xxxx-borders">1861 (26.5)</td><td class="xxxx-borders">1382</td><td class="xxxx-borders">74.3 (72.2â76.2)</td><td class="xxxr-borders">0.97 (0.94â1.01)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Sedibeng</td><td class="xxxx-borders shading">564 (8.0)</td><td class="xxxx-borders shading">397</td><td class="xxxx-borders shading">70.4 (66.5â74.0)</td><td class="xxxr-borders shading">0.92 (0.87â0.98)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Tshwane</td><td class="xxxx-borders">1464 (20.9)</td><td class="xxxx-borders">975</td><td class="xxxx-borders">66.7 (54.2â69.0)</td><td class="xxxr-borders">0.87 (0.84â0.91)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging13 shading" data-xml-align="left">West Rand</td><td class="xbxx-borders shading">653 (9.3)</td><td class="xbxx-borders shading">489</td><td class="xbxx-borders shading">74.9 (71.4â78.1)</td><td class="xbxr-borders shading">0.98 (0.94â1.03)</td></tr></tbody></table></div><figcaption><div class="caption">Seroprevalence of IgG against SARS-CoV-2 Spike Protein or Nucleocapsid Protein in Gauteng, South Africa, from October 22 to December 9, 2021, and Risk Factors for Seropositivity.<a href="#t1fn1" role="doc-noteref">*</a></div><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="t1fn1" role="paragraph">Covid-19 denotes coronavirus disease 2019, HIV human immunodeficiency virus, and SARS-CoV-2 severe acute respiratory syndrome coronavirus 2.</div></div><div role="doc-footnote" data-has="label"><div class="label">â </div><div id="t1fn2" role="paragraph">Analyses of associations with seropositivity for SARS-CoV-2 were performed with the use of generalized linear models with log link to estimate risk ratios. These were unadjusted, univariable analyses for each risk factor. Confidence intervals were not adjusted for multiplicity and should not be used for inference.</div></div><div role="doc-footnote" data-has="label"><div class="label">â¡</div><div id="t1fn3" role="paragraph">Two participants had serologic test results that could not be linked to the main questionnaire and were excluded from the analyses.</div></div><div role="doc-footnote" data-has="label"><div class="label">Â§</div><div id="t1fn4" role="paragraph">Age group and vaccination status were not included in the regression model; instead, an interaction term between age group and vaccination status was introduced to account for the differences in seroprevalence according to vaccination status across age groups. Vaccination status was obtained from vaccination certificates for 1026 of the 1327 participants (77.3%) who reported being vaccinated.</div></div><div role="doc-footnote" data-has="label"><div class="label">Â¶</div><div id="t1fn5" role="paragraph">The median and interquartile range are shown, rather than the number and percentage. The risk ratio shows the increase in the risk of seropositivity with one additional household member per room (i.e., for every additional household member, there is a 1.01 increase in risk).</div></div><div role="doc-footnote" data-has="label"><div class="label">â</div><div id="t1fn6" role="paragraph">Smoking status was assessed only in the 5740 participants who were 18 years of age or older.</div></div><div role="doc-footnote" data-has="label"><div class="label">**</div><div id="t1fn7" role="paragraph">Dwelling types were defined in accordance with the national census classification.</div></div></div></figcaption></figure></div></section><section id="sec-2-2"><h3>Seroprevalence</h3><div role="paragraph">Among unvaccinated participants, the overall prevalence of anti-spike or anti-nucleocapsid IgG seropositivity was 68.4% (95% confidence interval [CI], 67.2 to 69.6), whereas the prevalence of anti-nucleocapsid IgG seropositivity was 39.7% (95% CI, 38.4 to 41.0), a finding that indicates a lack of sensitivity of anti-nucleocapsid IgG for the detection of previous infection. We thus focused on the overall prevalence of anti-spike or anti-nucleocapsid IgG seropositivity.</div><div role="paragraph">Among all participants, the overall seroprevalence was 73.1% (95% CI, 72.0 to 74.1) (<a href="#t1">Table 1</a>). The seroprevalence was heterogeneous across provincial districts, ranging from 66.7% (95% CI, 54.2 to 69.0) in Tshwane, where the omicron variant was first identified, to 76.2% (95% CI, 74.5 to 77.8) in Johannesburg (Fig. S2). In addition, the seroprevalence was heterogeneous across subdistricts, ranging from 72.7% to 85.8% within Johannesburg and from 58.9% to 77.4% within Tshwane (Table S4).</div><div role="paragraph">Female participants were more likely to be seropositive than male participants (76.9% vs. 67.9%; risk ratio, 1.13; 95% CI, 1.10 to 1.17). The seroprevalence varied according to age group; it was lowest among children younger than 12 years of age (56.2%) and highest among adults older than 50 years of age (79.7%). Children 12 to 17 years of age were more likely to be seropositive than children younger than 12 years of age (73.8% vs. 56.2%; risk ratio, 1.31; 95% CI, 1.21 to 1.42). Participants who had received a Covid-19 vaccine were more likely to be seropositive than unvaccinated participants (93.1% vs. 68.4%; risk ratio, 1.36; 95% CI, 1.33 to 1.39). Among vaccinated participants, the seroprevalence was consistently high across age groups; among adults 18 to 50 years of age, those who were vaccinated had a higher seroprevalence than those who were unvaccinated.</div><div role="paragraph">Participants who had previously tested positive for SARS-CoV-2 infection were more likely to be seropositive than participants who had never been tested (88.2% vs. 71.7%; risk ratio, 1.23; 95% CI, 1.17 to 1.30). Participants living in an informal settlement had a lower seroprevalence than participants living in a standalone house (66.3% vs. 74.2%; risk ratio, 0.89; 95% CI, 0.86 to 0.93). Daily smoking was associated with a lower seroprevalence than was not smoking (66.5% vs. 77.6%; risk ratio, 0.86; 95% CI, 0.82 to 0.90).</div></section><section id="sec-2-3"><h3>Covid-19 Trends</h3><div role="paragraph">Daily cases, weekly hospitalizations, daily recorded deaths, and weekly excess deaths attributable to Covid-19 in Gauteng are shown in <a href="#f2">Figure 2</a>. Daily cases, hospitalizations, and recorded deaths are also shown with stratification according to age group (<a href="#f3">Figure 3</a>) and according to sex (Fig. S3).</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 2</div><nav><a href="#f2" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119658_f2.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f2" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f2" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119658_f2.jpg"><img src="/cms/10.1056/NEJMoa2119658/asset/efd94502-396c-4de6-ada2-108a741770fd/assets/images/large/nejmoa2119658_f2.jpg" height="2000" width="2640" aria-labelledby="f2" loading="lazy"></a><figcaption><div class="caption">Cases, Hospitalizations, Recorded Deaths, and Excess Deaths Attributable to Covid-19 in Gauteng, South Africa, from the Start of the Pandemic through January 12, 2022.</div><div class="notes"><div role="doc-footnote">Shown are incidences of daily cases, weekly hospitalizations, daily recorded deaths, and weekly excess deaths attributable to coronavirus disease 2019 (Covid-19). The inset shows the incidence of daily recorded deaths on an enlarged y axis. The horizontal dashed line indicates an incidence of zero. The data were sourced from the National Institute for Communicable Diseases daily databases through January 12, 2022, except for the data regarding weekly excess deaths attributable to Covid-19, which were defined by and sourced from the South African Medical Research Council through January 8, 2022.<sup><a href="#core-r16" role="doc-biblioref" data-xml-rid="r16" id="body-ref-r16-2" href-manipulated="true" aria-label="Reference 16">16</a></sup> The B.1.1.529 (omicron) variant was first identified on November 25, 2021. Cases included asymptomatic and symptomatic infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confirmed by either a nucleic acid amplification assay or a rapid antigen test. Changes in the frequency of testing limit direct comparisons of case numbers; in particular, the lower frequency of testing during the first wave, which was due to constraints in laboratory capacity and prioritization of testing for hospitalized persons, prevents the direct comparison of cases from the first wave with those from subsequent waves. Hospitalizations included admissions for SARS-CoV-2 infection, as well as admissions for other illnesses in which SARS-CoV-2 infection was incidentally identified on routine screening at the time of admission. The DATCOV system was developed during the first wave, with gradual onboarding of facilities; thus, hospitalizations from the first wave may be underestimated. Definitions of recorded death and excess death attributable to Covid-19 are provided in the <a href="#ap1">Supplementary Appendix</a>.</div></div></figcaption></figure></div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Figure 3</div><nav><a href="#f3" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119658_f3.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="f3" class="graphic"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#f3" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119658_f3.jpg"><img src="/cms/10.1056/NEJMoa2119658/asset/09301c66-3bac-4e1c-a405-b2e7e9aa81ea/assets/images/large/nejmoa2119658_f3.jpg" height="1963" width="2640" aria-labelledby="f3" loading="lazy"></a><figcaption><div class="caption">Covid-19 Cases, Hospitalizations, and Recorded Deaths in Gauteng, South Africa, According to Age Group.</div><div class="notes"><div role="doc-footnote">Shown are 7-day moving averages of the incidences of daily cases, hospitalizations, and recorded deaths among participants 4 years of age or younger (Panel A), 5 to 17 years of age (Panel B), 18 to 44 years of age (Panel C), 45 to 59 years of age (Panel D), and 60 years of age or older (Panel E). The horizontal dashed line indicates an incidence of zero. Because the incidences differ across age groups, different y-axis scales are used for each age group to provide clarity and aid in the visual interpretation of the trends in each group.</div></div></figcaption></figure></div><div role="paragraph">During the fourth wave of Covid-19, in which the omicron variant was dominant, the daily case incidence increased more rapidly and also appeared to be decreasing more quickly than it had during the three previous waves (<a href="#f2">Figure 2</a>). The time from the onset to the peak of the wave was 1 month in the fourth wave, as compared with 2 months in the third wave. As of January 12, 2022, the case incidence had not yet fully returned to the level before the onset of the fourth wave, but the wave was nearing its end, on the basis of the trajectory shown in <a href="#f2">Figure 2</a>. At that time, there were almost no recorded or excess deaths attributable to Covid-19 per 100,000 population.</div><div role="paragraph">The number of documented Covid-19 cases in the fourth wave (226,932) was higher than that in the second wave (182,564) and lower than that in the third wave (511,638), whereas the incidences of hospitalization, recorded death, and excess death attributable to Covid-19 in the fourth wave were consistently lower than the incidences in earlier waves (<a href="#t2">Table 2</a>). In addition, the peak incidences of hospitalization, recorded death, and excess death in the fourth wave were lower than the peak incidences in previous waves. The fourth wave contributed 11.2%, 3.9%, and 3.3% of overall hospitalizations, recorded deaths, and excess deaths due to Covid-19, respectively, whereas the third wave, in which the delta variant was dominant, contributed 43.6%, 49.3%, and 52.7%. Similar trends were observed across all districts (Fig. S4). Although there is a lag in the reporting of weekly excess deaths, the incidence in the fourth wave as of January 8, 2022 (12 per 100,000 population), was lower than the incidence in the third wave (197 per 100,000 population). As of January 12, 2022, incidences were on an ongoing downward trajectory, with a 7-day moving average of 7.28 cases, 0.96 hospitalizations, and 0.11 recorded deaths per 100,000 population â a decrease by a factor of 9.3, 3.3, and 2.4 from the peak incidence of 67.56 cases, 3.18 hospitalizations, and 0.26 recorded deaths per 100,000 population, respectively. The incidences were nearing prewave levels (as of October 25, 2021) of 0.46 cases, 0.15 hospitalizations, and 0.04 recorded deaths per 100,000 population.</div><div class="figure-wrap" data-presentation="diminished-in-flow"><header><div class="label">Table 2</div><nav><a href="#t2" title="Open in viewer" class="open-in-viewer" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119658_t2.jpg"><i aria-hidden="true" class="icon-expand"></i></a></nav></header><figure id="t2" class="table"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><a aria-label="Open figure in viewer" class="open-in-viewer" data-index="0" href="#t2" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119658_t2.jpg"><img src="/cms/10.1056/NEJMoa2119658/asset/015ce533-697b-4212-9351-adfb2b58443d/assets/images/large/nejmoa2119658_t2.jpg" height="2389" width="1711" loading="lazy"></a></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Outcome</th><th class="txxx-borders">Wave 1, Wild-Type</th><th class="txxx-borders">Wave 2, Beta</th><th class="txxx-borders">Wave 3, Delta</th><th class="txxx-borders">Wave 4, Omicron</th><th class="txxr-borders">Total</th></tr></thead><tbody><tr data-type="row"><td class="xxlx-borders hanging01 shading"><b>Cases<a href="#t2fn2" role="doc-noteref">â </a></b></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left">Period of wave</td><td class="xxxx-borders">March 7â Nov. 13, 2020</td><td class="xxxx-borders">Nov. 14, 2020â March 30, 2021</td><td class="xxxx-borders">March 31â Oct. 25, 2021</td><td class="xxxx-borders">Oct. 26, 2021â Jan. 12, 2022</td><td class="xxxr-borders">March 7, 2020â Jan. 12, 2022</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">No.</td><td class="xxxx-borders shading">232,130</td><td class="xxxx-borders shading">182,564</td><td class="xxxx-borders shading">511,638</td><td class="xxxx-borders shading">226,932</td><td class="xxxr-borders shading">1,153,264</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left">No. per 100,000 population</td><td class="xxxx-borders">1498</td><td class="xxxx-borders">1178</td><td class="xxxx-borders">3301</td><td class="xxxx-borders">1464</td><td class="xxxr-borders">7440</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">Percent of total</td><td class="xxxx-borders shading">20.1</td><td class="xxxx-borders shading">15.8</td><td class="xxxx-borders shading">44.4</td><td class="xxxx-borders shading">19.7</td><td class="xxxr-borders shading">100</td></tr><tr data-type="row"><td class="xxlx-borders hanging01"><b>Hospitalizations<a href="#t2fn3" role="doc-noteref">â¡</a></b></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">Period of wave</td><td class="xxxx-borders shading">March 7â Nov. 6, 2020</td><td class="xxxx-borders shading">Nov. 7, 2020â April 6, 2021</td><td class="xxxx-borders shading">April 7â Oct. 31, 2021</td><td class="xxxx-borders shading">Nov. 1, 2021â Jan. 12, 2022</td><td class="xxxr-borders shading">March 7, 2020â Jan. 12, 2022</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left">No.</td><td class="xxxx-borders">33,315</td><td class="xxxx-borders">30,685</td><td class="xxxx-borders">61,642</td><td class="xxxx-borders">15,789</td><td class="xxxr-borders">141,431</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">No. per 100,000 population</td><td class="xxxx-borders shading">215</td><td class="xxxx-borders shading">198</td><td class="xxxx-borders shading">398</td><td class="xxxx-borders shading">102</td><td class="xxxr-borders shading">912</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left">Percent of total</td><td class="xxxx-borders">23.6</td><td class="xxxx-borders">21.7</td><td class="xxxx-borders">43.6</td><td class="xxxx-borders">11.2</td><td class="xxxr-borders">100</td></tr><tr data-type="row"><td class="xxlx-borders hanging01 shading"><b>Recorded deaths<a href="#t2fn4" role="doc-noteref">Â§</a></b></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left">Period of wave</td><td class="xxxx-borders">March 31â Dec. 14, 2020</td><td class="xxxx-borders">Dec. 15, 2020â May 2, 2021</td><td class="xxxx-borders">May 3â Nov. 19, 2021</td><td class="xxxx-borders">Nov. 20, 2021â Jan. 12, 2022</td><td class="xxxr-borders">March 31, 2020â Jan. 12, 2022</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">No.</td><td class="xxxx-borders shading">6443</td><td class="xxxx-borders shading">7084</td><td class="xxxx-borders shading">14,256</td><td class="xxxx-borders shading">1116</td><td class="xxxr-borders shading">28,899</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left">No. per 100,000 population</td><td class="xxxx-borders">42</td><td class="xxxx-borders">46</td><td class="xxxx-borders">92</td><td class="xxxx-borders">7</td><td class="xxxr-borders">186</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">Percent of total</td><td class="xxxx-borders shading">22.3</td><td class="xxxx-borders shading">24.5</td><td class="xxxx-borders shading">49.3</td><td class="xxxx-borders shading">3.9</td><td class="xxxr-borders shading">100</td></tr><tr data-type="row"><td class="xxlx-borders hanging01"><b>Excess deaths<a href="#t2fn4" role="doc-noteref">Â§</a></b></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">Period of wave</td><td class="xxxx-borders shading">May 9â Dec. 19, 2020</td><td class="xxxx-borders shading">Dec. 20, 2020â March 26, 2021</td><td class="xxxx-borders shading">March 27â Nov. 25, 2021</td><td class="xxxx-borders shading">Nov. 26, 2021â Jan. 8, 2022</td><td class="xxxr-borders shading">May 9, 2020â Jan. 8, 2022</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left">No.</td><td class="xxxx-borders">13,476</td><td class="xxxx-borders">11,970</td><td class="xxxx-borders">30,546</td><td class="xxxx-borders">1,927</td><td class="xxxr-borders">57,919</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">No. per 100,000 population</td><td class="xxxx-borders shading">87</td><td class="xxxx-borders shading">77</td><td class="xxxx-borders shading">197</td><td class="xxxx-borders shading">12</td><td class="xxxr-borders shading">374</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging01" data-xml-align="left">Percent of total</td><td class="xbxx-borders">23.3</td><td class="xbxx-borders">20.7</td><td class="xbxx-borders">52.7</td><td class="xbxx-borders">3.3</td><td class="xbxr-borders">100</td></tr></tbody></table></div><figcaption><div class="caption">Cumulative Reported Cases, Hospitalizations, Recorded Deaths, and Excess Deaths Attributable to Covid-19 in Gauteng, South Africa, According to Covid-19 Wave.<a href="#t2fn1" role="doc-noteref">*</a></div><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="t2fn1" role="paragraph">Data are shown for the first wave of Covid-19, dominated by wild-type virus; the second wave, dominated by the B.1.351 (beta) variant; the third wave, dominated by the B.1.617.2 (delta) variant; and the fourth wave, dominated by the B.1.1.529 (omicron) variant. The data were sourced from the National Institute for Communicable Diseases daily databases through January 12, 2022, except for the data regarding weekly excess deaths attributable to Covid-19, which were defined by and sourced from the South African Medical Research Council through January 8, 2022.<sup><a href="#core-r16" role="doc-biblioref" data-xml-rid="r16" id="body-ref-r16-3" href-manipulated="true" aria-label="Reference 16">16</a></sup> As compared with the reporting of cases, there was a lag in the reporting of hospitalizations, recorded deaths, and excess deaths; thus, each of these outcomes has a different period for each wave. As of January 12, 2022, the case incidence had not yet fully returned to the level before the onset of the fourth wave; numbers, incidences, and proportions of cases, hospitalizations, and deaths were anticipated to continue to increase somewhat. However, the subsequent increases were limited, with the incidence of excess death attributable to Covid-19 having declined to 0 per 100,000 population by January 15, 2022.</div></div><div role="doc-footnote" data-has="label"><div class="label">â </div><div id="t2fn2" role="paragraph">Cases included asymptomatic and symptomatic SARS-CoV-2 infections confirmed by either a nucleic acid amplification assay or a rapid antigen test. Changes in the frequency of testing limit direct comparisons of case numbers; in particular, the lower frequency of testing during the first wave, which was due to constraints in laboratory capacity and prioritization of testing for hospitalized persons, prevents the direct comparison of cases from the first wave with those from subsequent waves.</div></div><div role="doc-footnote" data-has="label"><div class="label">â¡</div><div id="t2fn3" role="paragraph">Hospitalizations included admissions for SARS-CoV-2 infection, as well as admissions for other illnesses in which SARS-CoV-2 infection was incidentally identified on routine screening at the time of admission. The DATCOV system was developed during the first wave, with gradual onboarding of facilities; thus, hospitalizations from the first wave may be underestimated.</div></div><div role="doc-footnote" data-has="label"><div class="label">Â§</div><div id="t2fn4" role="paragraph">Definitions of recorded death and excess death attributable to Covid-19 are provided in the <a href="#ap1">Supplementary Appendix</a>.</div></div></div></figcaption></figure></div><div role="paragraph">During the fourth wave, decreased incidences of hospitalization and recorded death were evident across all age groups older than 17 years and among both men and women. The incidences of hospitalization and recorded death among children 17 years of age or younger, which have consistently been markedly lower than the incidences in older age groups, were similar to the incidences during earlier waves, except for a lower mortality among children 5 to 17 years of age during the fourth wave than during the third (delta-dominant) wave (<a href="#f3">Figure 3</a> and Tables S5, S6, and S7).</div></section></section><section id="sec-3" data-type="discussion"><h2>Discussion</h2><div role="paragraph">In Gauteng, the resurgence of Covid-19 that was dominated by the omicron variant evolved at a time when Covid-19 vaccine coverage was 36.0% among persons 12 years of age or older, with only 20.1% having received at least two doses of a Covid-19 vaccine as part of the national vaccine rollout program. Nevertheless, the results of our survey showed widespread underlying SARS-CoV-2 seropositivity across the province (73.1%), including a prevalence at the subdistrict level of up to 85.8%, before the onset of the omicron-dominant wave. This high seroprevalence was primarily induced by previous SARS-CoV-2 infection, as evidenced by the 68.4% seroprevalence among participants who had not received a Covid-19 vaccine. The methods used for selecting the random sample of households in the survey, with a distribution proportionate to subdistrict population sizes, ensured that the sample was representative of the general population of Gauteng.</div><div role="paragraph">In this context, we observed a dramatic decoupling of hospitalizations and deaths from infections during the fourth wave of Covid-19, as compared with the proportions seen during the three previous waves. The biologic basis for this decoupling could be the extensive cell-mediated immunity in the population that was induced by previous natural infection and vaccination. At least one vaccine dose had been administered to 61.2% of adults older than 50 years of age (1,479,288 of 2,416,045), who had accounted for 81.0% of all deaths (22,269 of 27,500) due to Covid-19 in Gauteng through the end of the third wave.<sup><a href="#core-r17" role="doc-biblioref" data-xml-rid="r17" id="body-ref-r17" href-manipulated="true" aria-label="Reference 17">17</a></sup> Although we did not evaluate cell-mediated immunity, other studies have shown that natural infection induces a diverse polyepitopic cell-mediated immune response that targets the spike protein, nucleocapsid protein, and membrane protein.<sup><a href="#core-r18" role="doc-biblioref" data-xml-rid="r18" id="body-ref-r18" href-manipulated="true" aria-label="Reference 18">18</a></sup> Consequently, cell-mediated immunity is likely to be more durable than neutralizing antibodyâmediated immunity in the context of small mutations,<sup><a href="#core-r19" role="doc-biblioref" data-xml-rid="r19" id="body-ref-r19-1" href-manipulated="true" aria-label="Reference 19">19</a></sup> particularly those mainly affecting the spike protein, such as those in the omicron variant. Furthermore, natural infection induces robust memory T-cell responses, including long-lived cytotoxic (CD8+) T cells, which have a half-life of 125 to 255 days.<sup><a href="#core-r20" role="doc-biblioref" data-xml-rid="r20" id="body-ref-r20" href-manipulated="true" aria-label="Reference 20">20</a></sup></div><div role="paragraph">We think that the evolution of cell-mediated immunity from previous natural infection and vaccination has resulted in the decoupling of the high case incidence seen with the omicron variant from the incidence of severe disease (hospitalizations and deaths). This decoupling has occurred despite evidence that the omicron variant evades neutralizing antibody activity induced by spike-proteinâbased vaccines and by previous infection with other variants that did not harbor the same full set of putatively antibody-evasive mutations. Our hypothesis is supported by two recent preprint publications, which indicated that most of the T-cell response induced by vaccination or natural infection cross-recognizes the omicron variant, thereby probably contributing to protection against severe disease.<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21 r22" id="body-ref-r22-1" href-manipulated="true">21,22</a></sup> An alternative or additional mechanism by which protection against severe disease may be conferred, despite the reduced neutralizing antibody activity against the omicron variant, is through Fc-mediated effector functions of non-neutralizing antibodies that induce antibody-mediated cellular phagocytosis, complement deposition, and natural killerâcell activation.<sup><a href="#core-r19" role="doc-biblioref" data-xml-rid="r19 r23" id="body-ref-r23-1" href-manipulated="true">19,23</a></sup> In addition, the omicron variant may be less potent in causing serious illness.</div><div role="paragraph">We saw a high incidence of Covid-19 cases due to the omicron variant despite the high seroprevalence of humoral immune responses, a finding consistent with the antibody-evasive nature of the omicron variant. Reports have indicated that the omicron variant is more capable of evading neutralizing antibody activity than even the beta variant.<sup><a href="#core-r7" role="doc-biblioref" data-xml-rid="r7 r24 r25 r26" id="body-ref-r26" href-manipulated="true">7,24â26</a></sup> Neutralizing antibody activity against the omicron variant after two doses of BNT162b2 or AZD1222 (also known as ChAdOx1 nCoV-19) was shown to be substantially lower than vaccine-induced neutralizing antibody activity against wild-type virus.<sup><a href="#core-r27" role="doc-biblioref" data-xml-rid="r27 r28" id="body-ref-r28" href-manipulated="true">27,28</a></sup> Nevertheless, the majority of persons with hybrid immunity from natural infection and BNT162b2 or AZD1222 vaccination have measurable neutralizing antibody activity against the omicron variant, albeit a lower level than that against the wild-type virus.<sup><a href="#core-r24" role="doc-biblioref" data-xml-rid="r24" id="body-ref-r24-2" href-manipulated="true" aria-label="Reference 24">24</a></sup> In this context, a high incidence of breakthrough cases and reinfections with the omicron variant was to be expected in South Africa, where the majority of persons had immunity from natural infection, which induces a lower magnitude of anti-spike neutralizing and binding antibody responses than vaccination.<sup><a href="#core-r25" role="doc-biblioref" data-xml-rid="r25" id="body-ref-r25-2" href-manipulated="true" aria-label="Reference 25">25</a></sup> Furthermore, as part of its vaccine rollout at the time of the evolution of the fourth wave, South Africa was providing only a single dose of Ad26.COV2.S, which induces lower titers of neutralizing and blocking antibodies than two doses of BNT162b2<sup><a href="#core-r25" role="doc-biblioref" data-xml-rid="r25" id="body-ref-r25-3" href-manipulated="true" aria-label="Reference 25">25</a></sup>; the third (booster) dose of BNT162b2 had not been introduced in South Africa at that time.</div><div role="paragraph">This clinical evidence of the antibody-evasive nature of the omicron variant is corroborated by early studies that showed limited vaccine effectiveness against omicron at 25 weeks after two doses of AZD1222 or BNT162b2.<sup><a href="#core-r29" role="doc-biblioref" data-xml-rid="r29" id="body-ref-r29-1" href-manipulated="true" aria-label="Reference 29">29</a></sup> However, vaccine effectiveness was substantially increased at 2 weeks after a booster dose of BNT162b2,<sup><a href="#core-r29" role="doc-biblioref" data-xml-rid="r29" id="body-ref-r29-2" href-manipulated="true" aria-label="Reference 29">29</a></sup> which results in much higher neutralizing antibody titers than two doses of the vaccine<sup><a href="#core-r30" role="doc-biblioref" data-xml-rid="r30" id="body-ref-r30" href-manipulated="true" aria-label="Reference 30">30</a></sup> and thus may partly mitigate the relative antibody-evasiveness of the omicron variant. In addition, in South Africa, vaccine effectiveness against hospitalization was 70% with the omicron variant, as compared with 93% with the delta variant.<sup><a href="#core-r31" role="doc-biblioref" data-xml-rid="r31" id="body-ref-r31-1" href-manipulated="true" aria-label="Reference 31">31</a></sup> These data, together with the very limited neutralizing antibody activity against the omicron variant after two doses of AZD1222 or BNT162b2, further corroborate the evidence that protection against severe Covid-19 due to the omicron variant is probably mediated by much lower neutralizing antibody titers than those required to protect against SARS-CoV-2 infection or mild Covid-19<sup><a href="#core-r25" role="doc-biblioref" data-xml-rid="r25" id="body-ref-r25-4" href-manipulated="true" aria-label="Reference 25">25</a></sup> or is provided by cell-mediated immunity or the Fc-effector functions of non-neutralizing antibodies (or a combination of these mechanisms).<sup><a href="#core-r19" role="doc-biblioref" data-xml-rid="r19 r23" id="body-ref-r23-2" href-manipulated="true">19,23</a></sup></div><div role="paragraph">The antibody-evasive nature of the omicron variant is analogous to the antibody-evasiveness of the beta variant in recipients of AZD1222, the AstraZeneca chimpanzee adenovirusâbased vaccine. AZD1222 was shown to have no effectiveness against mild-to-moderate Covid-19 due to the beta variant.<sup><a href="#core-r32" role="doc-biblioref" data-xml-rid="r32" id="body-ref-r32-1" href-manipulated="true" aria-label="Reference 32">32</a></sup> However, vaccine effectiveness against hospitalization or death due to the beta or P.1 (gamma) variant was 80% in a report from Canada.<sup><a href="#core-r33" role="doc-biblioref" data-xml-rid="r33" id="body-ref-r33" href-manipulated="true" aria-label="Reference 33">33</a></sup> Although AZD1222 induced nominal neutralizing antibody activity against the beta variant, only 11 of the 87 spike-protein epitopes targeted by T-cell immune responses induced by AZD1222 were affected by mutations in the beta variant.<sup><a href="#core-r32" role="doc-biblioref" data-xml-rid="r32" id="body-ref-r32-2" href-manipulated="true" aria-label="Reference 32">32</a></sup> The dissociation between the lack of AZD1222-induced neutralizing antibody activity and the protection against severe disease involving the lower respiratory tract was also observed in a challenge study with AZD1222 against the beta variant in a Syrian golden hamster model.<sup><a href="#core-r34" role="doc-biblioref" data-xml-rid="r34" id="body-ref-r34" href-manipulated="true" aria-label="Reference 34">34</a></sup></div><div role="paragraph">Evidence of the high transmissibility of the omicron variant is corroborated by the rapid rise in reported Covid-19 cases in Gauteng during the fourth wave. Indeed, the increase in the case incidence during the fourth wave occurred faster than that during any previous wave, a finding that indicates that the omicron variant is more transmissible than even the delta variant, which had an estimated reproductive number (R<sub>0</sub>) of 5 to 6.<sup><a href="#core-r35" role="doc-biblioref" data-xml-rid="r35" id="body-ref-r35" href-manipulated="true" aria-label="Reference 35">35</a></sup></div><div role="paragraph">Our study has some limitations. First, we used publicly available data regarding Covid-19 morbidity and mortality that were collated in surveillance systems and could have changed over time, which could affect comparisons across the four waves. The DATCOV database does not distinguish between patients hospitalized for SARS-CoV-2 infection and patients hospitalized for other illnesses who incidentally had a positive test for SARS-CoV-2 on routine screening. Nevertheless, data from these systems are unlikely to have changed since the third wave. Second, changes in the frequency of testing over time limit head-to-head comparisons of case numbers across waves, although the criteria for testing have been similar since the start of the second wave. Finally, the fourth wave had not fully subsided at the time of this analysis. The numbers, incidences, and proportions of total cumulative cases, hospitalizations, and deaths attributable to this wave â in particular, the data for hospitalizations and deaths, because there is a lag in the reporting of these data â were anticipated to continue to increase somewhat. However, the subsequent increases were limited, with the incidence of excess death attributable to Covid-19 having declined to 0 per 100,000 population by January 15, 2022.</div><div role="paragraph">Our hypothesis that cell-mediated immunity primarily due to natural infection, with or without Covid-19 vaccination, has resulted in the decoupling of cases from severe disease remains to be investigated. In particular, the extent to which the polyepitopic T-cell response induced by vaccination against the spike protein â as well as the even more diverse polyepitopic T-cell response stimulated by natural infection, with or without vaccination â remains cross-reactive against the omicron variant warrants further investigation.<sup><a href="#core-r21" role="doc-biblioref" data-xml-rid="r21 r22" id="body-ref-r22-2" href-manipulated="true">21,22</a></sup> Another possible contributing factor to the decoupling of cases from severe disease with the omicron variant, as compared with the proportions seen with previous variants, is that the omicron variant may be more adept at infecting the upper airways and less adept at infecting the lower airways, which could result in reduced virulence.<sup><a href="#core-r36" role="doc-biblioref" data-xml-rid="r36" id="body-ref-r36" href-manipulated="true" aria-label="Reference 36">36</a></sup> The difference in the prevalence of immunity across waves limits our ability to draw any conclusions regarding the relative roles of reduced virulence and higher prevalence of underlying cell-mediated immunity in contributing to the decoupling of cases from severe disease observed with the omicron variant in our study.</div><div role="paragraph">We think that the decoupling of the incidence of Covid-19 cases from the incidences of hospitalization and death during the omicron-dominant wave in South Africa heralds a turning point in the Covid-19 pandemic, if the primary goal is protection against severe disease and death rather than prevention of infection. The 70% vaccine effectiveness against severe disease with BNT162b2 in South Africa<sup><a href="#core-r31" role="doc-biblioref" data-xml-rid="r31" id="body-ref-r31-2" href-manipulated="true" aria-label="Reference 31">31</a></sup> might well be due to the hybrid cell-mediated immunity induced by vaccination and natural infection. Whether the same protection against severe Covid-19 due to the omicron variant will be seen in countries in which immunity is mainly from vaccination remains to be determined.</div></section>



        
        
</div></section><section id="backmatter" data-extent="backmatter" data-location="articleTab_article"><div class="core-container"><section id="backnotes" data-location="notes_article"><h2>Notes</h2><div data-type="version-of-record" role="paragraph">This is the <i>New England Journal of Medicine</i> version of record, which includes all <i>Journal</i> editing and enhancements. The Author Final Manuscript, which is the authorâs version after external peer review and before publication in the <i>Journal</i>, is available under a CC BY license at <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908853" target="_blank">PMC8908853</a>.</div><div data-type="published/updated" role="paragraph">This article was published on February 23, 2022, at NEJM.org.</div><div data-type="data-sharing" role="paragraph">Data are available at <a href="https://www.wits-vida.org" target="_blank">www.wits-vida.org</a>; requests for data sharing should be directed to Dr. Madhi at <a href="mailto:shabir.madhi@wits.ac.za">shabir.madhi@wits.ac.za</a>.</div><div role="paragraph">Supported by the Bill and Melinda Gates Foundation (INV-023514). DATCOV, a national surveillance system, is funded by the National Institute for Communicable Diseases and the South African Government.</div><div role="paragraph"><a href="#ap2">Disclosure forms</a> provided by the authors are available with the full text of this article at NEJM.org.</div><div role="paragraph">We thank the epidemiology team (Andronica Moipone Shonhiwa, Genevie Ntshoe, Joy Ebonwu, Lactatia Motsuku, Liliwe Shuping, Mazvita Muchengeti, Jackie Kleynhans, Gillian Hunt, Victor Odhiambo Olago, Husna Ismail, Nevashan Govender, Ann Mathews, Vivien Essel, Veerle Msimang, Tendesayi Kufa-Chakezha, Nkengafac Villyen Motaze, Natalie Mayet, Tebogo Mmaborwa Matjokotja, Mzimasi Neti, Tracy Arendse, Teresa Lamola, Itumeleng Matiea, Darren Muganhiri, Babongile Ndlovu, Khuliso Ravhuhali, Emelda Ramutshila, Salaminah Mhlanga, Akhona Mzoneli, Nimesh Naran, Trisha Whitbread, Mpho Moeti, Chidozie Iwu, Eva Mathatha, Fhatuwani Gavhi, Masingita Makamu, Matimba Makhubele, Simbulele Mdleleni, Bracha Chiger, Jackie Kleynhans, and Michelle Groome) and the information technology team (Tsumbedzo Mukange, Trevor Bell, Lincoln Darwin, Fazil McKenna, Ndivhuwo Munava, Muzammil Raza Bano, and Themba Ngobeni) at the National Institute for Communicable Diseases Notifiable Medical Conditions Surveillance System; Steve Hill, Ph.D., of Ashfield MedComms (an Ashfield Health company, part of UDG Healthcare) for medical writing and editing support for an earlier version of the manuscript, which was funded by AstraZeneca in accordance with Good Publication Practice guidelines; and the Gauteng Department of Health for providing the vaccine coverage data.</div></section><section id="supplementary-materials" class="core-supplementary-materials"><h2>Supplementary Material</h2><div role="list"><div id="ap1" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Supplementary Appendix</span> <span class="core-filename">(nejmoa2119658_appendix.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2119658/suppl_file/nejmoa2119658_appendix.pdf" download="nejmoa2119658_appendix.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2119658_appendix.pdf" data-doi="10.1056/NEJMoa2119658">Download</a></li><li>1.52 MB</li></ul></div></div><div id="ap2" class="core-supplementary-material" role="listitem"><div class="core-description"><span class="core-label">Disclosure Forms</span> <span class="core-filename">(nejmoa2119658_disclosures.pdf)</span></div><div class="core-link"><ul><li><a href="/doi/suppl/10.1056/NEJMoa2119658/suppl_file/nejmoa2119658_disclosures.pdf" download="nejmoa2119658_disclosures.pdf" data-interactiontype="multimedia_download" data-multimedia-type="Supplementary Material" data-behavior="trackDownloadEvent" data-multimedia-filename="nejmoa2119658_disclosures.pdf" data-doi="10.1056/NEJMoa2119658">Download</a></li><li>298.83 KB</li></ul></div></div></div></section><section id="bibliography" class="core-reference-list" role="doc-bibliography" data-location="references_article"><h2>References</h2><div role="list" data-method="clamp" id="collapsible-text"><div role="listitem" data-has="label"><div class="label">1.</div><div id="r1" class="citations"><div class="citation"><div class="citation-content">Callaway E. Heavily mutated Omicron variant puts scientists on alert. <em>Nature</em> 2021;600:21-21.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/d41586-021-03552-w" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34824381/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000724224500013" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Heavily+mutated+Omicron+variant+puts+scientists+on+alert.&amp;publication_year=2021&amp;journal=Nature&amp;pages=21-21&amp;doi=10.1038%2Fd41586-021-03552-w&amp;pmid=34824381" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="r2" class="citations"><div class="citation"><div class="citation-content">World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. November 26, 2021 (<a href="https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern">https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r2"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Classification+of+Omicron+%28B.1.1.529%29%3A+SARS-CoV-2+variant+of+concern&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="r3" class="citations"><div class="citation"><div class="citation-content">European Centre for Disease Prevention and Control. Implications of the emergence and spread of the SARS-CoV-2 B.1.1. 529 variant of concern (Omicron) for the EU/EEA. November 26, 2021 (<a href="https://www.ecdc.europa.eu/sites/default/files/documents/Implications-emergence-spread-SARS-CoV-2%20B.1.1.529-variant-concern-Omicron-for-the-EU-EEA-Nov2021.pdf">https://www.ecdc.europa.eu/sites/default/files/documents/Implications-emergence-spread-SARS-CoV-2%20B.1.1.529-variant-concern-Omicron-for-the-EU-EEA-Nov2021.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r5"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Implications+of+the+emergence+and+spread+of+the+SARS-CoV-2+B.1.1.+529+variant+of+concern+%28Omicron%29+for+the+EU%2FEEA&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="r4" class="citations"><div class="citation"><div class="citation-content">UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 29. November 26, 2021 (<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1036501/Technical_Briefing_29_published_26_November_2021.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1036501/Technical_Briefing_29_published_26_November_2021.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r5"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variants+of+concern+and+variants+under+investigation+in+England%3A+technical+briefing+29&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="r5" class="citations"><div class="citation"><div class="citation-content">Chen J, Wang R, Gilby NB, Wei GW. Omicron variant (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance. <em>J Chem Inf Model</em> 2022;62:412-422.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r5"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jcim.1c01451" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34989238/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000743548000001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Omicron+variant+%28B.1.1.529%29%3A+infectivity%2C+vaccine+breakthrough%2C+and+antibody+resistance.&amp;publication_year=2022&amp;journal=J+Chem+Inf+Model&amp;pages=412-422&amp;doi=10.1021%2Facs.jcim.1c01451&amp;pmid=34989238" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="r6" class="citations"><div class="citation"><div class="citation-content">Callaway E, Ledford H. How bad is Omicron? What scientists know so far. <em>Nature</em> 2021;600:197-199.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r6"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/d41586-021-03614-z" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34857948/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000727856300008" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=How+bad+is+Omicron%3F+What+scientists+know+so+far.&amp;publication_year=2021&amp;journal=Nature&amp;pages=197-199&amp;doi=10.1038%2Fd41586-021-03614-z&amp;pmid=34857948" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="r7" class="citations"><div class="citation"><div class="citation-content">Cele S, Gazy I, Jackson L, et al. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. <em>Nature</em> 2021;593:142-146.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r7" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-021-03471-w" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33780970/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000642083300001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Escape+of+SARS-CoV-2+501Y.V2+from+neutralization+by+convalescent+plasma.&amp;publication_year=2021&amp;journal=Nature&amp;pages=142-146&amp;doi=10.1038%2Fs41586-021-03471-w&amp;pmid=33780970" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r7" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r7-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and 1 nucleocapsid-protein mutation. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r26" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] activity than even the beta variant. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="r8" class="citations"><div class="citation"><div class="citation-content">South African National Institute for Communicable Diseases. Network for genomic surveillance in South Africa SARS-CoV-2 sequencing update. December 31, 2021 (<a href="https://www.nicd.ac.za/wp-content/uploads/2022/01/Update-of-SA-sequencing-data-from-GISAID-30-Dec-2021_dash.pdf">https://www.nicd.ac.za/wp-content/uploads/2022/01/Update-of-SA-sequencing-data-from-GISAID-30-Dec-2021_dash.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r8"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Network+for+genomic+surveillance+in+South+Africa+SARS-CoV-2+sequencing+update&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="r9" class="citations"><div class="citation"><div class="citation-content">Mutevedzi PC, Kawonga M, Kwatra G, et al. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey. <em>Int J Epidemiol</em> 2021 October 30 (Epub ahead of print).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r9" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/ije/dyab217" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34718591/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000790047400001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Estimated+SARS-CoV-2+infection+rate+and+fatality+risk+in+Gauteng+Province%2C+South+Africa%3A+a+population-based+seroepidemiological+survey.&amp;publication_year=2021&amp;journal=Int+J+Epidemiol&amp;doi=10.1093%2Fije%2Fdyab217&amp;pmid=34718591" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r9" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r9-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] that was completed on January 22, 2021. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r9-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] 5% to 43% across provincial subdistricts. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r9-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] from November 4, 2020, to January 22, 2021. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r9-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] framework used, have been published </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r9-5" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] the use of an electronic questionnaire. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r9-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] in our previous survey have been published </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#f1" role="menuitem" data-target="#fv-body-ref-r9-7"><i aria-hidden="true" class="icon-return"></i><span>g [...] November 4, 2020, to January 22, 2021). </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="r10" class="citations"><div class="citation"><div class="citation-content">South African National Institute for Communicable Diseases. SARS-CoV-2 genomic surveillance update June 2021. July 1, 2021 (<a href="https://www.nicd.ac.za/wp-content/uploads/2021/07/Sequencing-update-1July-2021_V14.pdf">https://www.nicd.ac.za/wp-content/uploads/2021/07/Sequencing-update-1July-2021_V14.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r10"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+genomic+surveillance+update+June+2021&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="r11" class="citations"><div class="citation"><div class="citation-content">Statistics South Africa. Statistical release P0302: mid-year population estimates 2020. July 31, 2021 (<a href="http://www.statssa.gov.za/publications/P0302/P03022020.pdf">http://www.statssa.gov.za/publications/P0302/P03022020.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r11" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Statistical+release+P0302%3A+mid-year+population+estimates+2020&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r11" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r11-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] West Rand) that comprise 26 subdistricts. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r11-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] population (15.5 of 59.6 million persons). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r11-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] for South Africa and its provinces. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="r12" class="citations"><div class="citation"><div class="citation-content">Kwatra G, Nunes M, Dhar N, et al. Correlation of dried blood spots and plasma for quantification of Immunoglobulin (IgG) against receptor binding domain and full length spike protein of SARS-CoV-2. <em>J Virol Methods</em> 2022;300:114394-114394.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r13"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jviromet.2021.114394" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34861318/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000755192700013" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Correlation+of+dried+blood+spots+and+plasma+for+quantification+of+Immunoglobulin+%28IgG%29+against+receptor+binding+domain+and+full+length+spike+protein+of+SARS-CoV-2.&amp;publication_year=2022&amp;journal=J+Virol+Methods&amp;pages=114394-114394&amp;doi=10.1016%2Fj.jviromet.2021.114394&amp;pmid=34861318" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="r13" class="citations"><div class="citation"><div class="citation-content">Madhi SA, Koen AL, Izu A, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. <em>Lancet HIV</em> 2021;8(9):e568-e580.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r13"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S2352-3018(21)00157-0" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34416193/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000692541700012" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+immunogenicity+of+the+ChAdOx1+nCoV-19+%28AZD1222%29+vaccine+against+SARS-CoV-2+in+people+living+with+and+without+HIV+in+South+Africa%3A+an+interim+analysis+of+a+randomised%2C+double-blind%2C+placebo-controlled%2C+phase+1B%2F2A+trial.&amp;publication_year=2021&amp;journal=Lancet+HIV&amp;pages=e568-e580&amp;doi=10.1016%2FS2352-3018%2821%2900157-0&amp;pmid=34416193" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="r14" class="citations"><div class="citation"><div class="citation-content">National Institute for Communicable Diseases. Daily hospital surveillance (DATCOV) report (<a href="https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/">https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Daily+hospital+surveillance+%28DATCOV%29+report" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="r15" class="citations"><div class="citation"><div class="citation-content">Jassat W, Mudara C, Ozougwu L, et al. Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study. <em>Lancet Glob Health</em> 2021;9(9):e1216-e1225.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S2214-109X(21)00289-8" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34252381/" target="_blank">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Difference+in+mortality+among+individuals+admitted+to+hospital+with+COVID-19+during+the+first+and+second+waves+in+South+Africa%3A+a+cohort+study.&amp;publication_year=2021&amp;journal=Lancet+Glob+Health&amp;pages=e1216-e1225&amp;doi=10.1016%2FS2214-109X%2821%2900289-8&amp;pmid=34252381" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="r16" class="citations"><div class="citation"><div class="citation-content">Bradshaw D, Laubscher R, Dorrington R, Groenewald P, Moultrie T. Report on weekly deaths in South Africa 26 Dec 2021 â 1 Jan 2022 (week 52). <em>South African Medical Research Council</em>, January 4, 2022 (<a href="https://www.samrc.ac.za/sites/default/files/files/2022-01-05/weekly1Jan2022.pdf">https://www.samrc.ac.za/sites/default/files/files/2022-01-05/weekly1Jan2022.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r16" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Report+on+weekly+deaths+in+South+Africa+26+Dec+2021+%E2%80%94+1+Jan+2022+%28week+52%29&amp;publication_year=2022" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r16" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r16-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] Research Council through January 8, 2022. </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#f2" role="menuitem" data-target="#fv-body-ref-r16-2"><i aria-hidden="true" class="icon-return"></i><span>b [...] Research Council through January 8, 2022. </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t2" role="menuitem" data-target="#fv-body-ref-r16-3"><i aria-hidden="true" class="icon-return"></i><span>c [...] Research Council through January 8, 2022. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">17.</div><div id="r17" class="citations"><div class="citation"><div class="citation-content">National Institute for Communicable Diseases. Weekly hospital surveillance (DATCOV) update (<a href="https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/weekly-hospital-surveillance-datcov-update/">https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/weekly-hospital-surveillance-datcov-update/</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r17"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Weekly+hospital+surveillance+%28DATCOV%29+update" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">18.</div><div id="r18" class="citations"><div class="citation"><div class="citation-content">Milne G, Hames T, Scotton C, et al. Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity? <em>Lancet Respir Med</em> 2021;9:1450-1466.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r18"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S2213-2600(21)00407-0" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34688434/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000729806800029" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Does+infection+with+or+vaccination+against+SARS-CoV-2+lead+to+lasting+immunity%3F&amp;publication_year=2021&amp;journal=Lancet+Respir+Med&amp;pages=1450-1466&amp;doi=10.1016%2FS2213-2600%2821%2900407-0&amp;pmid=34688434" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">19.</div><div id="r19" class="citations"><div class="citation"><div class="citation-content">Alter G, Yu J, Liu J, et al. Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans. <em>Nature</em> 2021;596:268-272.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r19" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-021-03681-2" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34107529/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000668492400001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Immunogenicity+of+Ad26.COV2.S+vaccine+against+SARS-CoV-2+variants+in+humans.&amp;publication_year=2021&amp;journal=Nature&amp;pages=268-272&amp;doi=10.1038%2Fs41586-021-03681-2&amp;pmid=34107529" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r19" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r19-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] immunity in the context of small mutations, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r23-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and natural killerâcell activation. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r23-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] (or a combination of these mechanisms). </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">20.</div><div id="r20" class="citations"><div class="citation"><div class="citation-content">Dan JM, Mateus J, Kato Y, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. <em>Science</em> 2021;371:eabf4063-eabf4063.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.abf4063" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33408181/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000615715300044" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Immunological+memory+to+SARS-CoV-2+assessed+for+up+to+8+months+after+infection.&amp;publication_year=2021&amp;journal=Science&amp;pages=eabf4063-eabf4063&amp;doi=10.1126%2Fscience.abf4063&amp;pmid=33408181" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">21.</div><div id="r21" class="citations"><div class="citation"><div class="citation-content">Keeton R, Tincho MB, Ngomti A, et al. SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron. December 28, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.12.26.21268380v1">https://www.medrxiv.org/content/10.1101/2021.12.26.21268380v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r21" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+spike+T+cell+responses+induced+upon+vaccination+or+infection+remain+robust+against+Omicron&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r21" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r22-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] to protection against severe disease. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r22-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] variant warrants further investigation. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">22.</div><div id="r22" class="citations"><div class="citation"><div class="citation-content">Tarke A, Coelho CH, Zhang Z, et al. SARS-CoV-2 vaccination induces immunological memory able to cross-recognize variants from Alpha to Omicron. December 28, 2021 (<a href="https://www.biorxiv.org/content/10.1101/2021.12.28.474333v1">https://www.biorxiv.org/content/10.1101/2021.12.28.474333v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r22" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+vaccination+induces+immunological+memory+able+to+cross-recognize+variants+from+Alpha+to+Omicron&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r22" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r22-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] to protection against severe disease. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r22-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] variant warrants further investigation. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">23.</div><div id="r23" class="citations"><div class="citation"><div class="citation-content">Gorman MJ, Patel N, Guebre-Xabier M, et al. Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination. <em>Cell Rep Med</em> 2021;2:100405-100405.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r23" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.xcrm.2021.100405" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34485950/" target="_blank">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Fab+and+Fc+contribute+to+maximal+protection+against+SARS-CoV-2+following+NVX-CoV2373+subunit+vaccine+with+Matrix-M+vaccination.&amp;publication_year=2021&amp;journal=Cell+Rep+Med&amp;pages=100405-100405&amp;doi=10.1016%2Fj.xcrm.2021.100405&amp;pmid=34485950" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r23" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r23-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and natural killerâcell activation. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r23-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] (or a combination of these mechanisms). </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">24.</div><div id="r24" class="citations"><div class="citation"><div class="citation-content">RÃ¶ssler A, Riepler L, Bante D, von Laer D, Kimpel J. SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals. December 11, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.12.08.21267491v1">https://www.medrxiv.org/content/10.1101/2021.12.08.21267491v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r24" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+B.1.1.529+variant+%28Omicron%29+evades+neutralization+by+sera+from+vaccinated+and+convalescent+individuals&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r24" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r26" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] activity than even the beta variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r24-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] than that against the wild-type virus. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">25.</div><div id="r25" class="citations"><div class="citation"><div class="citation-content">Gilbert PB, Montefiori DC, McDermott AB, et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. <em>Science</em> 2022;375:43-50.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r25" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.abm3425" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34812653/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000740261400037" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Immune+correlates+analysis+of+the+mRNA-1273+COVID-19+vaccine+efficacy+clinical+trial.&amp;publication_year=2022&amp;journal=Science&amp;pages=43-50&amp;doi=10.1126%2Fscience.abm3425&amp;pmid=34812653" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r25" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r26" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] activity than even the beta variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r25-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] antibody responses than vaccination. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r25-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] antibodies than two doses of BNT162b2 </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r25-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] SARS-CoV-2 infection or mild Covid-19 </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">26.</div><div id="r26" class="citations"><div class="citation"><div class="citation-content">Dejnirattisai W, Huo J, Zhou D, et al. Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. December 22, 2021 (<a href="https://www.biorxiv.org/content/10.1101/2021.12.03.471045v2">https://www.biorxiv.org/content/10.1101/2021.12.03.471045v2</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r26"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Omicron-B.1.1.529+leads+to+widespread+escape+from+neutralizing+antibody+responses&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">27.</div><div id="r27" class="citations"><div class="citation"><div class="citation-content">Dejnirattisai W, Shaw RH, Supasa P, et al. Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. <em>Lancet</em> 2022;399:234-236.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r28"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)02844-0" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34942101/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000746041700016" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Reduced+neutralisation+of+SARS-CoV-2+omicron+B.1.1.529+variant+by+post-immunisation+serum.&amp;publication_year=2022&amp;journal=Lancet&amp;pages=234-236&amp;doi=10.1016%2FS0140-6736%2821%2902844-0&amp;pmid=34942101" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">28.</div><div id="r28" class="citations"><div class="citation"><div class="citation-content">Cele S, Jackson L, Khan K, et al. SARS-CoV-2 omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. December 17, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.12.08.21267417v3">https://www.medrxiv.org/content/10.1101/2021.12.08.21267417v3</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r28"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+omicron+has+extensive+but+incomplete+escape+of+Pfizer+BNT162b2+elicited+neutralization+and+requires+ACE2+for+infection&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">29.</div><div id="r29" class="citations"><div class="citation"><div class="citation-content">Andrews N, Stowe J, Kirsebom F, et al. Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern. December 14, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.12.14.21267615v1">https://www.medrxiv.org/content/10.1101/2021.12.14.21267615v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r29" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+COVID-19+vaccines+against+the+Omicron+%28B.1.1.529%29+variant+of+concern&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r29" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r29-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] after two doses of AZD1222 or BNT162b2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r29-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] 2 weeks after a booster dose of BNT162b2, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">30.</div><div id="r30" class="citations"><div class="citation"><div class="citation-content">Munro APS, Janani L, Cornelius V, et al. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. <em>Lancet</em> 2021;398:2258-2276.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r30"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)02717-3" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34863358/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000731484500012" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+immunogenicity+of+seven+COVID-19+vaccines+as+a+third+dose+%28booster%29+following+two+doses+of+ChAdOx1+nCov-19+or+BNT162b2+in+the+UK+%28COV-BOOST%29%3A+a+blinded%2C+multicentre%2C+randomised%2C+controlled%2C+phase+2+trial.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=2258-2276&amp;doi=10.1016%2FS0140-6736%2821%2902717-3&amp;pmid=34863358" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">31.</div><div id="r31" class="citations"><div class="citation"><div class="citation-content">Collie S, Champion J, Moultrie H, Bekker LG, Gray G. Effectiveness of BNT162b2 vaccine against Omicron variant in South Africa. <em>N Engl J Med</em> 2021;386:494-496.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r31" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_32_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119658&amp;key=10.1056%2FNEJMc2119270&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34965358/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000735528700001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+BNT162b2+vaccine+against+Omicron+variant+in+South+Africa.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=494-496&amp;doi=10.1056%2FNEJMc2119270&amp;pmid=34965358" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r31" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r31-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] compared with 93% with the delta variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r31-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] disease with BNT162b2 in South Africa </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">32.</div><div id="r32" class="citations"><div class="citation"><div class="citation-content">Madhi SA, Baillie V, Cutland CL, et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. <em>N Engl J Med</em> 2021;384:1885-1898.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r32" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_33_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119658&amp;key=10.1056%2FNEJMoa2102214&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33725432/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000640360100001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+the+ChAdOx1+nCoV-19+Covid-19+vaccine+against+the+B.1.351+variant.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1885-1898&amp;doi=10.1056%2FNEJMoa2102214&amp;pmid=33725432" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r32" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r32-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] Covid-19 due to the beta variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r32-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] affected by mutations in the beta variant. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">33.</div><div id="r33" class="citations"><div class="citation"><div class="citation-content">Nasreen S, Chung H, He S, et al. Effectiveness of COVID-19 vaccines against variants of concern in Ontario, Canada. July 16, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.06.28.21259420v2">https://www.medrxiv.org/content/10.1101/2021.06.28.21259420v2</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r33"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+COVID-19+vaccines+against+variants+of+concern+in+Ontario%2C+Canada&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">34.</div><div id="r34" class="citations"><div class="citation"><div class="citation-content">Fischer RJ, van Doremalen N, Adney DR, et al. ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7. <em>Nat Commun</em> 2021;12:5868-5868.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r34"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-021-26178-y" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34620866/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000704983300013" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=ChAdOx1+nCoV-19+%28AZD1222%29+protects+Syrian+hamsters+against+SARS-CoV-2+B.1.351+and+B.1.1.7.&amp;publication_year=2021&amp;journal=Nat+Commun&amp;pages=5868-5868&amp;doi=10.1038%2Fs41467-021-26178-y&amp;pmid=34620866" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">35.</div><div id="r35" class="citations"><div class="citation"><div class="citation-content">Liu Y, RocklÃ¶v J. The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus. <em>J Travel Med</em> 2021;28:taab124-taab124.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r35"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/jtm/taab124" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34369565/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000711240500024" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+reproductive+number+of+the+Delta+variant+of+SARS-CoV-2+is+far+higher+compared+to+the+ancestral+SARS-CoV-2+virus.&amp;publication_year=2021&amp;journal=J+Travel+Med&amp;pages=taab124-taab124&amp;doi=10.1093%2Fjtm%2Ftaab124&amp;pmid=34369565" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">36.</div><div id="r36" class="citations"><div class="citation"><div class="citation-content">Diamond M, Halfmann P, Maemura T, et al. The SARS-CoV-2 B.1.1.529 omicron virus causes attenuated infection and disease in mice and hamsters. December 29, 2021 (<a href="https://www.researchsquare.com/article/rs-1211792/v1">https://www.researchsquare.com/article/rs-1211792/v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r36"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+SARS-CoV-2+B.1.1.529+omicron+virus+causes+attenuated+infection+and+disease+in+mice+and+hamsters&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div></div><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--secondary" aria-expanded="false" aria-controls="collapsible-text"><span>Show all references</span></button></div></section></div></section></div><div class="core-collateral"><div id="core-collateral-info" role="tabpanel" data-core-tabs="core-collateral-info" tabindex="-1" aria-labelledby="pane-core-collateral-info"><header><h2 id="pane-core-collateral-info"><i class="icon-info" aria-hidden="true"></i>Information &amp; Authors</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-information" role="tab" id="tab-information-label" aria-selected="true" class="active">Information</button><button aria-controls="tab-contributors" role="tab" id="tab-contributors-label" tabindex="-1" aria-selected="false">Authors</button></div><section id="tab-information" aria-labelledby="tab-information-label" role="tabpanel" tabindex="0"><h3>Information</h3><section class="core-self-citation"><h4>Published In</h4><div class="core-journal-presentation"><div class="core-journal-description"><div property="isPartOf" typeof="Periodical"><span property="name">New England Journal of Medicine</span></div><div class="core-enumeration"><a href="/toc/nejm/386/14"><span property="isPartOf" typeof="PublicationVolume">Volume <span property="volumeNumber">386</span></span> â¢ <span property="isPartOf" typeof="PublicationIssue">Number <span property="issueNumber">14</span></span> â¢ <span property="datePublished">April 7, 2022</span></a></div><div class="core-pagination"><span class="heading">Pages</span>: <span class="content"><span property="pageStart">1314</span>-<span property="pageEnd">1326</span></span></div></div></div></section><section class="core-copyright"><h4>Copyright</h4><div role="paragraph">Copyright Â© 2022 Massachusetts Medical Society. All rights reserved.</div><div>For personal use only. Any commercial reuse of NEJM Group content requires <a href="mailto:permissions@nejm.org">permission</a>.</div></section><section class="core-history"><h4>History</h4><div><b class="core-label">Published online</b>: February 23, 2022</div><div><b class="core-label">Published in issue</b>: April 7, 2022</div></section><section data-location="recirc_topics_article" class="core-classifications"><h4>Topics</h4><div class="keywords"><ol><li><a href="/browse/topic/coronavirus" alt="View article keyword Coronavirus" data-interactiontype="article_recirculation_click">Coronavirus</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li><li><a href="/browse/topic/vaccines" alt="View article keyword Vaccines" data-interactiontype="article_recirculation_click">Vaccines</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li><li><a href="/browse/topic/viral-infections" alt="View article keyword Viral Infections" data-interactiontype="article_recirculation_click">Viral Infections</a></li><li role="presentation" aria-hidden="true" class="list-line-break"></li></ol></div></section></section><section id="tab-contributors" aria-labelledby="tab-contributors-label" role="tabpanel" tabindex="-1"><h3>Authors</h3><section class="core-authors"><h4>Authors</h4><div role="paragraph"><span property="author" typeof="Person"><span property="givenName">Shabir A.</span> <span property="familyName">Madhi</span>, <span property="honorificSuffix">Ph.D.</span> <a class="orcid-id" href="https://orcid.org/0000-0002-7629-0636" property="identifier" aria-label="ORCID identifier" target="_blank">https://orcid.org/0000-0002-7629-0636</a></span>, <span property="author" typeof="Person"><span property="givenName">Gaurav</span> <span property="familyName">Kwatra</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Jonathan E.</span> <span property="familyName">Myers</span>, <span property="honorificSuffix">M.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Waasila</span> <span property="familyName">Jassat</span>, <span property="honorificSuffix">M.Med.</span></span>, <span property="author" typeof="Person"><span property="givenName">Nisha</span> <span property="familyName">Dhar</span>, <span property="honorificSuffix">Ph.D.</span></span>, <span property="author" typeof="Person"><span property="givenName">Christian K.</span> <span property="familyName">Mukendi</span>, <span property="honorificSuffix">M.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Amit J.</span> <span property="familyName">Nana</span>, <span property="honorificSuffix">B.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Lucille</span> <span property="familyName">Blumberg</span>, <span property="honorificSuffix">M.Med.</span></span>, <span property="author" typeof="Person"><span property="givenName">Richard</span> <span property="familyName">Welch</span>, <span property="honorificSuffix">B.Sc.</span></span>, <span property="author" typeof="Person"><span property="givenName">Nicoletta</span> <span property="familyName">Ngorima-Mabhena</span>, <span property="honorificSuffix">M.B., Ch.B.</span></span>, and <span property="author" typeof="Person"><span property="givenName">Portia C.</span> <span property="familyName">Mutevedzi</span>, <span property="honorificSuffix">Ph.D.</span></span></div></section><section class="core-affiliations"><h4>Affiliations</h4><div property="affiliation" typeof="Organization"><span property="name">From the South African Medical Research Council Vaccine and Infectious Diseases Analytics Research Unit (S.A.M., G.K., N.D., C.K.M., A.J.N., P.C.M.) and African Leadership in Vaccinology Expertise (S.A.M., G.K.), University of the Witwatersrand, the National Institute for Communicable Diseases, National Health Laboratory Service (W.J., L.B., R.W.), and ResearchLinkMe (N.N.-M.), Johannesburg, the Centre for Environmental and Occupational Health Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town (J.E.M.), and Right to Care, Centurion (L.B.) â all in South Africa.</span></div></section><section class="core-authors-notes"><h4>Notes</h4><div role="doc-footnote">Dr. Madhi can be contacted at <a href="mailto:shabir.madhi@wits.ac.za">shabir.madhi@wits.ac.za</a> or at the University of the Witwatersrand, Phillip Tobias Bldg., Princess of Wales St., Parktown, 2193, Gauteng, South Africa.</div></section></section></div><div id="core-collateral-metrics" role="tabpanel" data-core-tabs="core-collateral-metrics" tabindex="-1" aria-labelledby="pane-core-collateral-metrics"><header><h2 id="pane-core-collateral-metrics"><i class="icon-timeline" aria-hidden="true"></i>Metrics &amp; Citations</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-metrics-inner" role="tab" id="tab-metrics-inner-label" aria-selected="true" class="active" data-interactiontype="article_tab" data-tabname="metricsWindow">Metrics</button><button aria-controls="tab-citations" role="tab" id="tab-citations-label" tabindex="-1" aria-selected="false" data-interactiontype="article_tab" data-tabname="metricsWindow">Citations<span class="citations-count">278</span></button></div><section id="tab-metrics-inner" aria-labelledby="tab-metrics-inner-label" role="tabpanel" tabindex="0"><h3>Metrics</h3><section>









    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="95ea9f58-ec0e-4db2-b2ab-280fc876af53" data-location="article_metrics_article">
        



        
            <h4 class="">
                Altmetrics
            </h4>
        
        <div data-badge-details="right" data-badge-type="large-donut" data-doi="10.1056/NEJMoa2119658" data-hide-no-mentions="true" data-link-target="_blank" class="altmetric-embed" data-uuid="9f327a5e-554b-f73b-0cd3-35b748bdcba4"><div style="overflow:hidden;">
    <div class="altmetric-normal-legend">
        <a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123562072" style="display:inline-block;">
                <img alt="Article has an altmetric score of 469" src="https://badges.altmetric.com/?size=320&amp;score=469&amp;types=mabtttfd" width="180" height="180" style="border:0; margin:0; max-width: none;">
        </a>
        <p class="altmetric-see-more-details" style="padding-top: 10px; text-align: center;"><a target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123562072">See more details</a></p>
    </div>
    <div id="_altmetric_popover_el_9f327a5e-554b-f73b-0cd3-35b748bdcba4" class="altmetric-embed right" style="margin:0; padding:0; display:inline-block; float:left; position:relative;">
        <div class="altmetric_container">
            <div class="altmetric-embed altmetric-popover-inner right">
                <div style="padding:0; margin: 0;" class="altmetric-embed altmetric-popover-content">
                        <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123562072&amp;tab=news">
          Picked up by <b>43</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #ffd140;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123562072&amp;tab=blogs">
          Blogged by <b>4</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #9f79f2;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123562072&amp;tab=policy-documents">
          Referenced in <b>1</b> policy sources
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123562072&amp;tab=twitter">
          Posted by <b>202</b> X users
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #f27700;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123562072&amp;tab=patents">
          Referenced in <b>1</b> patents
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #2445bd;">
      <a class="link-to-altmetric-details-tab" target="_blank" href="https://www.altmetric.com/details.php?domain=www.nejm.org&amp;citation_id=123562072&amp;tab=facebook">
          On <b>4</b> Facebook pages
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>284</b> readers on Mendeley
          </div>
    </div>

                </div>
            </div>
        </div>
    </div>
</div></div>
<script async="" type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" nonce="94d6c9e08714a4d7-GRU"></script>

        </div>
    

</section></section><section id="tab-citations" aria-labelledby="tab-citations-label" role="tabpanel" tabindex="-1"><h3>Citations</h3><section>



        
            <h4 class="">
                Export citation
            </h4>
        
        <div class="citation-download cd-sec">
<p class="citation-download_msg">Select the format you want to export the citation of this publication.</p>
<form action="/action/downloadCitation" name="frmCitmgr" method="post" target="_self" class="citation-download_form"><input type="hidden" name="doi" value="10.1056/NEJMoa2119658"> <input type="hidden" name="downloadFileName" value="csp_386_"> <input type="hidden" name="include" value="abs">
<div class="dropdown dropdown-selectable dropdown-selectable--form-control"><input type="hidden" name="format" value=""> <label class="form-label">Format*</label> <button id="slct_format" type="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="btn dropdown-toggle d-flex align-items-center justify-content-between">Please Select </button>
<div aria-labelledby="slct_format" role="listbox" class="dropdown-menu"><a href="#" data-value="ris" class="dropdown-item">RIS (ProCite, Reference Manager)</a><a href="#" data-value="endnote" class="dropdown-item">EndNote</a><a href="#" data-value="bibtex" class="dropdown-item">BibTex</a><a href="#" data-value="medlars" class="dropdown-item">Medlars</a><a href="#" data-value="refworks" class="dropdown-item">RefWorks</a></div>
<div class="invalid-feedback">Please select an item in the list</div>
</div>
<div class="citation-download_checkbox"><label class="checkbox--primary"><input type="checkbox" name="direct" value="true"><span class="checkbox--primary-icons"><span class="checkbox--primary-unchecked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxUnchecked"></use></svg></span></span><span class="checkbox--primary-checked"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#toggles-checboxChecked"></use></svg></span></span></span><span class="checkbox--primary-label"><span class="checkbox--primary-label-text">Direct Import</span></span></label></div>
<div class="citation-download_btn"><button type="submit" name="submit" value="Download" class="ng-btn_default ng-btn_iconLeft" data-interactiontype="article_tools_citation_download" data-multimedia-type="Citation"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#citations"></use></svg></span><span class="ng-btn_text">Export citation</span></button></div>
</form></div>
</section><section>









    
    
        <div data-widget-def="UX3CitedByWidget" data-widget-id="efb4df9a-8e1a-47f9-bfb7-271959277a9f" data-location="citedby_article">
        



        
            <h4 class="">
                Cited by
            </h4>
        
        <section id="cited-by" class="cited-by"><div class="cited-by__wrapper"><div id="cited-by__content" class="cited-by__content"><ol data-source="/pb/widgets/citedBy?page=1&amp;widgetId=efb4df9a-8e1a-47f9-bfb7-271959277a9f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Anejm%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3Adoi%5C%3A10.1056%2FNEJMoa2119658%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AMMS+NextGen+Website+Group%3Bissue%3Aissue%3Adoi%5C%3A10.1056%2Fnejm_2022.386.issue-14%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bwebsite%3Awebsite%3Amms-site%3Bjournal%3Ajournal%3Anejms" data-lazyload="false" data-total="278" class="cited-by__list list-unstyled"><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Reshmi Dassaye, </li><li class="list-inline-item cited-by__entry__author">Terusha Chetty, </li><li class="list-inline-item cited-by__entry__author">Brodie Daniels, </li><li class="list-inline-item cited-by__entry__author">Trisha Ramraj, </li><li class="list-inline-item cited-by__entry__author">Zakir Gaffoor, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Spooner, </li><li class="list-inline-item cited-by__entry__author">Ncengani Mthethwa, </li><li class="list-inline-item cited-by__entry__author">Duduzile Faith Nsibande, </li><li class="list-inline-item cited-by__entry__author">Vuyolwethu Magasana, </li><li class="list-inline-item cited-by__entry__author">Khanya Mohlabi, </li><li class="list-inline-item cited-by__entry__author">Isaac Singini, </li><li class="list-inline-item cited-by__entry__author">Nomonde Gwebushe, </li><li class="list-inline-item cited-by__entry__author">Kubashni Woeber, </li><li class="list-inline-item cited-by__entry__author">Ameena Goga, </li></ul><span class="cited-by__entry__title">SARS-CoV-2 seroprevalence among learners in grades 1â7, their parents and teachers in KwaZulu-Natal, South Africa: a cross-sectional study, </span><span class="cited-by__entry__series-title">Frontiers in Public Health, </span><span class="cited-by__entry__volume"><strong>13</strong>, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.3389/fpubh.2025.1548945" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.3389/fpubh.2025.1548945</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.3389/fpubh.2025.1548945" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Juliette Besson, </li><li class="list-inline-item cited-by__entry__author">RÃ©gine Audran, </li><li class="list-inline-item cited-by__entry__author">Maxime Karlen, </li><li class="list-inline-item cited-by__entry__author">Alix Miauton, </li><li class="list-inline-item cited-by__entry__author">HÃ©lÃ¨ne Maby-El Hajjami, </li><li class="list-inline-item cited-by__entry__author">Loane Warpelin-Decrausaz, </li><li class="list-inline-item cited-by__entry__author">Loredana Sene, </li><li class="list-inline-item cited-by__entry__author">Sylvain Schaufelberger, </li><li class="list-inline-item cited-by__entry__author">Vincent Faivre, </li><li class="list-inline-item cited-by__entry__author">Mohamed Faouzi, </li><li class="list-inline-item cited-by__entry__author">Mary-Anne Hartley, </li><li class="list-inline-item cited-by__entry__author">FranÃ§ois Spertini, </li><li class="list-inline-item cited-by__entry__author">Blaise Genton, </li></ul><span class="cited-by__entry__title">A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland, </span><span class="cited-by__entry__series-title">BMC Infectious Diseases, </span><span class="cited-by__entry__volume"><strong>25</strong>, </span><span class="cited-by__entry__issue">1, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1186/s12879-025-10844-3" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1186/s12879-025-10844-3</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1186/s12879-025-10844-3" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Godfrey Tawodzera, </li><li class="list-inline-item cited-by__entry__author">Jonathan Crush, </li></ul><span class="cited-by__entry__title">Pandemic Precarity, Food Insecurity and Zimbabwean Migrants in South Africa During COVID-19, </span><span class="cited-by__entry__series-title">New Directions in South-South Migration, </span><span class="cited-by__entry__page-range">(427-445), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1007/978-981-97-9715-8_23" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1007/978-981-97-9715-8_23</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1007/978-981-97-9715-8_23" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Igor Rudan, </li><li class="list-inline-item cited-by__entry__author">Steven Kerr, </li><li class="list-inline-item cited-by__entry__author">Colin R Simpson, </li><li class="list-inline-item cited-by__entry__author">Amanj Kurdi, </li><li class="list-inline-item cited-by__entry__author">Davies Adeloye, </li><li class="list-inline-item cited-by__entry__author">Chris Robertson, </li><li class="list-inline-item cited-by__entry__author">Aziz Sheikh, </li></ul><span class="cited-by__entry__title">The COVID-19 pandemic in children and young people during 2022â24: what new did we learn?, </span><span class="cited-by__entry__series-title">Journal of Global Health, </span><span class="cited-by__entry__volume"><strong>15</strong>, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.7189/jogh.15.01002" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.7189/jogh.15.01002</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.7189/jogh.15.01002" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"></ul><span class="cited-by__entry__title">Are children and adolescents living with HIV in Europe and South Africa at higher risk of SARS-CoV-2 and poor COVID-19 outcomes?, </span><span class="cited-by__entry__series-title">Epidemiology and Infection, </span><span class="cited-by__entry__volume"><strong>153</strong>, </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1017/S0950268825000135" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1017/S0950268825000135</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1017/S0950268825000135" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Nigel Garrett, </li><li class="list-inline-item cited-by__entry__author">Asa Tapley, </li><li class="list-inline-item cited-by__entry__author">Aaron Hudson, </li><li class="list-inline-item cited-by__entry__author">Sufia Dadabhai, </li><li class="list-inline-item cited-by__entry__author">Bo Zhang, </li><li class="list-inline-item cited-by__entry__author">Nyaradzo M. Mgodi, </li><li class="list-inline-item cited-by__entry__author">Jessica Andriesen, </li><li class="list-inline-item cited-by__entry__author">Azwidihwi Takalani, </li><li class="list-inline-item cited-by__entry__author">Leigh H. Fisher, </li><li class="list-inline-item cited-by__entry__author">Jia Jin Kee, </li><li class="list-inline-item cited-by__entry__author">Craig A. Magaret, </li><li class="list-inline-item cited-by__entry__author">Manuel Villaran, </li><li class="list-inline-item cited-by__entry__author">John Hural, </li><li class="list-inline-item cited-by__entry__author">Erica Andersen-Nissen, </li><li class="list-inline-item cited-by__entry__author">Guido Ferarri, </li><li class="list-inline-item cited-by__entry__author">Maurine D. Miner, </li><li class="list-inline-item cited-by__entry__author">Bert Le Roux, </li><li class="list-inline-item cited-by__entry__author">Eduan Wilkinson, </li><li class="list-inline-item cited-by__entry__author">Richard Lessells, </li><li class="list-inline-item cited-by__entry__author">Tulio de Oliveira, </li><li class="list-inline-item cited-by__entry__author">Jackline Odhiambo, </li><li class="list-inline-item cited-by__entry__author">Parth Shah, </li><li class="list-inline-item cited-by__entry__author">Laura Polakowski, </li><li class="list-inline-item cited-by__entry__author">Margaret Yacovone, </li><li class="list-inline-item cited-by__entry__author">Taraz Samandari, </li><li class="list-inline-item cited-by__entry__author">Zvavahera Chirenje, </li><li class="list-inline-item cited-by__entry__author">Peter James Elyanu, </li><li class="list-inline-item cited-by__entry__author">Joseph Makhema, </li><li class="list-inline-item cited-by__entry__author">Ethel Kamuti, </li><li class="list-inline-item cited-by__entry__author">Harriet Nuwagaba-Biribonwoha, </li><li class="list-inline-item cited-by__entry__author">Sharlaa Badal-Faesen, </li><li class="list-inline-item cited-by__entry__author">William Brumskine, </li><li class="list-inline-item cited-by__entry__author">Soritha Coetzer, </li><li class="list-inline-item cited-by__entry__author">Rodney Dawson, </li><li class="list-inline-item cited-by__entry__author">Sinead Delany-Moretlwe, </li><li class="list-inline-item cited-by__entry__author">Andreas Henri Diacon, </li><li class="list-inline-item cited-by__entry__author">Samantha Fry, </li><li class="list-inline-item cited-by__entry__author">Katherine Margaret Gill, </li><li class="list-inline-item cited-by__entry__author">Zaheer Ahmed Ebrahim Hoosain, </li><li class="list-inline-item cited-by__entry__author">Mina C. Hosseinipour, </li><li class="list-inline-item cited-by__entry__author">Mubiana Inambao, </li><li class="list-inline-item cited-by__entry__author">Craig Innes, </li><li class="list-inline-item cited-by__entry__author">Steve Innes, </li><li class="list-inline-item cited-by__entry__author">Dishiki Kalonji, </li><li class="list-inline-item cited-by__entry__author">Margaret Kasaro, </li><li class="list-inline-item cited-by__entry__author">Priya Kassim, </li><li class="list-inline-item cited-by__entry__author">Noel Kayange, </li><li class="list-inline-item cited-by__entry__author">William Kilembe, </li><li class="list-inline-item cited-by__entry__author">Fatima Laher, </li><li class="list-inline-item cited-by__entry__author">Moelo Malahleha, </li><li class="list-inline-item cited-by__entry__author">Vongane Louisa Maluleke, </li><li class="list-inline-item cited-by__entry__author">Grace Mboya, </li><li class="list-inline-item cited-by__entry__author">Kirsten McHarry, </li><li class="list-inline-item cited-by__entry__author">Essack Mitha, </li><li class="list-inline-item cited-by__entry__author">Kathryn Mngadi, </li><li class="list-inline-item cited-by__entry__author">Pamela Mda, </li><li class="list-inline-item cited-by__entry__author">Tumelo Moloantoa, </li><li class="list-inline-item cited-by__entry__author">Cissy Kityo Mutuluuza, </li><li class="list-inline-item cited-by__entry__author">Nivashnee Naicker, </li><li class="list-inline-item cited-by__entry__author">Vimla Naicker, </li><li class="list-inline-item cited-by__entry__author">Anusha Nana, </li><li class="list-inline-item cited-by__entry__author">Annet Nanvubya, </li><li class="list-inline-item cited-by__entry__author">Maphoshane Nchabeleng, </li><li class="list-inline-item cited-by__entry__author">Walter Otieno, </li><li class="list-inline-item cited-by__entry__author">Elsje Louise Potgieter, </li><li class="list-inline-item cited-by__entry__author">Disebo Potloane, </li><li class="list-inline-item cited-by__entry__author">Zelda Punt, </li><li class="list-inline-item cited-by__entry__author">Jamil Said, </li><li class="list-inline-item cited-by__entry__author">Yashna Singh, </li><li class="list-inline-item cited-by__entry__author">Mohammed Siddique Tayob, </li><li class="list-inline-item cited-by__entry__author">Yacoob Vahed, </li><li class="list-inline-item cited-by__entry__author">Deo Ogema Wabwire, </li><li class="list-inline-item cited-by__entry__author">M. Juliana McElrath, </li><li class="list-inline-item cited-by__entry__author">James G. Kublin, </li><li class="list-inline-item cited-by__entry__author">Linda-Gail Bekker, </li><li class="list-inline-item cited-by__entry__author">Peter B. Gilbert, </li><li class="list-inline-item cited-by__entry__author">Lawrence Corey, </li><li class="list-inline-item cited-by__entry__author">Glenda E. Gray, </li><li class="list-inline-item cited-by__entry__author">Yunda Huang, </li><li class="list-inline-item cited-by__entry__author">Philip Kotze, </li><li class="list-inline-item cited-by__entry__author">Sharlaa Badal-Faesen, </li><li class="list-inline-item cited-by__entry__author">Kagisho Baepanye, </li><li class="list-inline-item cited-by__entry__author">Veronique Bailey, </li><li class="list-inline-item cited-by__entry__author">Katekani Baloyi-Oseh, </li><li class="list-inline-item cited-by__entry__author">Mumtaz Booley, </li><li class="list-inline-item cited-by__entry__author">Johannes Louis Botha, </li><li class="list-inline-item cited-by__entry__author">Yolande Brown, </li><li class="list-inline-item cited-by__entry__author">Valerie Brown, </li><li class="list-inline-item cited-by__entry__author">Lisa Bunts, </li><li class="list-inline-item cited-by__entry__author">Soritha Coetzer, </li><li class="list-inline-item cited-by__entry__author">Myron Cohen, </li><li class="list-inline-item cited-by__entry__author">Shirley Collie, </li><li class="list-inline-item cited-by__entry__author">Rodney Dawson, </li><li class="list-inline-item cited-by__entry__author">Pallabi Deb, </li><li class="list-inline-item cited-by__entry__author">Hana El Sahly, </li><li class="list-inline-item cited-by__entry__author">Jill El-Khorazaty, </li><li class="list-inline-item cited-by__entry__author">Andries Engelbrecht, </li><li class="list-inline-item cited-by__entry__author">Marianne Gildea, </li><li class="list-inline-item cited-by__entry__author">Dhevium Govender, </li><li class="list-inline-item cited-by__entry__author">Jen Hanke, </li><li class="list-inline-item cited-by__entry__author">Jayla Harris, </li><li class="list-inline-item cited-by__entry__author">Simone Hendricks, </li><li class="list-inline-item cited-by__entry__author">Nick Hopkinson, </li><li class="list-inline-item cited-by__entry__author">Haley Howell, </li><li class="list-inline-item cited-by__entry__author">Nzeera Ketter, </li><li class="list-inline-item cited-by__entry__author">Kentse Khuto, </li><li class="list-inline-item cited-by__entry__author">Faatima Laher Omar, </li><li class="list-inline-item cited-by__entry__author">Leolin Katsidzira, </li><li class="list-inline-item cited-by__entry__author">Kim Linton, </li><li class="list-inline-item cited-by__entry__author">James Ludwig, </li><li class="list-inline-item cited-by__entry__author">Bongile Mabilane, </li><li class="list-inline-item cited-by__entry__author">Matshidiso Malefo, </li><li class="list-inline-item cited-by__entry__author">Ndiitwani Mamushiana, </li><li class="list-inline-item cited-by__entry__author">Daciana Margineantu, </li><li class="list-inline-item cited-by__entry__author">Jeanine May, </li><li class="list-inline-item cited-by__entry__author">Fatima Mayat, </li><li class="list-inline-item cited-by__entry__author">Cindy Molitor, </li><li class="list-inline-item cited-by__entry__author">Yeshnee Naidoo, </li><li class="list-inline-item cited-by__entry__author">Michelle Nebergall, </li><li class="list-inline-item cited-by__entry__author">Alan Nguyen, </li><li class="list-inline-item cited-by__entry__author">Sarah Nikles, </li><li class="list-inline-item cited-by__entry__author">Bianca Noronha, </li><li class="list-inline-item cited-by__entry__author">Melissa Peda, </li><li class="list-inline-item cited-by__entry__author">Tamara Phiri, </li><li class="list-inline-item cited-by__entry__author">Shanthie Pillay, </li><li class="list-inline-item cited-by__entry__author">Sureshnee Pillay, </li><li class="list-inline-item cited-by__entry__author">Lori Proulx-Burns, </li><li class="list-inline-item cited-by__entry__author">Laurie Rinn, </li><li class="list-inline-item cited-by__entry__author">Lisa Sanders, </li><li class="list-inline-item cited-by__entry__author">Carrie Sopher, </li><li class="list-inline-item cited-by__entry__author">Smitha Sripathy, </li><li class="list-inline-item cited-by__entry__author">Michael Stirewalt, </li><li class="list-inline-item cited-by__entry__author">Houriiyah Tegally, </li><li class="list-inline-item cited-by__entry__author">Sara Thiebaud, </li><li class="list-inline-item cited-by__entry__author">Alicia Toledano, </li><li class="list-inline-item cited-by__entry__author">Stephanie Van Wyk, </li><li class="list-inline-item cited-by__entry__author">Shamaya Whitby, </li><li class="list-inline-item cited-by__entry__author">Stephany Wilcox, </li><li class="list-inline-item cited-by__entry__author">Eduan Wilkinson, </li><li class="list-inline-item cited-by__entry__author">Haven Wilvich, </li><li class="list-inline-item cited-by__entry__author">Charles Wiysonge, </li><li class="list-inline-item cited-by__entry__author">Nelisiwe Xaba, </li><li class="list-inline-item cited-by__entry__author">Ntokozo Xulu, </li></ul><span class="cited-by__entry__title">Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study, </span><span class="cited-by__entry__series-title">eClinicalMedicine, </span><span class="cited-by__entry__volume"><strong>80</strong>, </span><span class="cited-by__entry__page-range">(103054), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1016/j.eclinm.2024.103054" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1016/j.eclinm.2024.103054</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1016/j.eclinm.2024.103054" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Daniel J Hoffmann, </li><li class="list-inline-item cited-by__entry__author">Pieter W A Meyer, </li><li class="list-inline-item cited-by__entry__author">Catherine M Worsley, </li><li class="list-inline-item cited-by__entry__author">Mieke A van der Mescht, </li><li class="list-inline-item cited-by__entry__author">A Visser, </li><li class="list-inline-item cited-by__entry__author">Tahir S Pillay, </li></ul><span class="cited-by__entry__title">SARS-CoV-2 seropositivity amongst healthcare workers in South Africa during the Omicron wave: natural infection versus vaccination, </span><span class="cited-by__entry__series-title">Journal of Clinical Pathology, </span><span class="cited-by__entry__page-range">(jcp-2024-209722), </span><span class="cited-by__entry__pub-date">(2025).</span><a href="https://doi.org/10.1136/jcp-2024-209722" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1136/jcp-2024-209722</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1136/jcp-2024-209722" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Tomoo Nagai, </li><li class="list-inline-item cited-by__entry__author">Hitomi Horinouchi, </li><li class="list-inline-item cited-by__entry__author">Koichiro Yoshioka, </li><li class="list-inline-item cited-by__entry__author">Yuji Ikari, </li></ul><span class="cited-by__entry__title">Comparisons of echocardiographic findings of COVID-19 patients in intensive care units before and after the omicron variant propagation, </span><span class="cited-by__entry__series-title">Journal of Echocardiography, </span><span class="cited-by__entry__pub-date">(2024).</span><a href="https://doi.org/10.1007/s12574-024-00673-9" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.1007/s12574-024-00673-9</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.1007/s12574-024-00673-9" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Maria A. Gonzalez-Carmona, </li><li class="list-inline-item cited-by__entry__author">Alina M. Schmitz, </li><li class="list-inline-item cited-by__entry__author">Moritz Berger, </li><li class="list-inline-item cited-by__entry__author">Leona I. Baier, </li><li class="list-inline-item cited-by__entry__author">Jens G. Gorny, </li><li class="list-inline-item cited-by__entry__author">Farsaneh Sadeghlar, </li><li class="list-inline-item cited-by__entry__author">Thomas Anhalt, </li><li class="list-inline-item cited-by__entry__author">Xin Zhou, </li><li class="list-inline-item cited-by__entry__author">Taotao Zhou, </li><li class="list-inline-item cited-by__entry__author">Robert Mahn, </li><li class="list-inline-item cited-by__entry__author">Christian MÃ¶hring, </li><li class="list-inline-item cited-by__entry__author">Thomas Linnemann, </li><li class="list-inline-item cited-by__entry__author">Matthias Schmid, </li><li class="list-inline-item cited-by__entry__author">Christian P. Strassburg, </li><li class="list-inline-item cited-by__entry__author">Christoph Boesecke, </li><li class="list-inline-item cited-by__entry__author">JÃ¼rgen K. Rockstroh, </li><li class="list-inline-item cited-by__entry__author">Anna-Maria Eis-HÃ¼binger, </li><li class="list-inline-item cited-by__entry__author">Malte B. Monin, </li></ul><span class="cited-by__entry__title">Longitudinal Study of SARS-CoV-2 Vaccinations and Infections in Patients with Gastrointestinal Cancer: Stabilizing Immune Responses and Neutralizing Emerging Variants with Variant-Adapted Antigen Exposures, </span><span class="cited-by__entry__series-title">International Journal of Molecular Sciences, </span><span class="cited-by__entry__volume"><strong>25</strong>, </span><span class="cited-by__entry__issue">24, </span><span class="cited-by__entry__page-range">(13613), </span><span class="cited-by__entry__pub-date">(2024).</span><a href="https://doi.org/10.3390/ijms252413613" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.3390/ijms252413613</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.3390/ijms252413613" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry border-bottom pb-16 mb-24"><ul class="cited-by__entry__authors list-inline"><li class="list-inline-item cited-by__entry__author">Reshmi Dassaye, </li><li class="list-inline-item cited-by__entry__author">Terusha Chetty, </li><li class="list-inline-item cited-by__entry__author">Brodie Daniels, </li><li class="list-inline-item cited-by__entry__author">Zakir Gaffoor, </li><li class="list-inline-item cited-by__entry__author">Elizabeth Spooner, </li><li class="list-inline-item cited-by__entry__author">Trisha Ramraj, </li><li class="list-inline-item cited-by__entry__author">Ncengani Mthethwa, </li><li class="list-inline-item cited-by__entry__author">Duduzile Faith Nsibande, </li><li class="list-inline-item cited-by__entry__author">Saresha Pillay, </li><li class="list-inline-item cited-by__entry__author">Arvin Bhana, </li><li class="list-inline-item cited-by__entry__author">Vuyolwethu Magasana, </li><li class="list-inline-item cited-by__entry__author">Tarylee Reddy, </li><li class="list-inline-item cited-by__entry__author">Khanya Mohlabi, </li><li class="list-inline-item cited-by__entry__author">Penelope Linda Moore, </li><li class="list-inline-item cited-by__entry__author">Wendy A Burgers, </li><li class="list-inline-item cited-by__entry__author">Tulio de Oliveira, </li><li class="list-inline-item cited-by__entry__author">Nokukhanya Msomi, </li><li class="list-inline-item cited-by__entry__author">Ameena Goga, </li></ul><span class="cited-by__entry__title">SARS-CoV-2 Infections in a Triad of Primary School Learners (Grades 1-7), Their Parents, and Teachers in KwaZulu-Natal, South Africa: Protocol for a Cross-Sectional and Nested Case-Cohort Study, </span><span class="cited-by__entry__series-title">JMIR Research Protocols, </span><span class="cited-by__entry__volume"><strong>13</strong>, </span><span class="cited-by__entry__page-range">(e52713), </span><span class="cited-by__entry__pub-date">(2024).</span><a href="https://doi.org/10.2196/52713" title="Crossref" target="_blank" class="cited-by__entry__doi">https://doi.org/10.2196/52713</a><div class="cited-by__entry__extra-links"><a href="https://doi.org/10.2196/52713" target="_blank" class="cited-by__entry__visitable">Crossref</a></div></li><li class="cited-by__entry--see-more"><a href="javascript:void(0)" data-source="/pb/widgets/citedBy?page=1&amp;widgetId=efb4df9a-8e1a-47f9-bfb7-271959277a9f&amp;pbContext=%3BrequestedJournal%3Ajournal%3Anejm%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3Adoi%5C%3A10.1056%2FNEJMoa2119658%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AMMS+NextGen+Website+Group%3Bissue%3Aissue%3Adoi%5C%3A10.1056%2Fnejm_2022.386.issue-14%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bwebsite%3Awebsite%3Amms-site%3Bjournal%3Ajournal%3Anejms" class="cited-by__see-more">See more</a></li></ol></div><div class="cited-by__spinner justify-content-center align-items-center d-none"><div role="status" class="spinner-border text-gray"><span class="sr-only">Loading...</span></div></div></div></section>

        </div>
    

</section></section></div><div id="core-collateral-fulltext-options" role="tabpanel" data-core-tabs="core-collateral-fulltext-options" tabindex="-1" aria-labelledby="pane-core-collateral-fulltext-options"><header><h2 id="pane-core-collateral-fulltext-options"><i class="icon-eye" aria-hidden="true"></i>View Options</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div class="section--wrapper"><h3>View options</h3><section class="format--pdf"><h4> <abbr title="Portable Document Format">PDF</abbr></h4><a href="https://www.nejm.org/doi/pdf/10.1056/NEJMoa2119658" class="btn btn--pdf" aria-label="View PDF" data-behavior="trackDownloadEvent" data-doi="10.1056/NEJMoa2119658" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2119658.pdf"><i aria-hidden="true" class="icon-pdf"></i><span>View PDF</span></a></section></div><!-- Its needed to duplicate this for PB check Collateral.js as well--></div><div id="core-collateral-media" role="tabpanel" data-core-tabs="core-collateral-media" tabindex="-1" aria-labelledby="pane-core-collateral-media"><header><h2 id="pane-core-collateral-media"><i class="icon-photo" aria-hidden="true"></i>Media</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><div role="tablist"><button aria-controls="tab-figures" role="tab" id="tab-figures-label" aria-selected="true" class="active">Figures</button><button aria-controls="tab-other" role="tab" id="tab-other-label" tabindex="-1" aria-selected="false" class="inactive" aria-disabled="true">Other</button></div><section id="tab-figures" aria-labelledby="tab-figures-label" role="tabpanel" tabindex="0"><h3>Figures</h3><div class="text-right"><a class="btn btn--inverse  open-in-viewer" href="#figures"><span>Open all in viewer</span><i class="icon-open_in_new" aria-hidden="true"></i></a></div><div id="core-f1"><figure class="graphic"><a class="open-in-viewer" href="#f1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119658_f1.jpg"><img src="/cms/10.1056/NEJMoa2119658/asset/4ef19b00-4065-4054-a454-07c112cf4901/assets/images/large/nejmoa2119658_f1.jpg" height="2465" width="1656" aria-labelledby="f1" loading="lazy"></a><figcaption><div class="caption">Survey Participants.</div><div class="notes"><div role="doc-footnote">This survey (conducted from October 22 to December 9, 2021) included the same households that were sampled during our previous survey (conducted from November 4, 2020, to January 22, 2021).<sup><a href="#core-r9" role="doc-biblioref" data-xml-rid="r9" id="core-body-ref-r9-7" href-manipulated="true" aria-label="Reference 9" data-to-manipulate="false">9</a></sup> To account for possible nonparticipation, out-migration, and death since the previous survey, there was a 10% increase in the households that were sampled; the additional households were sampled in the same clusters used previously.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f1"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f1" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119658_f1.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f2"><figure class="graphic"><a class="open-in-viewer" href="#f2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119658_f2.jpg"><img src="/cms/10.1056/NEJMoa2119658/asset/efd94502-396c-4de6-ada2-108a741770fd/assets/images/large/nejmoa2119658_f2.jpg" height="2000" width="2640" aria-labelledby="f2" loading="lazy"></a><figcaption><div class="caption">Cases, Hospitalizations, Recorded Deaths, and Excess Deaths Attributable to Covid-19 in Gauteng, South Africa, from the Start of the Pandemic through January 12, 2022.</div><div class="notes"><div role="doc-footnote">Shown are incidences of daily cases, weekly hospitalizations, daily recorded deaths, and weekly excess deaths attributable to coronavirus disease 2019 (Covid-19). The inset shows the incidence of daily recorded deaths on an enlarged y axis. The horizontal dashed line indicates an incidence of zero. The data were sourced from the National Institute for Communicable Diseases daily databases through January 12, 2022, except for the data regarding weekly excess deaths attributable to Covid-19, which were defined by and sourced from the South African Medical Research Council through January 8, 2022.<sup><a href="#core-r16" role="doc-biblioref" data-xml-rid="r16" id="core-body-ref-r16-2" href-manipulated="true" aria-label="Reference 16" data-to-manipulate="false">16</a></sup> The B.1.1.529 (omicron) variant was first identified on November 25, 2021. Cases included asymptomatic and symptomatic infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confirmed by either a nucleic acid amplification assay or a rapid antigen test. Changes in the frequency of testing limit direct comparisons of case numbers; in particular, the lower frequency of testing during the first wave, which was due to constraints in laboratory capacity and prioritization of testing for hospitalized persons, prevents the direct comparison of cases from the first wave with those from subsequent waves. Hospitalizations included admissions for SARS-CoV-2 infection, as well as admissions for other illnesses in which SARS-CoV-2 infection was incidentally identified on routine screening at the time of admission. The DATCOV system was developed during the first wave, with gradual onboarding of facilities; thus, hospitalizations from the first wave may be underestimated. Definitions of recorded death and excess death attributable to Covid-19 are provided in the <a href="#ap1">Supplementary Appendix</a>.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f2"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f2" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119658_f2.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-f3"><figure class="graphic"><a class="open-in-viewer" href="#f3" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119658_f3.jpg"><img src="/cms/10.1056/NEJMoa2119658/asset/09301c66-3bac-4e1c-a405-b2e7e9aa81ea/assets/images/large/nejmoa2119658_f3.jpg" height="1963" width="2640" aria-labelledby="f3" loading="lazy"></a><figcaption><div class="caption">Covid-19 Cases, Hospitalizations, and Recorded Deaths in Gauteng, South Africa, According to Age Group.</div><div class="notes"><div role="doc-footnote">Shown are 7-day moving averages of the incidences of daily cases, hospitalizations, and recorded deaths among participants 4 years of age or younger (Panel A), 5 to 17 years of age (Panel B), 18 to 44 years of age (Panel C), 45 to 59 years of age (Panel D), and 60 years of age or older (Panel E). The horizontal dashed line indicates an incidence of zero. Because the incidences differ across age groups, different y-axis scales are used for each age group to provide clarity and aid in the visual interpretation of the trends in each group.</div></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#f3"><i class="icon-return" aria-hidden="true"></i><span>Go to Figure</span></a><a class="open-in-viewer" href="#f3" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119658_f3.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div></section><section id="tab-other" aria-labelledby="tab-other-label" role="tabpanel" tabindex="-1"><h3>Other</h3></section></div><div id="core-collateral-tables" role="tabpanel" data-core-tabs="core-collateral-tables" tabindex="-1" aria-labelledby="pane-core-collateral-tables"><header><h2 id="pane-core-collateral-tables"><i class="icon-tables" aria-hidden="true"></i>Tables</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><!-- There is no content. --><div class="section--wrapper"><div class="text-right"><a class="btn btn--inverse  open-in-viewer" href="#tables"><span>Open all in viewer</span><i class="icon-open_in_new" aria-hidden="true"></i></a></div><div id="core-t1"><figure class="table"><a class="open-in-viewer" href="#t1" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119658_t1.jpg"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><img src="/cms/10.1056/NEJMoa2119658/asset/3bf78d71-c370-4922-84f3-7faff734fcf9/assets/images/large/nejmoa2119658_t1.jpg" height="3438" width="1334" loading="lazy"></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Variable</th><th class="txxx-borders">Overall</th><th class="txxx-borders" colspan="2"><span>Seroprevalence</span></th><th class="txxr-borders">Association with Seropositivity<a href="#core-t1fn2" role="doc-noteref">â </a></th></tr><tr class="head3" data-type="row head3" data-xml-valign="top"><td class="xxlx-borders hanging03">&nbsp;</td><th class="xxxx-borders">no. (%)</th><th class="xxxx-borders">no.</th><th class="xxxx-borders">% (95% CI)</th><th class="xxxr-borders">risk ratio (95% CI)</th></tr></thead><tbody><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging03 shading" data-xml-align="left">All participants<a href="#core-t1fn3" role="doc-noteref">â¡</a></td><td class="xxxx-borders shading">7010 (100)</td><td class="xxxx-borders shading">5123</td><td class="xxxx-borders shading">73.1 (72.0â74.1)</td><td class="xxxr-borders shading">â</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Sex</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Male</td><td class="xxxx-borders shading">2941 (42.0)</td><td class="xxxx-borders shading">1998</td><td class="xxxx-borders shading">67.9 (66.2â69.6)</td><td class="xxxr-borders shading">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Female</td><td class="xxxx-borders">4065 (58.0)</td><td class="xxxx-borders">3125</td><td class="xxxx-borders">76.9 (75.5â78.1)</td><td class="xxxr-borders">1.13 (1.10â1.17)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Not reported</td><td class="xxxx-borders shading">4 (&lt;0.1)</td><td class="xxxx-borders shading">â</td><td class="xxxx-borders shading">â</td><td class="xxxr-borders shading">â</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Age group<a href="#core-t1fn4" role="doc-noteref">Â§</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">&lt;12 yr</td><td class="xxxx-borders shading">753 (10.7)</td><td class="xxxx-borders shading">423</td><td class="xxxx-borders shading">56.2 (52.6â59.7)</td><td class="xxxr-borders shading">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">12 to 17 yr</td><td class="xxxx-borders">622 (8.9)</td><td class="xxxx-borders">459</td><td class="xxxx-borders">73.8 (70.2â77.1)</td><td class="xxxr-borders">1.31 (1.21â1.42)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">18 to 50 yr</td><td class="xxxx-borders shading">4047 (57.7)</td><td class="xxxx-borders shading">2977</td><td class="xxxx-borders shading">73.6 (72.2â74.9)</td><td class="xxxr-borders shading">1.30 (1.23â1.40)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">&gt;50 yr</td><td class="xxxx-borders">1588 (22.7)</td><td class="xxxx-borders">1264</td><td class="xxxx-borders">79.7 (77.6â81.5)</td><td class="xxxr-borders">1.42 (1.32â1.52)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">Vaccination status<a href="#core-t1fn4" role="doc-noteref">Â§</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Unvaccinated</td><td class="xxxx-borders">5691 (81.2)</td><td class="xxxx-borders">3895</td><td class="xxxx-borders">68.4 (67.2â69.6)</td><td class="xxxr-borders">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Vaccinated</td><td class="xxxx-borders shading">1319 (18.8)</td><td class="xxxx-borders shading">1228</td><td class="xxxx-borders shading">93.1 (91.6â94.3)</td><td class="xxxr-borders shading">1.36 (1.33â1.39)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Vaccination status according to age group<a href="#core-t1fn4" role="doc-noteref">Â§</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-type="row"><td class="xxlx-borders hanging13 shading">Unvaccinated</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23" data-xml-align="left">&lt;12 yr</td><td class="xxxx-borders">753 (10.7)</td><td class="xxxx-borders">423</td><td class="xxxx-borders">55.8 (52.2â59.4)</td><td class="xxxr-borders">0.81 (0.76â0.86)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23 shading" data-xml-align="left">12 to 17 yr</td><td class="xxxx-borders shading">603 (8.6)</td><td class="xxxx-borders shading">443</td><td class="xxxx-borders shading">73.5 (69.8â76.8)</td><td class="xxxr-borders shading">1.06 (1.00â1.11)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23" data-xml-align="left">18 to 50 yr</td><td class="xxxx-borders">3356 (47.9)</td><td class="xxxx-borders">2334</td><td class="xxxx-borders">69.5 (68.0â71.1)</td><td class="xxxr-borders">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23 shading" data-xml-align="left">&gt;50 yr</td><td class="xxxx-borders shading">979 (14.0)</td><td class="xxxx-borders shading">695</td><td class="xxxx-borders shading">71.0 (68.1â73.7)</td><td class="xxxr-borders shading">1.02 (0.97â1.07)</td></tr><tr data-type="row"><td class="xxlx-borders hanging13">Vaccinated</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23 shading" data-xml-align="left">&lt;12 yr</td><td class="xxxx-borders shading">0</td><td class="xxxx-borders shading">0</td><td class="xxxx-borders shading">â</td><td class="xxxr-borders shading">â</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23" data-xml-align="left">12 to 17 yr</td><td class="xxxx-borders">19 (0.3)</td><td class="xxxx-borders">16</td><td class="xxxx-borders">84.2 (60.8â94.8)</td><td class="xxxr-borders">1.21 (1.00â1.47)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23 shading" data-xml-align="left">18 to 50 yr</td><td class="xxxx-borders shading">691 (9.9)</td><td class="xxxx-borders shading">643</td><td class="xxxx-borders shading">93.1 (90.9â94.7)</td><td class="xxxr-borders shading">1.33 (1.30â1.38)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging23" data-xml-align="left">&gt;50 yr</td><td class="xxxx-borders">609 (8.7)</td><td class="xxxx-borders">569</td><td class="xxxx-borders">93.4 (91.2â95.1)</td><td class="xxxr-borders">1.34 (1.30â1.39)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">Previous Covid-19 testing</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Never tested</td><td class="xxxx-borders">5956 (85.0)</td><td class="xxxx-borders">4271</td><td class="xxxx-borders">71.7 (70.6â72.8)</td><td class="xxxr-borders">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Tested positive</td><td class="xxxx-borders shading">195 (2.8)</td><td class="xxxx-borders shading">172</td><td class="xxxx-borders shading">88.2 (82.9â92.0)</td><td class="xxxr-borders shading">1.23 (1.17â1.30)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Tested negative</td><td class="xxxx-borders">859 (12.3)</td><td class="xxxx-borders">680</td><td class="xxxx-borders">79.3 (76.3â81.8)</td><td class="xxxr-borders">1.10 (1.06â1.15)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging03 shading" data-xml-align="left">Household members per room<a href="#core-t1fn5" role="doc-noteref">Â¶</a></td><td class="xxxx-borders shading">1 (0.5â1.5)</td><td class="xxxx-borders shading">â</td><td class="xxxx-borders shading">â</td><td class="xxxr-borders shading">1.01 (1.00â1.02)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Occupation</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Unemployed</td><td class="xxxx-borders shading">4102 (58.5)</td><td class="xxxx-borders shading">3014</td><td class="xxxx-borders shading">73.5 (72.1â74.8)</td><td class="xxxr-borders shading">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Production</td><td class="xxxx-borders">381 (5.4)</td><td class="xxxx-borders">279</td><td class="xxxx-borders">73.2 (68.6â77.4)</td><td class="xxxr-borders">1.00 (0.94â1.06)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Education, public transportation, or retail</td><td class="xxxx-borders shading">661 (9.4)</td><td class="xxxx-borders shading">509</td><td class="xxxx-borders shading">77.0 (73.6â80.1)</td><td class="xxxr-borders shading">1.05 (1.00â1.10)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Health care</td><td class="xxxx-borders">73 (1.0)</td><td class="xxxx-borders">63</td><td class="xxxx-borders">86.3 (76.4â92.5)</td><td class="xxxr-borders">1.17 (1.07â1.29)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Office work or other</td><td class="xxxx-borders shading">353 (5.0)</td><td class="xxxx-borders shading">277</td><td class="xxxx-borders shading">78.5 (73.9â82.4)</td><td class="xxxr-borders shading">1.06 (1.01â1.13)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Student</td><td class="xxxx-borders">1440 (20.5)</td><td class="xxxx-borders">981</td><td class="xxxx-borders">68.1 (65.7â70.5)</td><td class="xxxr-borders">0.93 (0.89â0.96)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">Smoking status<a href="#core-t1fn6" role="doc-noteref">â</a></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">None</td><td class="xxxx-borders">4168 (59.5)</td><td class="xxxx-borders">3234</td><td class="xxxx-borders">77.6 (76.3â78.8)</td><td class="xxxr-borders">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Daily</td><td class="xxxx-borders shading">1125 (16.1)</td><td class="xxxx-borders shading">748</td><td class="xxxx-borders shading">66.5 (63.7â69.2)</td><td class="xxxr-borders shading">0.86 (0.82â0.90)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Once or twice a week</td><td class="xxxx-borders">244 (3.5)</td><td class="xxxx-borders">181</td><td class="xxxx-borders">74.2 (68.3â79.3)</td><td class="xxxr-borders">0.96 (0.89â1.03)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Occasionally</td><td class="xxxx-borders shading">203 (2.9)</td><td class="xxxx-borders shading">157</td><td class="xxxx-borders shading">77.3 (71.1â82.6)</td><td class="xxxr-borders shading">1.00 (0.92â1.08)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Coexisting conditions</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">None</td><td class="xxxx-borders shading">4731 (67.5)</td><td class="xxxx-borders shading">3507</td><td class="xxxx-borders shading">74.1 (72.9â75.4)</td><td class="xxxr-borders shading">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">â¥1</td><td class="xxxx-borders">2279 (32.5)</td><td class="xxxx-borders">1616</td><td class="xxxx-borders">70.9 (69.0â72.7)</td><td class="xxxr-borders">0.96 (0.93â0.99)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03 shading">HIV status</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Negative</td><td class="xxxx-borders">6460 (92.2)</td><td class="xxxx-borders">4727</td><td class="xxxx-borders">73.2 (72.1â74.2)</td><td class="xxxr-borders">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Positive</td><td class="xxxx-borders shading">550 (7.8)</td><td class="xxxx-borders shading">396</td><td class="xxxx-borders shading">72.0 (68.1â75.6)</td><td class="xxxr-borders shading">0.98 (0.93â1.04)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">Dwelling type<a href="#core-t1fn7" role="doc-noteref">**</a></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Formal standalone house</td><td class="xxxx-borders shading">4700 (67.0)</td><td class="xxxx-borders shading">3488</td><td class="xxxx-borders shading">74.2 (72.9â75.4)</td><td class="xxxr-borders shading">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Informal settlement</td><td class="xxxx-borders">1147 (16.4)</td><td class="xxxx-borders">761</td><td class="xxxx-borders">66.3 (63.6â69.0)</td><td class="xxxr-borders">0.89 (0.86â0.93)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Block of flats or high-rise building</td><td class="xxxx-borders shading">423 (6.0)</td><td class="xxxx-borders shading">329</td><td class="xxxx-borders shading">77.8 (73.6â81.5)</td><td class="xxxr-borders shading">1.05 (0.99â1.11)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Subsidized low-income housing</td><td class="xxxx-borders">666 (9.5)</td><td class="xxxx-borders">494</td><td class="xxxx-borders">74.3 (70.8â77.4)</td><td class="xxxr-borders">1.00 (0.95â1.05)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Other</td><td class="xxxx-borders shading">74 (1.1)</td><td class="xxxx-borders shading">51</td><td class="xxxx-borders shading">68.9 (57.5â78.4)</td><td class="xxxr-borders shading">0.93 (0.80â1.08)</td></tr><tr data-type="row"><td class="xxlx-borders hanging03">District</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Johannesburg</td><td class="xxxx-borders shading">2468 (35.2)</td><td class="xxxx-borders shading">1880</td><td class="xxxx-borders shading">76.2 (74.5â77.8)</td><td class="xxxr-borders shading">Reference</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Ekurhuleni</td><td class="xxxx-borders">1861 (26.5)</td><td class="xxxx-borders">1382</td><td class="xxxx-borders">74.3 (72.2â76.2)</td><td class="xxxr-borders">0.97 (0.94â1.01)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13 shading" data-xml-align="left">Sedibeng</td><td class="xxxx-borders shading">564 (8.0)</td><td class="xxxx-borders shading">397</td><td class="xxxx-borders shading">70.4 (66.5â74.0)</td><td class="xxxr-borders shading">0.92 (0.87â0.98)</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging13" data-xml-align="left">Tshwane</td><td class="xxxx-borders">1464 (20.9)</td><td class="xxxx-borders">975</td><td class="xxxx-borders">66.7 (54.2â69.0)</td><td class="xxxr-borders">0.87 (0.84â0.91)</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging13 shading" data-xml-align="left">West Rand</td><td class="xbxx-borders shading">653 (9.3)</td><td class="xbxx-borders shading">489</td><td class="xbxx-borders shading">74.9 (71.4â78.1)</td><td class="xbxr-borders shading">0.98 (0.94â1.03)</td></tr></tbody></table></div><figcaption><div class="notes"><div role="doc-footnote" data-has="label"><div class="label">*</div><div id="core-t1fn1" role="paragraph" data-to-manipulate="true">Covid-19 denotes coronavirus disease 2019, HIV human immunodeficiency virus, and SARS-CoV-2 severe acute respiratory syndrome coronavirus 2.</div></div><div role="doc-footnote" data-has="label"><div class="label">â </div><div id="core-t1fn2" role="paragraph" data-to-manipulate="true">Analyses of associations with seropositivity for SARS-CoV-2 were performed with the use of generalized linear models with log link to estimate risk ratios. These were unadjusted, univariable analyses for each risk factor. Confidence intervals were not adjusted for multiplicity and should not be used for inference.</div></div><div role="doc-footnote" data-has="label"><div class="label">â¡</div><div id="core-t1fn3" role="paragraph" data-to-manipulate="true">Two participants had serologic test results that could not be linked to the main questionnaire and were excluded from the analyses.</div></div><div role="doc-footnote" data-has="label"><div class="label">Â§</div><div id="core-t1fn4" role="paragraph" data-to-manipulate="true">Age group and vaccination status were not included in the regression model; instead, an interaction term between age group and vaccination status was introduced to account for the differences in seroprevalence according to vaccination status across age groups. Vaccination status was obtained from vaccination certificates for 1026 of the 1327 participants (77.3%) who reported being vaccinated.</div></div><div role="doc-footnote" data-has="label"><div class="label">Â¶</div><div id="core-t1fn5" role="paragraph" data-to-manipulate="true">The median and interquartile range are shown, rather than the number and percentage. The risk ratio shows the increase in the risk of seropositivity with one additional household member per room (i.e., for every additional household member, there is a 1.01 increase in risk).</div></div><div role="doc-footnote" data-has="label"><div class="label">â</div><div id="core-t1fn6" role="paragraph" data-to-manipulate="true">Smoking status was assessed only in the 5740 participants who were 18 years of age or older.</div></div><div role="doc-footnote" data-has="label"><div class="label">**</div><div id="core-t1fn7" role="paragraph" data-to-manipulate="true">Dwelling types were defined in accordance with the national census classification.</div></div></div></figcaption></a><figcaption><div class="caption">Seroprevalence of IgG against SARS-CoV-2 Spike Protein or Nucleocapsid Protein in Gauteng, South Africa, from October 22 to December 9, 2021, and Risk Factors for Seropositivity.<a href="#core-t1fn1" role="doc-noteref">*</a></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#t1"><i class="icon-return" aria-hidden="true"></i><span>Go to Table</span></a><a class="open-in-viewer" href="#t1" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119658_t1.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div><div id="core-t2"><figure class="table"><a class="open-in-viewer" href="#t2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119658_t2.jpg"><div class="graphic-wrap" data-presentation="suppressed-in-viewer"><img src="/cms/10.1056/NEJMoa2119658/asset/015ce533-697b-4212-9351-adfb2b58443d/assets/images/large/nejmoa2119658_t2.jpg" height="2389" width="1711" loading="lazy"></div><div class="table-wrap catalyst-standard" data-presentation="suppressed-in-flow"><table data-shading="custom"><thead><tr class="head1" data-type="row head1"><th class="txlx-borders" data-xml-align="left">Outcome</th><th class="txxx-borders">Wave 1, Wild-Type</th><th class="txxx-borders">Wave 2, Beta</th><th class="txxx-borders">Wave 3, Delta</th><th class="txxx-borders">Wave 4, Omicron</th><th class="txxr-borders">Total</th></tr></thead><tbody><tr data-type="row"><td class="xxlx-borders hanging01 shading"><b>Cases<a href="#core-t2fn2" role="doc-noteref">â </a></b></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left">Period of wave</td><td class="xxxx-borders">March 7â Nov. 13, 2020</td><td class="xxxx-borders">Nov. 14, 2020â March 30, 2021</td><td class="xxxx-borders">March 31â Oct. 25, 2021</td><td class="xxxx-borders">Oct. 26, 2021â Jan. 12, 2022</td><td class="xxxr-borders">March 7, 2020â Jan. 12, 2022</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">No.</td><td class="xxxx-borders shading">232,130</td><td class="xxxx-borders shading">182,564</td><td class="xxxx-borders shading">511,638</td><td class="xxxx-borders shading">226,932</td><td class="xxxr-borders shading">1,153,264</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left">No. per 100,000 population</td><td class="xxxx-borders">1498</td><td class="xxxx-borders">1178</td><td class="xxxx-borders">3301</td><td class="xxxx-borders">1464</td><td class="xxxr-borders">7440</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">Percent of total</td><td class="xxxx-borders shading">20.1</td><td class="xxxx-borders shading">15.8</td><td class="xxxx-borders shading">44.4</td><td class="xxxx-borders shading">19.7</td><td class="xxxr-borders shading">100</td></tr><tr data-type="row"><td class="xxlx-borders hanging01"><b>Hospitalizations<a href="#core-t2fn3" role="doc-noteref">â¡</a></b></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">Period of wave</td><td class="xxxx-borders shading">March 7â Nov. 6, 2020</td><td class="xxxx-borders shading">Nov. 7, 2020â April 6, 2021</td><td class="xxxx-borders shading">April 7â Oct. 31, 2021</td><td class="xxxx-borders shading">Nov. 1, 2021â Jan. 12, 2022</td><td class="xxxr-borders shading">March 7, 2020â Jan. 12, 2022</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left">No.</td><td class="xxxx-borders">33,315</td><td class="xxxx-borders">30,685</td><td class="xxxx-borders">61,642</td><td class="xxxx-borders">15,789</td><td class="xxxr-borders">141,431</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">No. per 100,000 population</td><td class="xxxx-borders shading">215</td><td class="xxxx-borders shading">198</td><td class="xxxx-borders shading">398</td><td class="xxxx-borders shading">102</td><td class="xxxr-borders shading">912</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left">Percent of total</td><td class="xxxx-borders">23.6</td><td class="xxxx-borders">21.7</td><td class="xxxx-borders">43.6</td><td class="xxxx-borders">11.2</td><td class="xxxr-borders">100</td></tr><tr data-type="row"><td class="xxlx-borders hanging01 shading"><b>Recorded deaths<a href="#core-t2fn4" role="doc-noteref">Â§</a></b></td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxx-borders shading">&nbsp;</td><td class="xxxr-borders shading">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left">Period of wave</td><td class="xxxx-borders">March 31â Dec. 14, 2020</td><td class="xxxx-borders">Dec. 15, 2020â May 2, 2021</td><td class="xxxx-borders">May 3â Nov. 19, 2021</td><td class="xxxx-borders">Nov. 20, 2021â Jan. 12, 2022</td><td class="xxxr-borders">March 31, 2020â Jan. 12, 2022</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">No.</td><td class="xxxx-borders shading">6443</td><td class="xxxx-borders shading">7084</td><td class="xxxx-borders shading">14,256</td><td class="xxxx-borders shading">1116</td><td class="xxxr-borders shading">28,899</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left">No. per 100,000 population</td><td class="xxxx-borders">42</td><td class="xxxx-borders">46</td><td class="xxxx-borders">92</td><td class="xxxx-borders">7</td><td class="xxxr-borders">186</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">Percent of total</td><td class="xxxx-borders shading">22.3</td><td class="xxxx-borders shading">24.5</td><td class="xxxx-borders shading">49.3</td><td class="xxxx-borders shading">3.9</td><td class="xxxr-borders shading">100</td></tr><tr data-type="row"><td class="xxlx-borders hanging01"><b>Excess deaths<a href="#core-t2fn4" role="doc-noteref">Â§</a></b></td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxx-borders">&nbsp;</td><td class="xxxr-borders">&nbsp;</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">Period of wave</td><td class="xxxx-borders shading">May 9â Dec. 19, 2020</td><td class="xxxx-borders shading">Dec. 20, 2020â March 26, 2021</td><td class="xxxx-borders shading">March 27â Nov. 25, 2021</td><td class="xxxx-borders shading">Nov. 26, 2021â Jan. 8, 2022</td><td class="xxxr-borders shading">May 9, 2020â Jan. 8, 2022</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01" data-xml-align="left">No.</td><td class="xxxx-borders">13,476</td><td class="xxxx-borders">11,970</td><td class="xxxx-borders">30,546</td><td class="xxxx-borders">1,927</td><td class="xxxr-borders">57,919</td></tr><tr data-xml-align="center" data-type="row"><td class="xxlx-borders hanging01 shading" data-xml-align="left">No. per 100,000 population</td><td class="xxxx-borders shading">87</td><td class="xxxx-borders shading">77</td><td class="xxxx-borders shading">197</td><td class="xxxx-borders shading">12</td><td class="xxxr-borders shading">374</td></tr><tr data-xml-align="center" data-type="row"><td class="xblx-borders hanging01" data-xml-align="left">Percent of total</td><td class="xbxx-borders">23.3</td><td class="xbxx-borders">20.7</td><td class="xbxx-borders">52.7</td><td class="xbxx-borders">3.3</td><td class="xbxr-borders">100</td></tr></tbody></table></div></a><figcaption><a class="open-in-viewer" href="#t2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119658_t2.jpg"></a><div class="notes"><a class="open-in-viewer" href="#t2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119658_t2.jpg"></a><div role="doc-footnote" data-has="label"><a class="open-in-viewer" href="#t2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119658_t2.jpg"><div class="label">*</div></a><div id="core-t2fn1" role="paragraph" data-to-manipulate="true"><a class="open-in-viewer" href="#t2" data-index="0" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119658_t2.jpg">Data are shown for the first wave of Covid-19, dominated by wild-type virus; the second wave, dominated by the B.1.351 (beta) variant; the third wave, dominated by the B.1.617.2 (delta) variant; and the fourth wave, dominated by the B.1.1.529 (omicron) variant. The data were sourced from the National Institute for Communicable Diseases daily databases through January 12, 2022, except for the data regarding weekly excess deaths attributable to Covid-19, which were defined by and sourced from the South African Medical Research Council through January 8, 2022.<sup></sup></a><a href="#core-r16" role="doc-biblioref" data-xml-rid="r16" id="core-body-ref-r16-3" href-manipulated="true" aria-label="Reference 16" data-to-manipulate="false">16</a> As compared with the reporting of cases, there was a lag in the reporting of hospitalizations, recorded deaths, and excess deaths; thus, each of these outcomes has a different period for each wave. As of January 12, 2022, the case incidence had not yet fully returned to the level before the onset of the fourth wave; numbers, incidences, and proportions of cases, hospitalizations, and deaths were anticipated to continue to increase somewhat. However, the subsequent increases were limited, with the incidence of excess death attributable to Covid-19 having declined to 0 per 100,000 population by January 15, 2022.</div></div><div role="doc-footnote" data-has="label"><div class="label">â </div><div id="core-t2fn2" role="paragraph" data-to-manipulate="true">Cases included asymptomatic and symptomatic SARS-CoV-2 infections confirmed by either a nucleic acid amplification assay or a rapid antigen test. Changes in the frequency of testing limit direct comparisons of case numbers; in particular, the lower frequency of testing during the first wave, which was due to constraints in laboratory capacity and prioritization of testing for hospitalized persons, prevents the direct comparison of cases from the first wave with those from subsequent waves.</div></div><div role="doc-footnote" data-has="label"><div class="label">â¡</div><div id="core-t2fn3" role="paragraph" data-to-manipulate="true">Hospitalizations included admissions for SARS-CoV-2 infection, as well as admissions for other illnesses in which SARS-CoV-2 infection was incidentally identified on routine screening at the time of admission. The DATCOV system was developed during the first wave, with gradual onboarding of facilities; thus, hospitalizations from the first wave may be underestimated.</div></div><div role="doc-footnote" data-has="label"><div class="label">Â§</div><div id="core-t2fn4" role="paragraph" data-to-manipulate="true">Definitions of recorded death and excess death attributable to Covid-19 are provided in the <a href="#ap1">Supplementary Appendix</a>.</div></div></div></figcaption><figcaption><div class="caption">Cumulative Reported Cases, Hospitalizations, Recorded Deaths, and Excess Deaths Attributable to Covid-19 in Gauteng, South Africa, According to Covid-19 Wave.<a href="#core-t2fn1" role="doc-noteref">*</a></div></figcaption></figure><div class="external-links"><a class="pill__to-original" href="#t2"><i class="icon-return" aria-hidden="true"></i><span>Go to Table</span></a><a class="open-in-viewer" href="#t2" data-interactiontype="multimedia_click" data-multimedia-type="Table" data-multimedia-filename="nejmoa2119658_t2.jpg"><span>Open in Viewer</span><i class="icon-expand" aria-hidden="true"></i></a></div></div></div></div><div id="core-collateral-share" role="tabpanel" data-core-tabs="core-collateral-share" tabindex="-1" aria-labelledby="pane-core-collateral-share"><header><h2 id="pane-core-collateral-share"><i class="icon-share" aria-hidden="true"></i>Share</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>Share</h3><div class="section--wrapper"><section><h4>CONTENT LINK</h4><div id="share-self"><p data-id="article-share-self-link" class="share-self__source">https://www.nejm.org/doi/full/10.1056/NEJMoa2119658</p><button data-id="article-share-access" aria-label="CONTENT LINK" class="share-self__action btn btn--inverse"><i aria-hidden="true" class="icon-copy-o"></i><span>Copy Link</span></button><div aria-live="polite" class="share-self__status"><p class="share-self__success"><i aria-hidden="true" class="icon-check_circle"></i><span>Copied!</span></p><p class="share-self__failed"><i aria-hidden="true" class="icon-x_btnclose"></i><span>Copying failed.</span></p></div></div></section><section data-location="share_tools_article"><h4>Share</h4><div class="share-buttons a2a a2a_kit" style="line-height: 16px;"><a href="/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i><span>Facebook</span></a><a href="/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i><span>X (formerly Twitter)</span></a><a href="/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i><span>LinkedIn</span></a><a href="/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i><span>email</span></a><a href="/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i><span>Bluesky</span></a></div></section></div></div><div data-location="references_article" id="core-collateral-references" role="tabpanel" aria-labelledby="pane-core-collateral-references" data-core-tabs="core-collateral-references" tabindex="-1"><header><h2 id="pane-core-collateral-references"><i aria-hidden="true" class="icon-references"></i>References</h2><button data-close="collateral" aria-label="Close"><i class="icon-close"></i></button></header><h3>References</h3><div role="list" class="section--wrapper"><div role="listitem" data-has="label"><div class="label">1.</div><div id="core-r1" class="citations"><div class="citation"><div class="citation-content">Callaway E. Heavily mutated Omicron variant puts scientists on alert. <em>Nature</em> 2021;600:21-21.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r1"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/d41586-021-03552-w" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34824381/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000724224500013" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Heavily+mutated+Omicron+variant+puts+scientists+on+alert.&amp;publication_year=2021&amp;journal=Nature&amp;pages=21-21&amp;doi=10.1038%2Fd41586-021-03552-w&amp;pmid=34824381" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">2.</div><div id="core-r2" class="citations"><div class="citation"><div class="citation-content">World Health Organization. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. November 26, 2021 (<a href="https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern">https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r2"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Classification+of+Omicron+%28B.1.1.529%29%3A+SARS-CoV-2+variant+of+concern&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">3.</div><div id="core-r3" class="citations"><div class="citation"><div class="citation-content">European Centre for Disease Prevention and Control. Implications of the emergence and spread of the SARS-CoV-2 B.1.1. 529 variant of concern (Omicron) for the EU/EEA. November 26, 2021 (<a href="https://www.ecdc.europa.eu/sites/default/files/documents/Implications-emergence-spread-SARS-CoV-2%20B.1.1.529-variant-concern-Omicron-for-the-EU-EEA-Nov2021.pdf">https://www.ecdc.europa.eu/sites/default/files/documents/Implications-emergence-spread-SARS-CoV-2%20B.1.1.529-variant-concern-Omicron-for-the-EU-EEA-Nov2021.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r5"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Implications+of+the+emergence+and+spread+of+the+SARS-CoV-2+B.1.1.+529+variant+of+concern+%28Omicron%29+for+the+EU%2FEEA&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">4.</div><div id="core-r4" class="citations"><div class="citation"><div class="citation-content">UK Health Security Agency. SARS-CoV-2 variants of concern and variants under investigation in England: technical briefing 29. November 26, 2021 (<a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1036501/Technical_Briefing_29_published_26_November_2021.pdf">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1036501/Technical_Briefing_29_published_26_November_2021.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r5"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+variants+of+concern+and+variants+under+investigation+in+England%3A+technical+briefing+29&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">5.</div><div id="core-r5" class="citations"><div class="citation"><div class="citation-content">Chen J, Wang R, Gilby NB, Wei GW. Omicron variant (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance. <em>J Chem Inf Model</em> 2022;62:412-422.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r5"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.jcim.1c01451" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34989238/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000743548000001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Omicron+variant+%28B.1.1.529%29%3A+infectivity%2C+vaccine+breakthrough%2C+and+antibody+resistance.&amp;publication_year=2022&amp;journal=J+Chem+Inf+Model&amp;pages=412-422&amp;doi=10.1021%2Facs.jcim.1c01451&amp;pmid=34989238" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">6.</div><div id="core-r6" class="citations"><div class="citation"><div class="citation-content">Callaway E, Ledford H. How bad is Omicron? What scientists know so far. <em>Nature</em> 2021;600:197-199.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r6"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/d41586-021-03614-z" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34857948/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000727856300008" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=How+bad+is+Omicron%3F+What+scientists+know+so+far.&amp;publication_year=2021&amp;journal=Nature&amp;pages=197-199&amp;doi=10.1038%2Fd41586-021-03614-z&amp;pmid=34857948" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">7.</div><div id="core-r7" class="citations"><div class="citation"><div class="citation-content">Cele S, Gazy I, Jackson L, et al. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. <em>Nature</em> 2021;593:142-146.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r7-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-021-03471-w" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33780970/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000642083300001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Escape+of+SARS-CoV-2+501Y.V2+from+neutralization+by+convalescent+plasma.&amp;publication_year=2021&amp;journal=Nature&amp;pages=142-146&amp;doi=10.1038%2Fs41586-021-03471-w&amp;pmid=33780970" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r7-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r7-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and 1 nucleocapsid-protein mutation. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r26" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] activity than even the beta variant. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">8.</div><div id="core-r8" class="citations"><div class="citation"><div class="citation-content">South African National Institute for Communicable Diseases. Network for genomic surveillance in South Africa SARS-CoV-2 sequencing update. December 31, 2021 (<a href="https://www.nicd.ac.za/wp-content/uploads/2022/01/Update-of-SA-sequencing-data-from-GISAID-30-Dec-2021_dash.pdf">https://www.nicd.ac.za/wp-content/uploads/2022/01/Update-of-SA-sequencing-data-from-GISAID-30-Dec-2021_dash.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r8"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Network+for+genomic+surveillance+in+South+Africa+SARS-CoV-2+sequencing+update&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">9.</div><div id="core-r9" class="citations"><div class="citation"><div class="citation-content">Mutevedzi PC, Kawonga M, Kwatra G, et al. Estimated SARS-CoV-2 infection rate and fatality risk in Gauteng Province, South Africa: a population-based seroepidemiological survey. <em>Int J Epidemiol</em> 2021 October 30 (Epub ahead of print).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r9-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/ije/dyab217" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34718591/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000790047400001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Estimated+SARS-CoV-2+infection+rate+and+fatality+risk+in+Gauteng+Province%2C+South+Africa%3A+a+population-based+seroepidemiological+survey.&amp;publication_year=2021&amp;journal=Int+J+Epidemiol&amp;doi=10.1093%2Fije%2Fdyab217&amp;pmid=34718591" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r9-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r9-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] that was completed on January 22, 2021. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r9-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] 5% to 43% across provincial subdistricts. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r9-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] from November 4, 2020, to January 22, 2021. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r9-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] framework used, have been published </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r9-5" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>e [...] the use of an electronic questionnaire. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r9-6" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>f [...] in our previous survey have been published </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#f1" role="menuitem" data-target="#fv-body-ref-r9-7"><i aria-hidden="true" class="icon-return"></i><span>g [...] November 4, 2020, to January 22, 2021). </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">10.</div><div id="core-r10" class="citations"><div class="citation"><div class="citation-content">South African National Institute for Communicable Diseases. SARS-CoV-2 genomic surveillance update June 2021. July 1, 2021 (<a href="https://www.nicd.ac.za/wp-content/uploads/2021/07/Sequencing-update-1July-2021_V14.pdf">https://www.nicd.ac.za/wp-content/uploads/2021/07/Sequencing-update-1July-2021_V14.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r10"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+genomic+surveillance+update+June+2021&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">11.</div><div id="core-r11" class="citations"><div class="citation"><div class="citation-content">Statistics South Africa. Statistical release P0302: mid-year population estimates 2020. July 31, 2021 (<a href="http://www.statssa.gov.za/publications/P0302/P03022020.pdf">http://www.statssa.gov.za/publications/P0302/P03022020.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r11-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Statistical+release+P0302%3A+mid-year+population+estimates+2020&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r11-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r11-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] West Rand) that comprise 26 subdistricts. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r11-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] population (15.5 of 59.6 million persons). </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r11-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] for South Africa and its provinces. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">12.</div><div id="core-r12" class="citations"><div class="citation"><div class="citation-content">Kwatra G, Nunes M, Dhar N, et al. Correlation of dried blood spots and plasma for quantification of Immunoglobulin (IgG) against receptor binding domain and full length spike protein of SARS-CoV-2. <em>J Virol Methods</em> 2022;300:114394-114394.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r13"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.jviromet.2021.114394" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34861318/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000755192700013" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Correlation+of+dried+blood+spots+and+plasma+for+quantification+of+Immunoglobulin+%28IgG%29+against+receptor+binding+domain+and+full+length+spike+protein+of+SARS-CoV-2.&amp;publication_year=2022&amp;journal=J+Virol+Methods&amp;pages=114394-114394&amp;doi=10.1016%2Fj.jviromet.2021.114394&amp;pmid=34861318" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">13.</div><div id="core-r13" class="citations"><div class="citation"><div class="citation-content">Madhi SA, Koen AL, Izu A, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial. <em>Lancet HIV</em> 2021;8(9):e568-e580.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r13"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S2352-3018(21)00157-0" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34416193/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000692541700012" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+immunogenicity+of+the+ChAdOx1+nCoV-19+%28AZD1222%29+vaccine+against+SARS-CoV-2+in+people+living+with+and+without+HIV+in+South+Africa%3A+an+interim+analysis+of+a+randomised%2C+double-blind%2C+placebo-controlled%2C+phase+1B%2F2A+trial.&amp;publication_year=2021&amp;journal=Lancet+HIV&amp;pages=e568-e580&amp;doi=10.1016%2FS2352-3018%2821%2900157-0&amp;pmid=34416193" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">14.</div><div id="core-r14" class="citations"><div class="citation"><div class="citation-content">National Institute for Communicable Diseases. Daily hospital surveillance (DATCOV) report (<a href="https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/">https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Daily+hospital+surveillance+%28DATCOV%29+report" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">15.</div><div id="core-r15" class="citations"><div class="citation"><div class="citation-content">Jassat W, Mudara C, Ozougwu L, et al. Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study. <em>Lancet Glob Health</em> 2021;9(9):e1216-e1225.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r15"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S2214-109X(21)00289-8" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34252381/" target="_blank">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Difference+in+mortality+among+individuals+admitted+to+hospital+with+COVID-19+during+the+first+and+second+waves+in+South+Africa%3A+a+cohort+study.&amp;publication_year=2021&amp;journal=Lancet+Glob+Health&amp;pages=e1216-e1225&amp;doi=10.1016%2FS2214-109X%2821%2900289-8&amp;pmid=34252381" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">16.</div><div id="core-r16" class="citations"><div class="citation"><div class="citation-content">Bradshaw D, Laubscher R, Dorrington R, Groenewald P, Moultrie T. Report on weekly deaths in South Africa 26 Dec 2021 â 1 Jan 2022 (week 52). <em>South African Medical Research Council</em>, January 4, 2022 (<a href="https://www.samrc.ac.za/sites/default/files/files/2022-01-05/weekly1Jan2022.pdf">https://www.samrc.ac.za/sites/default/files/files/2022-01-05/weekly1Jan2022.pdf</a>).</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r16-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Report+on+weekly+deaths+in+South+Africa+26+Dec+2021+%E2%80%94+1+Jan+2022+%28week+52%29&amp;publication_year=2022" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r16-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r16-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] Research Council through January 8, 2022. </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#f2" role="menuitem" data-target="#fv-body-ref-r16-2"><i aria-hidden="true" class="icon-return"></i><span>b [...] Research Council through January 8, 2022. </span></a></li><li role="none"><a class="to-citation open-in-viewer" href="#t2" role="menuitem" data-target="#fv-body-ref-r16-3"><i aria-hidden="true" class="icon-return"></i><span>c [...] Research Council through January 8, 2022. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">17.</div><div id="core-r17" class="citations"><div class="citation"><div class="citation-content">National Institute for Communicable Diseases. Weekly hospital surveillance (DATCOV) update (<a href="https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/weekly-hospital-surveillance-datcov-update/">https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/weekly-hospital-surveillance-datcov-update/</a>).</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r17"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Weekly+hospital+surveillance+%28DATCOV%29+update" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">18.</div><div id="core-r18" class="citations"><div class="citation"><div class="citation-content">Milne G, Hames T, Scotton C, et al. Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity? <em>Lancet Respir Med</em> 2021;9:1450-1466.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r18"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S2213-2600(21)00407-0" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34688434/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000729806800029" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Does+infection+with+or+vaccination+against+SARS-CoV-2+lead+to+lasting+immunity%3F&amp;publication_year=2021&amp;journal=Lancet+Respir+Med&amp;pages=1450-1466&amp;doi=10.1016%2FS2213-2600%2821%2900407-0&amp;pmid=34688434" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">19.</div><div id="core-r19" class="citations"><div class="citation"><div class="citation-content">Alter G, Yu J, Liu J, et al. Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans. <em>Nature</em> 2021;596:268-272.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r19-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-021-03681-2" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34107529/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000668492400001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Immunogenicity+of+Ad26.COV2.S+vaccine+against+SARS-CoV-2+variants+in+humans.&amp;publication_year=2021&amp;journal=Nature&amp;pages=268-272&amp;doi=10.1038%2Fs41586-021-03681-2&amp;pmid=34107529" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r19-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r19-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] immunity in the context of small mutations, </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r23-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] and natural killerâcell activation. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r23-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] (or a combination of these mechanisms). </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">20.</div><div id="core-r20" class="citations"><div class="citation"><div class="citation-content">Dan JM, Mateus J, Kato Y, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. <em>Science</em> 2021;371:eabf4063-eabf4063.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r20"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.abf4063" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33408181/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000615715300044" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Immunological+memory+to+SARS-CoV-2+assessed+for+up+to+8+months+after+infection.&amp;publication_year=2021&amp;journal=Science&amp;pages=eabf4063-eabf4063&amp;doi=10.1126%2Fscience.abf4063&amp;pmid=33408181" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">21.</div><div id="core-r21" class="citations"><div class="citation"><div class="citation-content">Keeton R, Tincho MB, Ngomti A, et al. SARS-CoV-2 spike T cell responses induced upon vaccination or infection remain robust against Omicron. December 28, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.12.26.21268380v1">https://www.medrxiv.org/content/10.1101/2021.12.26.21268380v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r21-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+spike+T+cell+responses+induced+upon+vaccination+or+infection+remain+robust+against+Omicron&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r21-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r22-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] to protection against severe disease. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r22-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] variant warrants further investigation. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">22.</div><div id="core-r22" class="citations"><div class="citation"><div class="citation-content">Tarke A, Coelho CH, Zhang Z, et al. SARS-CoV-2 vaccination induces immunological memory able to cross-recognize variants from Alpha to Omicron. December 28, 2021 (<a href="https://www.biorxiv.org/content/10.1101/2021.12.28.474333v1">https://www.biorxiv.org/content/10.1101/2021.12.28.474333v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r22-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+vaccination+induces+immunological+memory+able+to+cross-recognize+variants+from+Alpha+to+Omicron&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r22-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r22-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] to protection against severe disease. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r22-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] variant warrants further investigation. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">23.</div><div id="core-r23" class="citations"><div class="citation"><div class="citation-content">Gorman MJ, Patel N, Guebre-Xabier M, et al. Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination. <em>Cell Rep Med</em> 2021;2:100405-100405.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r23-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.xcrm.2021.100405" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34485950/" target="_blank">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Fab+and+Fc+contribute+to+maximal+protection+against+SARS-CoV-2+following+NVX-CoV2373+subunit+vaccine+with+Matrix-M+vaccination.&amp;publication_year=2021&amp;journal=Cell+Rep+Med&amp;pages=100405-100405&amp;doi=10.1016%2Fj.xcrm.2021.100405&amp;pmid=34485950" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r23-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r23-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] and natural killerâcell activation. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r23-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] (or a combination of these mechanisms). </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">24.</div><div id="core-r24" class="citations"><div class="citation"><div class="citation-content">RÃ¶ssler A, Riepler L, Bante D, von Laer D, Kimpel J. SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals. December 11, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.12.08.21267491v1">https://www.medrxiv.org/content/10.1101/2021.12.08.21267491v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r24-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+B.1.1.529+variant+%28Omicron%29+evades+neutralization+by+sera+from+vaccinated+and+convalescent+individuals&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r24-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r26" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] activity than even the beta variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r24-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] than that against the wild-type virus. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">25.</div><div id="core-r25" class="citations"><div class="citation"><div class="citation-content">Gilbert PB, Montefiori DC, McDermott AB, et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. <em>Science</em> 2022;375:43-50.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r25-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.abm3425" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34812653/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000740261400037" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Immune+correlates+analysis+of+the+mRNA-1273+COVID-19+vaccine+efficacy+clinical+trial.&amp;publication_year=2022&amp;journal=Science&amp;pages=43-50&amp;doi=10.1126%2Fscience.abm3425&amp;pmid=34812653" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r25-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r26" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] activity than even the beta variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r25-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] antibody responses than vaccination. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r25-3" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>c [...] antibodies than two doses of BNT162b2 </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r25-4" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>d [...] SARS-CoV-2 infection or mild Covid-19 </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">26.</div><div id="core-r26" class="citations"><div class="citation"><div class="citation-content">Dejnirattisai W, Huo J, Zhou D, et al. Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. December 22, 2021 (<a href="https://www.biorxiv.org/content/10.1101/2021.12.03.471045v2">https://www.biorxiv.org/content/10.1101/2021.12.03.471045v2</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r26"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Omicron-B.1.1.529+leads+to+widespread+escape+from+neutralizing+antibody+responses&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">27.</div><div id="core-r27" class="citations"><div class="citation"><div class="citation-content">Dejnirattisai W, Shaw RH, Supasa P, et al. Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum. <em>Lancet</em> 2022;399:234-236.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r28"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)02844-0" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34942101/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000746041700016" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Reduced+neutralisation+of+SARS-CoV-2+omicron+B.1.1.529+variant+by+post-immunisation+serum.&amp;publication_year=2022&amp;journal=Lancet&amp;pages=234-236&amp;doi=10.1016%2FS0140-6736%2821%2902844-0&amp;pmid=34942101" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">28.</div><div id="core-r28" class="citations"><div class="citation"><div class="citation-content">Cele S, Jackson L, Khan K, et al. SARS-CoV-2 omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection. December 17, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.12.08.21267417v3">https://www.medrxiv.org/content/10.1101/2021.12.08.21267417v3</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r28"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=SARS-CoV-2+omicron+has+extensive+but+incomplete+escape+of+Pfizer+BNT162b2+elicited+neutralization+and+requires+ACE2+for+infection&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">29.</div><div id="core-r29" class="citations"><div class="citation"><div class="citation-content">Andrews N, Stowe J, Kirsebom F, et al. Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern. December 14, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.12.14.21267615v1">https://www.medrxiv.org/content/10.1101/2021.12.14.21267615v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r29-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+COVID-19+vaccines+against+the+Omicron+%28B.1.1.529%29+variant+of+concern&amp;publication_year=2021" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r29-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r29-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] after two doses of AZD1222 or BNT162b2. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r29-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] 2 weeks after a booster dose of BNT162b2, </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">30.</div><div id="core-r30" class="citations"><div class="citation"><div class="citation-content">Munro APS, Janani L, Cornelius V, et al. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. <em>Lancet</em> 2021;398:2258-2276.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r30"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0140-6736(21)02717-3" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34863358/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000731484500012" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Safety+and+immunogenicity+of+seven+COVID-19+vaccines+as+a+third+dose+%28booster%29+following+two+doses+of+ChAdOx1+nCov-19+or+BNT162b2+in+the+UK+%28COV-BOOST%29%3A+a+blinded%2C+multicentre%2C+randomised%2C+controlled%2C+phase+2+trial.&amp;publication_year=2021&amp;journal=Lancet&amp;pages=2258-2276&amp;doi=10.1016%2FS0140-6736%2821%2902717-3&amp;pmid=34863358" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">31.</div><div id="core-r31" class="citations"><div class="citation"><div class="citation-content">Collie S, Champion J, Moultrie H, Bekker LG, Gray G. Effectiveness of BNT162b2 vaccine against Omicron variant in South Africa. <em>N Engl J Med</em> 2021;386:494-496.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r31-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_32_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119658&amp;key=10.1056%2FNEJMc2119270&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34965358/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000735528700001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+BNT162b2+vaccine+against+Omicron+variant+in+South+Africa.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=494-496&amp;doi=10.1056%2FNEJMc2119270&amp;pmid=34965358" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r31-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r31-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] compared with 93% with the delta variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r31-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] disease with BNT162b2 in South Africa </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">32.</div><div id="core-r32" class="citations"><div class="citation"><div class="citation-content">Madhi SA, Baillie V, Cutland CL, et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant. <em>N Engl J Med</em> 2021;384:1885-1898.</div><div class="external-links"><div class="to-citation__wrapper"><button aria-controls="to-citation__accordion-r32-core" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="Hide Citations" data-collapsed-title="Show Citations" class="accordion__toggle__title"></span></button></div><div class="core-xlink-crossref"><a href="/servlet/linkout?suffix=e_1_3_5_33_2&amp;dbid=4&amp;doi=10.1056%2FNEJMoa2119658&amp;key=10.1056%2FNEJMoa2102214&amp;site=mms-site" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33725432/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000640360100001" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Efficacy+of+the+ChAdOx1+nCoV-19+Covid-19+vaccine+against+the+B.1.351+variant.&amp;publication_year=2021&amp;journal=N+Engl+J+Med&amp;pages=1885-1898&amp;doi=10.1056%2FNEJMoa2102214&amp;pmid=33725432" target="_blank">Google Scholar</a></div><div role="menu" aria-label="links" class="to-citation__accordion no-separator" id="to-citation__accordion-r32-core" style="display: none;"><ul role="none"><li role="none"><a class="to-citation" href="#body-ref-r32-1" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>a [...] Covid-19 due to the beta variant. </span></a></li><li role="none"><a class="to-citation" href="#body-ref-r32-2" role="menuitem"><i aria-hidden="true" class="icon-return"></i><span>b [...] affected by mutations in the beta variant. </span></a></li></ul></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">33.</div><div id="core-r33" class="citations"><div class="citation"><div class="citation-content">Nasreen S, Chung H, He S, et al. Effectiveness of COVID-19 vaccines against variants of concern in Ontario, Canada. July 16, 2021 (<a href="https://www.medrxiv.org/content/10.1101/2021.06.28.21259420v2">https://www.medrxiv.org/content/10.1101/2021.06.28.21259420v2</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r33"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=Effectiveness+of+COVID-19+vaccines+against+variants+of+concern+in+Ontario%2C+Canada&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">34.</div><div id="core-r34" class="citations"><div class="citation"><div class="citation-content">Fischer RJ, van Doremalen N, Adney DR, et al. ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7. <em>Nat Commun</em> 2021;12:5868-5868.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r34"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41467-021-26178-y" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34620866/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000704983300013" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=ChAdOx1+nCoV-19+%28AZD1222%29+protects+Syrian+hamsters+against+SARS-CoV-2+B.1.351+and+B.1.1.7.&amp;publication_year=2021&amp;journal=Nat+Commun&amp;pages=5868-5868&amp;doi=10.1038%2Fs41467-021-26178-y&amp;pmid=34620866" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">35.</div><div id="core-r35" class="citations"><div class="citation"><div class="citation-content">Liu Y, RocklÃ¶v J. The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus. <em>J Travel Med</em> 2021;28:taab124-taab124.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r35"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/jtm/taab124" target="_blank">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34369565/" target="_blank">PubMed</a></div><div class="core-xlink-isi"><a href="https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&amp;DestApp=WOS_CPL&amp;UsrCustomerID=5e3815c904498985e796fc91436abd9a&amp;SrcAuth=atyponcel&amp;SrcApp=literatum&amp;DestLinkType=FullRecord&amp;KeyUT=000711240500024" target="_blank">Web of Science</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+reproductive+number+of+the+Delta+variant+of+SARS-CoV-2+is+far+higher+compared+to+the+ancestral+SARS-CoV-2+virus.&amp;publication_year=2021&amp;journal=J+Travel+Med&amp;pages=taab124-taab124&amp;doi=10.1093%2Fjtm%2Ftaab124&amp;pmid=34369565" target="_blank">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div class="label">36.</div><div id="core-r36" class="citations"><div class="citation"><div class="citation-content">Diamond M, Halfmann P, Maemura T, et al. The SARS-CoV-2 B.1.1.529 omicron virus causes attenuated infection and disease in mice and hamsters. December 29, 2021 (<a href="https://www.researchsquare.com/article/rs-1211792/v1">https://www.researchsquare.com/article/rs-1211792/v1</a>). preprint.</div><div class="external-links"><div class="to-citation__wrapper"><a class="to-citation" href="#body-ref-r36"><i aria-hidden="true" class="icon-return"></i><span>Go to Citation</span></a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?title=The+SARS-CoV-2+B.1.1.529+omicron+virus+causes+attenuated+infection+and+disease+in+mice+and+hamsters&amp;publication_year=2021" target="_blank">Google Scholar</a></div></div></div></div></div></div></div></div><aside data-core-aside="right-rail">



        
        <div id="DTM_Position_MedRectangle" class="ad">
 <!--emptycomment-->
</div>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="relatedArticlesWidget" data-widget-id="8206d5cd-cb8c-4ff9-8c46-3d22e0dee215" data-location="recirc_curatedRelated_article">
        



        
        <div class="ng-related-articles"><h3 class="ng-subsection-title"><span class="ng-subsection-title_text">Related articles</span></h3><ul class="ng-related-articles_list"><li class="ng-related-articles_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/editorial" class="issue-item_type">Editorial</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Apr 06, 2022</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMe2201812" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Omicron â Decoupling Infection from Severe Disease</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">P.L. Moore and L.R. Baden</span></div></div></div></div></div></li></ul></div>

        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <div id="nejm_jobs" class="nejm_jobs"> <!-- top red rectangle --><div id="nejm-widget" class="nejm-widget" style="display: block;"><div class="nejm-widget_logo">	<a target="nejm-win" href="https://www.nejmcareercenter.org/?query=fjw">		<img alt="CareerCenter" src="https://apps1.nejmcareercenter.org/images/nejmCCID-JobsWidget.gif" width="140" height="36">	</a></div><div class="nejm-widget_cont"> <!-- content --><div class="nejm-widget_title">PHYSICIAN JOBS</div><div class="nejm-widget_date">June 10, 2025</div><div class="nejm-widget_item"><div><span> Indianapolis, Indiana</span></div><div><span>Anesthesiology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/893316/academic-anesthesiology-pain-management-opportunity/?query=fjwp&amp;rid=17394">Academic Anesthesiology - Pain Management Opportunity</a></div></div><div class="nejm-widget_item"><div><span> Centerville, Ohio</span></div><div><span>Anesthesiology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/881348/anesthesiologist-hospital-based-dayton-oh-600-000-/?query=fjwp&amp;rid=74242">Anesthesiologist - Hospital-Based (Dayton, OH) - $600,000+ </a></div></div><div class="nejm-widget_item"><div><span> California</span></div><div><span>Neurology</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/889159/physician-neurology-soquel-ca-/?query=fjwf&amp;rid=845671">Physician, Neurology (Soquel, CA)</a></div></div><div class="nejm-widget_item"><div><span> Jacksonville, Florida</span></div><div><span>Hospitalist</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/885530/physician-hospitalist-baptist-medical-center-south-day-shift/?query=fjwf&amp;rid=462833">Physician - Hospitalist - Baptist Medical Center South - Day Shift</a></div></div><div class="nejm-widget_item"><div><span> Texas</span></div><div><span>Family Medicine</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/889030/physician-family-medicine/?query=fjwf&amp;rid=385607">Physician - Family Medicine</a></div></div><div class="nejm-widget_item"><div><span> Putnam, Connecticut</span></div><div><span>Primary Care</span></div><div><a target="nejm-job-win" onmouseover="jlho(this);" onmouseout="jlou(this);" href="https://www.nejmcareercenter.org/job/881629/physician-primary-care-prohealth-physicians-at-putnam-medical-associates/?query=fjwf&amp;rid=220874">Physician - Primary Care | ProHealth Physicians at Putnam Medical Associates</a></div></div></div> <!-- content --> <!-- footer --></div> <!-- nejm-widget --></div><script src="https://apps1.nejmcareercenter.org/?width=300&amp;sp=all"></script>




        
        <div class="ng-page_layout-sidebarSpacing"></div>










    
    
        <div data-widget-def="literatumAd" data-widget-id="001e4aa7-b6fe-4b21-9d5b-5bde81227c67" id="ad-article-right-rail-300x250-1">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <a href="/action/clickThrough?id=128720&amp;url=https%3A%2F%2Fstore.nejm.org%2Fsignup%2Fnejmai%2Fregister%2Faifallpdf24%3Fpromo%3DOAFQF4NA%26query%3Dcm-rr%26utm_source%3Dnejm%26utm_medium%3Dcm%26utm_campaign%3Daifallpdf24&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2119658&amp;pubId=41283530&amp;placeholderId=101337&amp;productId=1007" target="_blank"><img src="/sda/128720/NEJ-AI-Fall24-300x250---002.jpg" width="300" height="250"></a>
            
        </div>
    

    

    



        </div>
    





        
        <div class="ng-page_layout-sidebarSpacing"></div>




        
        <script src="https://widgets.nejm.org/onepub-widgets/loader/webcomponents-loader.js" async="" nonce="94d6c9e08714a4d7-GRU">
<script src="https://widgets.nejm.org/onepub-widgets/loader/polyfill-support.js"  nonce="94d6c9e08714a4d7-GRU"></script>
<script src="https://widgets.nejm.org/onepub-widgets/more-like-this.js" type="module" nonce="94d6c9e08714a4d7-GRU"></script>

<more-like-this class="onepub-widget" dataid="onepub-more-like-this" collections="catalyst-article, clinician-article, evidence-article, nejm-ai-article, nejm-article" headertitle="More Like This" maxitems="5"><!----><div class="more-like-this onepub-more-like-this_"><!--?lit$355073375$--><onepub-fonts><wc-fetch></wc-fetch><!--?lit$355073375$--><div class="mlt-wrapper"><div class="mlt-header-container"><div class="mlt-header-content-left"><div class="mlt-header-title-container"><span class="mlt-header-title">More Like This</span></div><!--?lit$355073375$--></div></div><div class="mlt-body"><!--?lit$355073375$--><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$355073375$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$355073375$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$355073375$-->Mar 31, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2118691?query=recirc_Semantic" target="_self">Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection</a></div><div class="mlt-article-authors"><!--?lit$355073375$-->V. Hall and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$355073375$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$355073375$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$355073375$-->May 20, 2021</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2102214?query=recirc_Semantic" target="_self">Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant</a></div><div class="mlt-article-authors"><!--?lit$355073375$-->S.A. Madhi and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$355073375$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$355073375$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$355073375$-->Dec 16, 2021</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2105290?query=recirc_Semantic" target="_self">Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine</a></div><div class="mlt-article-authors"><!--?lit$355073375$-->A.R. Falsey and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/original-article" target="_self"><!--?lit$355073375$-->Original Article</a> <span class="mlt-article-site-label"><!--?lit$355073375$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$355073375$-->Jun 09, 2022</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMoa2118946?query=recirc_Semantic" target="_self">Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2</a></div><div class="mlt-article-authors"><!--?lit$355073375$-->Y. Goldberg and Others</div></div><!----><!----><div class="mlt-article-container"><div class="mlt-article-container-header"><a data-location="recirc_Semantic" class="mlt-article-type nejm" href="https://www.nejm.org/browse/nejm-article-type/editorial" target="_self"><!--?lit$355073375$-->Editorial</a> <span class="mlt-article-site-label"><!--?lit$355073375$-->NEJM</span> <span class="mlt-article-pubdate"><!--?lit$355073375$-->Jan 14, 2021</span></div><div class="mlt-article-title"><a data-location="recirc_Semantic" href="https://www.nejm.org/doi/full/10.1056/NEJMe2100736?query=recirc_Semantic" target="_self">Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant</a></div><div class="mlt-article-authors"><!--?lit$355073375$-->E.J. Rubin and Others</div></div><!----></div><div class="mlt-footer"></div></div></onepub-fonts><style>:host{display:block}@keyframes fadeIn{0%{opacity:0}100%{opacity:1}}.more-like-this{max-width:25rem}.more-like-this *{font-variant-numeric:lining-nums}.mlt-wrapper{animation:fadeIn 1s}.mlt-header-container{border-bottom:#4d4d4d solid .0625rem;border-top:#4d4d4d solid .125rem}.mlt-header-title{color:#1a1a1a;display:block;font-family:var(--sans-serif);font-size:1rem;font-weight:700;letter-spacing:.02rem;line-height:1.5rem;padding-bottom:.94rem;padding-top:.94rem;text-transform:uppercase}.mlt-header-description{color:#333;display:block;font-family:ff-scala-sans-pro;font-size:.75rem;letter-spacing:.05rem;margin-top:-.5rem;padding-bottom:1rem;text-transform:uppercase}.mlt-article-container{border-bottom:#e5e5e5 solid .0625rem;margin-top:1.38rem}.mlt-article-container-header{font-family:var(--sans-serif);font-size:.6875rem;letter-spacing:.04em;line-height:1.125rem;margin:0 0 1rem;text-transform:uppercase}.mlt-article-type{font-weight:700;line-height:1.25rem;letter-spacing:.04rem;text-decoration:none}.mlt-article-type:hover{text-decoration:underline}.nejm{color:#f30}.nejm-ai{color:#006197}.nejm-catalyst{color:#5708a6}.nejm-evidence{color:#69a323}.mlt-article-site-label::after,.mlt-article-type::after{border-right:1px solid #e5e5e5;content:'';display:inline;padding:.1875rem .375rem .125rem 0;margin:0 .375rem 0 0}.mlt-article-pubdate{color:#666;font-style:normal;font-weight:700;line-height:1.25rem;letter-spacing:.04em}.mlt-article-authors{color:#666;font-family:var(--sans-serif);font-size:1rem;font-style:normal;font-weight:400;letter-spacing:normal;line-height:1.5rem;margin-bottom:1.38rem}.mlt-article-site-label{color:#666;font-style:normal;font-weight:700;letter-spacing:.04em}.mlt-article-title{margin-bottom:.5rem}.mlt-article-title>a{background-image:linear-gradient(#f30,#f30);background-position:0 90%;background-repeat:no-repeat;background-size:0 0;color:#1a1a1a;font-family:var(--quadraat-web);font-size:1.25rem;font-style:normal;font-weight:700;letter-spacing:normal;line-height:1.8rem;margin:1.5rem 0 .35rem 0;text-decoration:none;transition:background .25s ease-in-out}.mlt-article-title>a:hover{background-position:0 98%;background-size:100% .125rem;text-decoration:none}.skeleton-card{box-shadow:0 0 4px 1px rgba(0,0,0,.1);margin:1rem 0;padding:1rem}</style></div></more-like-this>




        
        <div><div class="pb-dropzone" data-pb-dropzone="col-0" title="col-0"></div></div>










    
    
        <div data-widget-def="UX3HTMLWidget" data-widget-id="ad06db99-f228-4c92-9ad7-c4ae0fdbdbf1" id="bc-web-rec">
        



        
        <!-- BlueConic TEST empty HTML widget with DIV wrapper with id=bc-web-rec -->

        </div>
    

</aside></article><div data-extent="article-wrapper"><div class="core-container"></div><div class="after-credits"><div class="core-container"><a href="/doi/pdf/10.1056/NEJMoa2119658?download=true" id="downloadPdfUrl" data-doi="10.1056/NEJMoa2119658" data-behavior="trackDownloadEvent" data-interactiontype="article_tools_download_pdf" data-multimedia-type="Article PDF" data-multimedia-filename="nejmoa2119658.pdf"><span>Download PDF</span></a></div></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1056/NEJMoa2119658"}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><div class="articles-nav"></div><template id="figure_nav_template"><nav><a href="#" title="Open in viewer" class="open-in-viewer"><i aria-hidden="true" class="icon-expand"></i></a></nav></template><template id="fv_panel_template" data-sharesocial="Share"><div class="fv__panel js--hidden"><div class="fv__panel__text"><div class="fv__panel__contentTitle"></div><div class="fv__panel__contentText"></div></div></div></template>
<template id="fv_directory_template" data-overlay="View figure"><div class="fv__directory"><div class="fv__header"><nav class="tab__nav"></nav><a href="#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"></div></div></template><template id="fv_directory_tabItem_template" data-figures="Figures" data-others="Others" data-tables="Tables"><button role="tab" data-toggle="tab" class="tab__nav__item"></button></template>
<template id="fv_lightbox_template" data-sr-back="Go to figure location within the article" data-sr-closealt="Close" data-sr-download="Toggle download panel" data-sr-download-pptx="Download PPT" data-sr-info="Toggle information panel" data-sr-panel="Close panel" data-sr-share="Toggle share panel" data-sr-zoom="Zoom" data-text-close="Back to article" data-text-nav-figures="All figures" data-text-nav-others="All others" data-text-nav-tables="All tables" data-text-viewall="View all material" data-title-back="Back to article" data-title-closealt="Close" data-title-download="Download" data-title-download-pptx="Download PPT" data-title-info="Info" data-title-share="Share" data-title-zoom="Zoom"></template>
<template id="fv_toolbar_template"><div class="fv__toolbar__info"><strong class="fv__toolbar__contentTitle uppercase"></strong><p class="fv__toolbar__contentText"></p></div></template><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-return"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-return"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-return"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--secondary"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-references="References" data-figure="Go to Figure" data-media="Go to Media" data-more="More" data-original="Go to original" data-table="Go to Table" data-inviewer="Open in Viewer" data-allinviewer="Open all in viewer"><svg data-tags="copyright" viewBox="0 0 24 24"><path d="M12 20.016q3.281 0 5.648-2.368T20.016 12t-2.368-5.648T12 3.984 6.352 6.352 3.984 12t2.368 5.648T12 20.016zm0-18q4.125 0 7.055 2.93T21.985 12t-2.93 7.055T12 21.985t-7.055-2.93T2.015 12t2.93-7.055T12 2.015zm-.14 7.125q-1.876 0-1.876 2.718v.282q0 2.718 1.875 2.718.704 0 1.172-.398t.469-1.008h1.781q0 1.172-1.031 2.063-.984.843-2.39.843-1.876 0-2.86-1.125t-.984-3.093v-.282q0-1.921.937-3 1.125-1.265 2.906-1.265 1.547 0 2.438.89.984.985.984 2.297H13.5q0-.328-.14-.61-.235-.468-.329-.562-.469-.468-1.172-.468z"></path></svg><span>Request permissions</span><i aria-hidden="true" class="icon-open_in_new"></i></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template>

        <div role="navigation" aria-label="Sticky Navigation" class="st-header"><div class="st-header__content"><div class="st-header__item st-header__menu"></div><div class="st-header__current st-header__item"><div class="st-header__label">Now Reading:</div><div class="st-header__title">Population Immunity and Covid-19 Severity with Omicron Variant in South Africa</div></div><div class="st-header__share st-header__item"><div class="share-dropblock dropdown"><a id="sticky-header-dropBlock" href="#" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false" class="dropdown-toggle"><span title="" data-toggle="tooltip" data-trigger="hover" data-original-title="Share options"><span class="sr-only">Share</span><i aria-hidden="true" class="icon-share"></i></span></a><div aria-labelledby="sticky-header-dropBlock" data-location="share_tools_article" class="dropdown-menu"><ul class="rlist--inline a2a a2a_kit" style="line-height: 16px;"><li><a href="/#facebook" aria-label="Share on Facebook" data-id="article-share-facebook" rel="nofollow noopener" role="link" target="_blank" title="Share on Facebook" class="btn btn--facebook a2a_button_facebook" data-interactiontype="social"><i aria-hidden="true" class="icon-facebook"></i></a></li><li><a href="/#twitter" aria-label="Share on X (formerly Twitter)" data-id="article-share-twitter" rel="nofollow noopener" role="link" target="_blank" title="Share on X (formerly Twitter)" class="btn btn--twitter a2a_button_twitter" data-interactiontype="social"><i aria-hidden="true" class="icon-twitter"></i></a></li><li><a href="/#linkedin" aria-label="Share on LinkedIn" data-id="article-share-linkedin" rel="nofollow noopener" role="link" target="_blank" title="Share on LinkedIn" class="btn btn--linkedin a2a_button_linkedin" data-interactiontype="social"><i aria-hidden="true" class="icon-linkedin"></i></a></li><li><a href="/#email" aria-label="Share on email" data-id="article-share-email" rel="nofollow noopener" role="link" target="_blank" title="Share on email" class="btn btn--email a2a_button_email" data-interactiontype="content_email_click"><i aria-hidden="true" class="icon-mail"></i></a></li><li><a href="/#bluesky" aria-label="Share on Bluesky" data-id="article-share-bluesky" rel="nofollow noopener" role="link" target="_blank" title="Share on Bluesky" class="btn btn--bluesky a2a_button_bluesky" data-interactiontype="social"><i aria-hidden="true" class="icon-bluesky"></i></a></li></ul></div></div></div><div class="st-header__nav st-header__item"><div class="content-navigation"><a href="/doi/full/10.1056/NEJMoa2118191" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>PREVIOUS ARTICLE</h6><div>Endovascular Therapy for Acute Stroke with a Large Ischemic Region</div></div></div><i aria-hidden="true" class="icon-arrow-left"></i><span>Previous</span></a><a href="/doi/full/10.1056/NEJMoa2105462" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><div aria-hidden="true" class="content-navigation__hint"><div class="content-navigation__hint__content"><h6>NEXT ARTICLE</h6><div>Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection</div></div></div><span>Next</span><i aria-hidden="true" class="icon-arrow-right"></i></a></div></div></div><div class="st-header__track"><div id="progress-tracker" class="st-header__tracker" style="width: 0px;"></div></div></div><div class="fv figureViewer js--has-focus-mode"><div class="fv__directory" data-core-tabs="default" style="display: flex;"><div class="fv__header"><nav class="tab__nav" role="tablist"><button role="tab" data-toggle="tab" class="tab__nav__item active" aria-controls="#tab-pane-figures" aria-selected="true">Figures</button><button role="tab" data-toggle="tab" class="tab__nav__item" aria-controls="#tab-pane-tables" tabindex="-1" aria-selected="false">Tables</button></nav><a href="#" title="Close figure viewer" class="fv__close"><i aria-hidden="true" class="icon-close"></i></a></div><div class="fv__content tab__content"><div class="tab__pane fv__list fv__list--figures" id="tab-pane-figures" aria-label="All figures" tabindex="0" role="tabpanel"><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f1" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119658_f1.jpg"><img src="/cms/10.1056/NEJMoa2119658/asset/4ef19b00-4065-4054-a454-07c112cf4901/assets/images/large/nejmoa2119658_f1.jpg" height="2465" width="1656" aria-labelledby="f1" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 1</div><div class="fv__item__description"><figcaption><div class="caption">Survey Participants.</div><div class="notes"><div role="doc-footnote">This survey (conducted from October 22 to December 9, 2021) included the same households that were sampled during our previous survey (conducted from November 4, 2020, to January 22, 2021).<sup><a href="#core-r9" role="doc-biblioref" data-xml-rid="r9" id="fv-body-ref-r9-7" href-manipulated="true" aria-label="Reference 9" data-to-manipulate="false">9</a></sup> To account for possible nonparticipation, out-migration, and death since the previous survey, there was a 10% increase in the households that were sampled; the additional households were sampled in the same clusters used previously.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f2" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119658_f2.jpg"><img src="/cms/10.1056/NEJMoa2119658/asset/efd94502-396c-4de6-ada2-108a741770fd/assets/images/large/nejmoa2119658_f2.jpg" height="2000" width="2640" aria-labelledby="f2" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 2</div><div class="fv__item__description"><figcaption><div class="caption">Cases, Hospitalizations, Recorded Deaths, and Excess Deaths Attributable to Covid-19 in Gauteng, South Africa, from the Start of the Pandemic through January 12, 2022.</div><div class="notes"><div role="doc-footnote">Shown are incidences of daily cases, weekly hospitalizations, daily recorded deaths, and weekly excess deaths attributable to coronavirus disease 2019 (Covid-19). The inset shows the incidence of daily recorded deaths on an enlarged y axis. The horizontal dashed line indicates an incidence of zero. The data were sourced from the National Institute for Communicable Diseases daily databases through January 12, 2022, except for the data regarding weekly excess deaths attributable to Covid-19, which were defined by and sourced from the South African Medical Research Council through January 8, 2022.<sup><a href="#core-r16" role="doc-biblioref" data-xml-rid="r16" id="fv-body-ref-r16-2" href-manipulated="true" aria-label="Reference 16" data-to-manipulate="false">16</a></sup> The B.1.1.529 (omicron) variant was first identified on November 25, 2021. Cases included asymptomatic and symptomatic infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confirmed by either a nucleic acid amplification assay or a rapid antigen test. Changes in the frequency of testing limit direct comparisons of case numbers; in particular, the lower frequency of testing during the first wave, which was due to constraints in laboratory capacity and prioritization of testing for hospitalized persons, prevents the direct comparison of cases from the first wave with those from subsequent waves. Hospitalizations included admissions for SARS-CoV-2 infection, as well as admissions for other illnesses in which SARS-CoV-2 infection was incidentally identified on routine screening at the time of admission. The DATCOV system was developed during the first wave, with gradual onboarding of facilities; thus, hospitalizations from the first wave may be underestimated. Definitions of recorded death and excess death attributable to Covid-19 are provided in the <a href="#ap1">Supplementary Appendix</a>.</div></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view fv__fit" href="#fv-f3" data-type="figures" data-interactiontype="multimedia_click" data-multimedia-type="Figure" data-multimedia-filename="nejmoa2119658_f3.jpg"><img src="/cms/10.1056/NEJMoa2119658/asset/09301c66-3bac-4e1c-a405-b2e7e9aa81ea/assets/images/large/nejmoa2119658_f3.jpg" height="1963" width="2640" aria-labelledby="f3" loading="lazy"><span class="fv__fit--overlay"><span>View figure</span></span></a><div class="fv__item__title">Figure 3</div><div class="fv__item__description"><figcaption><div class="caption">Covid-19 Cases, Hospitalizations, and Recorded Deaths in Gauteng, South Africa, According to Age Group.</div><div class="notes"><div role="doc-footnote">Shown are 7-day moving averages of the incidences of daily cases, hospitalizations, and recorded deaths among participants 4 years of age or younger (Panel A), 5 to 17 years of age (Panel B), 18 to 44 years of age (Panel C), 45 to 59 years of age (Panel D), and 60 years of age or older (Panel E). The horizontal dashed line indicates an incidence of zero. Because the incidences differ across age groups, different y-axis scales are used for each age group to provide clarity and aid in the visual interpretation of the trends in each group.</div></div></figcaption></div></div></div><div class="tab__pane fv__list fv__list--tables" id="tab-pane-tables" aria-label="All tables" tabindex="-1" role="tabpanel"><div class="fv__item"><a class="fv__open-item fv__item__view" href="#fv-t1" data-type="tables" data-interactiontype="multimedia_click" data-multimedia-type="Table"><i class="icon-tables"></i></a><div class="fv__item__title">Table 1</div><div class="fv__item__description"><figcaption><div class="caption">Seroprevalence of IgG against SARS-CoV-2 Spike Protein or Nucleocapsid Protein in Gauteng, South Africa, from October 22 to December 9, 2021, and Risk Factors for Seropositivity.<a href="#fv-t1fn1" role="doc-noteref">*</a></div></figcaption></div></div><div class="fv__item"><a class="fv__open-item fv__item__view" href="#fv-t2" data-type="tables" data-interactiontype="multimedia_click" data-multimedia-type="Table"><i class="icon-tables"></i></a><div class="fv__item__title">Table 2</div><div class="fv__item__description"><figcaption><div class="caption">Cumulative Reported Cases, Hospitalizations, Recorded Deaths, and Excess Deaths Attributable to Covid-19 in Gauteng, South Africa, According to Covid-19 Wave.<a href="#fv-t2fn1" role="doc-noteref">*</a></div></figcaption></div></div></div></div></div></div><div class="references-pop-up fade" aria-hidden="true"><div class="references-pop-up__heading text-dark d-flex align-items-center"><div class="references-pop-up__title flex-grow-1">Reference <span class="references-pop-up__heading-number">1</span></div><a class="references-pop-up__close text-dark" href="#" title="close pop-up" tabindex="-1" aria-hidden="true"><i class="icon-close" aria-hidden="true"></i></a></div><div class="references-pop-up__items citations to-citation__accordion external-links"></div></div></main>
    

</div>

                    
                        



        
        <div class="ng-page_layout ng-page_layout-fullWidth"><div class="container-fluid"><div class="row"><div class="col-12">



        
        




        
        <div class="ng-page_layout-contentSpacing"></div>










    
    
        <div data-widget-def="oneSearchMultiSearch" data-widget-id="778b3ad8-1a8d-43d8-8196-63b03df4a138" data-location="recirc_inIssue_bottom_article">
        



        
        <div class="os-ms os-ms-more-from-issue"><h3 class="ng-subsection-title"><a href="/toc/nejm/386/14" class="ng-subsection-title_link animation-icon-shift"><span class="ng-subsection-title_text">More from Vol. 386 No. 14</span><span class="ng-subsection-title_icon"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-longArrowRight"></use></svg></span></span></a></h3><ul class="os-ms-more-from-issue_list"><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Apr 07, 2022</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-video"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2112809" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Brief Report: Implanted System for Orthostatic Hypotension in Multiple-System Atrophy</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">J.W. Squair and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Apr 07, 2022</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-video"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2118191" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Endovascular Therapy for Acute Stroke with a Large Ischemic Region</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">S. Yoshimura and Others</span></div></div></div></div></div></li><li class="os-ms-more-from-issue_item"><div class="issue-item issue-item_sm"><div class="issue-item_meta"><ul class="issue-item_meta-list clearfix"><li class="issue-item_meta-item"><a href="/browse/nejm-article-type/original-article" class="issue-item_type">Original Article</a></li><li class="issue-item_meta-item"><span class="issue-item_date">Apr 07, 2022</span></li><li data-toggle="tooltip" data-original-title="Video" class="issue-item_meta-item"><span role="img" aria-label="Video" tabindex="0" class="issue-item_video"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#tooltip-video"></use></svg></span></span></li><li class="issue-item_meta-item"><span class="issue-item_free">FREE</span></li></ul></div><div class="issue-item_row"><div class="issue-item_left"><div class="issue-item_content clearfix"><h4 class="issue-item_title"><a href="/doi/full/10.1056/NEJMoa2105462" data-interactiontype="article_recirculation_click" class="issue-item_title-link animation-underline">Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection</a></h4><div class="issue-item_authors-and-text"><span class="issue-item_authors">P.B. Eckburg and Others</span></div></div></div></div></div></li></ul></div>

        </div>
    

</div></div></div></div>

                    
                        



        
        <div class="ng-page_layout-bottomAd"><div class="container-fluid"><div class="row"><div class="col-12">









    
    
        <div data-widget-def="literatumAd" data-widget-id="7e022d0d-4a48-44a7-af66-033cf5c13eb8" id="ad-article-bottom-FULLx320-1">
        



        
        



    
        <div class="pb-house-message adplaceholder exists">
            <!-- START: Circulation Footer 3 -->
<aside class="g-cta-subscribe">
	<style>
.bads_footer-banner24-ONJQNRF1{background:url(/pb-assets/contextual_messaging/footer-yel-background-2x-1513629627453.jpg) center center no-repeat;padding:20px;display:block;margin:0;min-height:inherit;background-size:cover;text-decoration:none!important;color:#1a1a1a;text-align:left}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:42px;line-height:44px;letter-spacing:.2px;margin:0 0 20px;font-family:ff-quadraat-web-pro,sans-serif;font-weight:600}.bads_footer-banner24-ONJQNRF1-inner{max-width:1300px;margin:0 auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions .a-btn{width:130px;padding-left:12px}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{position:static;color:#000;font-size:18px;line-height:27px;border:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:20px 0 20px 0;list-style-type:none;padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login a{color:#0a68ad}.bads_clearfix:after{visibility:hidden;display:block;font-size:0;content:" ";clear:both;height:0}.bads_clearfix{display:block}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{float:left;width:50%;padding:30px 0}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{float:left;padding-left:30px;width:50%}.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{display:block;max-width:100%;height:auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:18px;text-transform:uppercase;line-height:24px;font-weight:600;margin:-15px 0 0;letter-spacing:.2px}@media only screen and (max-width:480px){.bads_footer-banner24-ONJQNRF1-inner .bads_device-img,.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{width:100%;float:none}.bads_footer-banner24-ONJQNRF1-inner .bads_device-img{padding-left:0}.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:27px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding-top:0;padding-bottom:0}.bads_footer-banner24-ONJQNRF1{height:auto}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__actions{margin:0 0 12px;list-style-type:none}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{line-height:25px;font-size:15px;margin-bottom:10px}.bads_footer-banner24-ONJQNRF1 .bads_device-img{width:280px!important;margin:0 auto}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 3px;font-size:14px}}@media only screen and (min-width:480px) and (max-width:1024px){.bads_footer-banner24-ONJQNRF1 .g-cta-subscribe__title{font-size:20px;line-height:30px;margin-bottom:15px}.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:0}.bads_footer-banner24-ONJQNRF1-inner .g-cta-subscribe__login{font-size:14px}.bads_footer-banner24-ONJQNRF1 .bads_h5{font-size:13px;margin-top:0}}@media only screen and (min-width:1025px) and (max-width:1200px){.bads_footer-banner24-ONJQNRF1-inner .bads_subs-btn{padding:10px 0}.bads_footer-banner24-ONJQNRF1 .bads_h5{margin:0 0 5px}}@media only screen and (min-width:1401px){.bads_footer-banner24-ONJQNRF1 .bads_device-img>img{float:right}}
	</style>
	<div class="bads_footer-banner24-ONJQNRF1">
	  <div class="bads_footer-banner24-ONJQNRF1-inner bads_clearfix">
		 <div class="bads_subs-btn">
			<p class="g-cta-subscribe__title">Tap into groundbreaking research and clinically relevant insights</p>
			<ul class="g-cta-subscribe__actions">
				<li class="g-cta-subscribe__actions-primary">
				  <a href="/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dsubscribe%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa2119658%26promo%3DONFQNRF1&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2119658&amp;pubId=41283530&amp;placeholderId=101336&amp;productId=1035" class="ng-btn_primary ng-btn_iconRight"><span class="ng-btn_text">Subscribe </span><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#arrows-longArrowRight"></use></svg></span></a>
				</li>
			</ul>
			<p class="g-cta-subscribe__login">Already a subscriber? <a href="/action/clickThrough?id=127716&amp;url=%2Faction%2FstoreProxy%3Faction%3Dactivate%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fdoi%252Ffull%252F10.1056%252FNEJMoa2119658%26promo%3DONFQANR4&amp;loc=%2Fdoi%2Ffull%2F10.1056%2FNEJMoa2119658&amp;pubId=41283530&amp;placeholderId=101336&amp;productId=1035">Activate</a> your online access.</p>
		 </div>

		<div class="bads_device-img">
		   <img src="/sda/127716/footer-devices-2x.png" alt="Devices">
		</div>
	   </div>
	</div>
</aside>
<!--/END: Circulation Footer 3 -->
            
        </div>
    

    

    



        </div>
    

</div></div></div></div>

                    
                        



        
        <footer class="ng-footer footer__top" style="position: relative;"><div data-location="footer" class="ng-footer_columns"><div class="container-fluid"><div class="row"><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">ARTICLE CATEGORIES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item">
        <a href="/browse/nejm-article-category/research" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Research</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/review" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reviews</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/clinical-cases" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Clinical Cases</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/perspective" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Perspective</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/commentary" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Commentary</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/browse/nejm-article-category/other" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Other</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/medical-article-index" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Browse all Articles</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/toc/nejm/current" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Current Issue</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/loi/nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Issue Index</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">RESOURCES</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Authors &amp; Reviewers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/author-center/home" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Submit a Manuscript</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Subscribers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://tools.ovid.com/ovidtools/nejm.html" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Administrators</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/media" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Media</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/how-to-advertise" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertisers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/information-for-subscription-agents" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Agents</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/permissions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Permissions &amp; Licensing</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/reprints" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Reprints</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a>
    </li>
</ul>
</div></div></div><div class="col-lg-4 col-md-6 col-sm-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="About us">ABOUT US</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/about-nejm/about-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">About NEJM</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmgroup.org/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM Group</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Products &amp; Services</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/editors-and-publishers" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Editors &amp; Publishers</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/advertising-policies" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Advertising Policies</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/contact-nejm" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text" aria-label="Contact us">Contact Us</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/frequently-asked-questions?#Accessibility" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Accessibility</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/frequently-asked-questions" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">FAQs</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/help" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Help</span></a></li>
    <li class="ng-footer_column-list-item"><a href="mailto:sitefeedback@nejm.org" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Site Feedback</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">SUBSCRIPTIONS</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=subscribe&amp;promo=ONF4NRS3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Subscribe</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=renew&amp;product=nejm&amp;promo=ONFLNRR3&amp;prc=ONFARN52" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Renew</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=activate&amp;promo=ONFLNAA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Activate Subscription</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC4" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Manage Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=paybill&amp;product=nejm&amp;promo=BNFLPBA1" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Pay Bill</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.wolterskluwer.com/en/solutions/ovid/nejm-complete-collection" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Institutional Sales</span></a></li>    
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/special-content" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Special Content</span></a></li>
</ul>
</div></div></div><div class="col-lg-4 col-md-12 ng-footer_column"><div class="row"><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title">STAY CONNECTED</h4>
<ul class="ng-footer_column-list">
    <li class="ng-footer_column-list-item"><a href="https://myaccount.nejm.org/emails?section=NEJM" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Email Alerts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/action/storeProxy?action=register&amp;promo=ONFLNRC3" class="ng-footer_column-link animation-underline ro-mode_disabled"><span class="ng-footer_column-link-text">Create Account</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/products-and-services" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Apps</span></a></li>
    <li class="ng-footer_column-list-item"><a href="https://www.nejmcareercenter.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">NEJM CareerCenter</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Podcasts</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/rss-feed/" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">RSS Feed</span></a></li>
    <li class="ng-footer_column-list-item"><a href="/about-nejm/institutional-access" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-text">Remote Access</span></a></li>
</ul>
</div><div class="col-6 ng-footer_column-nested">



        
        <h4 class="ng-footer_column-title" aria-label="Follow us">FOLLOW US</h4>
<ul class="ng-footer_column-list">
<li class="ng-footer_column-list-item"><a href="https://www.facebook.com/TheNewEnglandJournalofMedicine" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-facebook"></use></svg></span></span><span class="ng-footer_column-link-text">Facebook</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://twitter.com/nejm" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-twitter"></use></svg></span></span><span class="ng-footer_column-link-text">X (formerly Twitter)</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.instagram.com/nejm/" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-instagram"></use></svg></span></span><span class="ng-footer_column-link-text">Instagram</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.youtube.com/user/NEJMvideo" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-youtube"></use></svg></span></span><span class="ng-footer_column-link-text">Youtube</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.linkedin.com/company/nejm-group" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-linkedin"></use></svg></span></span><span class="ng-footer_column-link-text">LinkedIn</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://bsky.app/profile/nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-bluesky"></use></svg></span></span><span class="ng-footer_column-link-text">Bluesky</span></a></li>
<li class="ng-footer_column-list-item"><a href="https://www.tiktok.com/@nejm.org" target="_blank" rel="noopener" class="ng-footer_column-link animation-underline"><span class="ng-footer_column-link-icon"><span class="icon-component"><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#social-tiktok"></use></svg></span></span><span class="ng-footer_column-link-text">TikTok</span></a></li>
</ul>
</div></div></div></div></div></div><div data-location="footer" class="ng-footer_journals"><div class="container-fluid"><div class="row"><div class="col-12">



        
        <h4 class="ng-footer_journals-label">JOURNALS</h4>
<ul class="ng-footer_journals-list">
<li class="ng-footer_journals-item"><a href="https://www.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">The New England Journal of Medicine</a></li>
<li class="ng-footer_journals-item"><a href="https://catalyst.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Catalyst Innovations in Care Delivery</a></li>
<li class="ng-footer_journals-item"><a href="https://evidence.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM Evidence</a></li>
<li class="ng-footer_journals-item"><a href="https://ai.nejm.org/" target="_blank" rel="noopener" class="ng-footer_journals-link">NEJM AI</a></li>
</ul>
</div></div></div></div><div data-location="legal" class="ng-footer_bottom"><div class="container-fluid"><div class="row"><div class="col-lg-7 col-md-6 ng-footer_bottom-left">



        
        <p>Copyright Â© 2025 <a href="https://www.massmed.org/" target="_blank" rel="noopener" class="ng-footer_bottom-link"><b>Massachusetts Medical Society</b></a>. All rights reserved, including those for text and data mining, AI training, and similar technologies. Electronic ISSN 1533-4406. Print ISSN 0028-4793.The content of this site is intended for health care professionals.</p>
</div><div class="col-lg-5 col-md-6 ng-footer_bottom-right">



        
        <style>
  #teconsent a {
    color: #666;
    text-decoration: none;
  }
  #teconsent a:hover {
    color: #666;
    text-decoration: underline;
  }
</style>
<ul class="ng-footer_bottom-list">
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/copyright-information.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Copyright</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/terms-of-use.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Terms</a></li>
<li class="ng-footer_bottom-list-item"><a href="https://www.nejmgroup.org/legal/privacy-policy.htm" target="_blank" rel="noopener" class="ng-footer_bottom-link">Privacy Policy</a></li>
<li class="ng-footer_bottom-list-item"><span id="teconsent" consent="undefined" aria-label="Open Cookie Preferences Modal" role="complementary"><a role="link" id="icon-id0818815767164939" tabindex="0" lang="en" aria-haspopup="dialog" aria-label="Cookie Preferences, opens a dedicated popup modal window" class="truste_cursor_pointer">Cookie Preferences</a></span></li>
</ul>
<a href="https://www.nejmgroup.org/" title="NEJM Group" target="_blank" rel="noopener" class="ng-footer_logo-link"><img src="/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/logo_group.svg" alt="NEJM Group logo" class="ng-footer_logo" loading="lazy" width="103" height="40"></a>
</div></div></div></div><div data-show-after="400" class="back-to-top back-to-top--align-right  "><button data-snap="footer__top" class="back-to-top__action position-relative p-0 m-0 border-0 d-flex flex-column align-items-center justify-content-center"><svg viewBox="0 0 36 36" class="position-relative"><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" class="back-to-top__action__ring-bg"></path><path d="M18 2.0845 a 15.9155 15.9155 0 0 1 0 31.831 a 15.9155 15.9155 0 0 1 0 -31.831" stroke-dasharray="0, 100" class="back-to-top__action__ring"></path></svg><span class="back-to-top__action-icon position-absolute d-flex"><span class="icon-component "><svg aria-hidden="true" style=""><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons-3acb348e68a3edd0c676698e8d598c68.spritemap.svg#arrows-up"></use></svg></span></span><span class="sr-only">Back to top</span></button></div></footer>

                    
                        



        
        <!-- TrustArc: Banner -->
<div id="consent_blackbar"><style>  #consent_blackbar{    position:relative;    width:100%;    z-index: 999999;  }    #trustarc-banner-overlay {  background-color: rgb(0, 0, 0);   opacity: 0.3;   position: fixed;   z-index: 1000000;   width: 100%;  height: 100%;   top: 0px;   left: 0px;   overflow: hidden;}.truste-title {  /*font-family: "Source Sans Pro", sans-serif;  font-size: 23px;  font-style: normal;  font-stretch: normal;*/  color: #222;  margin-bottom: 20px;  text-align: center;/*  font-weight:bold;*/}.truste-footer {  margin: 0 auto;      }.truste-left {  margin: 0px 0px 15px 15px;/*font-family: "Source Sans Pro", sans-serif;  font-size: 14px;    */}.truste-banner { margin: 0 auto; }.truste-messageColumn {/*font-family: "Source Sans Pro", sans-serif;  font-size: 14px;*/  color: #666666;  margin: 0px;}#truste-consent-button, #truste-consent-required {    background-color: #FF1E00;    color: #F2F1F1;    padding: 5px 10px;    border: 1px solid #FF1E00;    border-radius: 0px;    cursor: pointer;    text-transform:uppercase;/*    font-family: "Source Sans Pro",sans-serif;    font-size: 15px;*/  }      #truste-show-consent {    background-color: #FF1E00;    color: #F2F1F1;    border: 1px solid #FF1E00;    padding: 5px 10px;    border-radius: 0px;    cursor: pointer;    text-transform:uppercase;/*    font-family: "Source Sans Pro",sans-serif;    font-size: 15px;*/  }div.truste-consent-track-class {  position: fixed;  z-index:9999999;   background: #666;   border: 1px solid #333;    /*padding: 10px 60px;*/    bottom:0px;    right:0px;    left:0px;    margin: 10px;}.truste-left {  margin: 0;}div.text-content {  display: flex;  flex-direction: column;  align-self: baseline;}#truste-consent-text {    /*font-family: "Source Sans Pro", sans-serif;    font-size: 16px;*/    color: #fff;    margin: 15px 0px;}.truste-footer {  padding-top: 15px;}#truste-consent-content {  margin: 0 auto;    padding: 0 10px;    max-width: 1366px;}.truste-consent-footer {  display: none;}.flex-container {  display: block;  align-items: center;  justify-content: space-between;}#truste-consent-buttons {  float: right;  margin: 10px 5px 10px 0px;}#truste-show-consent { background: #F30 !important;}#truste-consent-button, #truste-consent-required { background: #F30 !important; } /* MEDIA QUERIES */  @media screen and (max-width: 500px) {  #truste-consent-track {    padding: 5px 20px;  }  }@media screen and (max-width: 375px) {  .truste-buttonsColumn {    float: none;    margin: 0;  }  #truste-consent-button, #truste-consent-required, #truste-show-consent {    width: 100%;    margin-bottom: 5px;  }          #truste-consent-buttons {  float: none;  margin: 10px 0px 10px 0px;	}}</style><div id="truste-consent-track" style="display: block; opacity: 1;">  <div id="trustarc-banner-overlay"></div>  <div class="truste-consent-track-class">    <div id="truste-consent-content" class="truste-banner">        <div class="flex-container">          <div class="text-content">            <div id="truste-consent-text" class="truste-messageColumn">This site uses cookies and related technologies, as described in our privacy policy, for purposes that may include site operation, analytics, enhanced user experience, or advertising. You may choose to consent to our use of these technologies, or manage your own preferences.                       </div>          </div>          <div id="truste-consent-buttons" class="truste-buttonsColumn">            <button id="truste-show-consent" aria-haspopup="dialog">Manage Settings</button>      <button id="truste-consent-button">Accept</button>      <!-- <button id="truste-consent-required">Decline All</button> -->          </div>        </div>                <div style="clear:both;"></div>    </div>  </div></div><!--emptycomment--></div>
<!-- /TrustArc: Banner -->

                    
                        



        
        <link rel="stylesheet" href="https://cssjs.nejm.org/mmsWidgets.css"><script nonce="94d6c9e08714a4d7-GRU" type="text/javascript" src="https://cssjs.nejm.org/mmsWidgets.js"></script><script nonce="94d6c9e08714a4d7-GRU" type="text/javascript">var litSSO = {
    "ucid": null,
    "accessToken": null,
    "authState": null
};

var loginUri = '/action/doSsoLogin';
var logoutUri = '/action/doLogout';

displayAuthenticatedMessage();

mmsWidgets.init({
    clientId: 'qsra7g4d6jwdsgn3zbe6udp6r6278mr9',
    origin: 'NEJM',
    xdReceiver: 'http://www.nejm.org/pb-assets/sso/xd.html',
    isFullPageSignIn: isSignInPage(),
    debug: true,

    onReady: function (e) {
        console.log('<<<<<<<<<< client: received onReady event.');
        $("A.litSsoLogin").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0) {
                mmsWidgets.signIn(e);
                return false;
            }
        });
        $("A.litSsoLogout").click(function (e) {
            mmsWidgets.signOut(e);
            return false;
        });
        $("A.litSsoCreate").click(function (e) {
            mmsWidgets.showRegModal(e);
            return false;
        });
        $("A.litSsoSubscribe").click(function (e) {
            if (!$(e.currentTarget).hasClass("noMd") || $(e.currentTarget).parents(".header_sm-login").length === 0)
                location.assign(e.currentTarget.href);
            return false;
        });
        if (window.doSSOLogin) {
            window.setTimeout(function () {
                mmsWidgets.signIn();
            }, 500);
        }
        ;
    },
    onLoginSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLoginSuccess event.' + JSON.stringify(e));

        const redirectUrl = getRedirectUri(window.location.search, location.href.replace(window.location.origin, ""));
        document.cookie = "skipSso=; expires=; path=/";
        if (!litSSO.ucid || e.ucid != litSSO.ucid || !litSSO.accessToken || e.accessToken != litSSO.accessToken) {
            location.assign(loginUri + "?ucid=" + e.profile.ucid
                + "&accessToken=" + e.accessToken
                + "&authState=" + e.authState
                + "&email=" + encodeURIComponent(e.profile.email)
                + "&givenNames=" + e.profile.givenName
                + "&surname=" + e.profile.familyName
                + "&redirectUri=" + redirectUrl
                + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                + "&rememberMe=" + e.rememberMe);
        }
    },
    onAuthStateReady: function (e) {
        console.log('<<<<<<<<<< client: received onAuthStateReady event.' + JSON.stringify(e))

        var isMmsSsoAuthenticated = (e.authState && e.authState !== "anonymous" && e.authState !== "lead" && e.ucid && e.accessToken) ? true : false;
        var isLitSsoAuthenticated = (litSSO.ucid && litSSO.accessToken && litSSO.authState) ? true : false;
        console.log('           isMmsSsoAuthenticated=' + isMmsSsoAuthenticated + ', isLitSsoAuthenticated=' + isLitSsoAuthenticated);

        if (isMmsSsoAuthenticated) {
            if (!isLitSsoAuthenticated || litSSO.ucid != e.ucid) {
                if (window.skipSso)
                    document.cookie = "skipSso=" + encodeURIComponent(e.ucid) + "; expires=; path=/";

                if (!window.skipSso && document.cookie.indexOf("skipSso=" + encodeURIComponent(e.ucid)) == -1) {
                    location.assign(loginUri + "?ucid=" + e.profile.ucid
                        + "&accessToken=" + e.accessToken
                        + "&authState=" + e.authState
                        + "&email=" + encodeURIComponent(e.profile.email)
                        + "&givenNames=" + e.profile.givenName
                        + "&surname=" + e.profile.familyName
                        + "&redirectUri=" + location.href.replace(window.location.origin, "")
                        + "&uccLastUpdatedDate=" + encodeURIComponent(e.profile.uccLastUpdatedDate)
                        + "&rememberMe=" + e.rememberMe);
                } else
                    console.log('**** client: Skip SSO ****');
            } else if (e.accessToken !== litSSO.accessToken)
                updateLitSession(e.ucid, e.accessToken);
        } else if (isLitSsoAuthenticated)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));

        if (document.getElementById("ssoerr-ucid"))
            document.getElementById("ssoerr-ucid").innerHTML = e.ucid;

    },
    onRegistrationSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onRegistrationSuccess event.' + JSON.stringify(e))
        document.cookie = "skipSso=; expires=; path=/";
        var uccLastUpdatedDate = '1812-01-01 00:00:00.1 +0000';
        location.assign(loginUri + "?ucid=" + e.profile.ucid
            + "&accessToken=" + e.accessToken
            + "&authState=" + e.authState
            + "&email=" + encodeURIComponent(e.profile.email)
            + "&givenNames=" + e.profile.givenName
            + "&surname=" + e.profile.familyName
            + "&redirectUri=" + location.href.replace(window.location.origin, "")
            + "&uccLastUpdatedDate=" + encodeURIComponent(uccLastUpdatedDate)
            + "&rememberMe=" + e.rememberMe);
    },
    onLogoutSuccess: function (e) {
        console.log('<<<<<<<<<< client: received onLogoutSuccess event.' + JSON.stringify(e))

        document.cookie = "skipSso=; expires=; path=/";
        location.assign(logoutUri);
    },
});

function updateLitSession(ucid, accessToken) {
    $.ajax({
        method: "GET",
        url: "/action/doSsoSessionUpdate",
        data: {ucid: ucid, accessToken: accessToken},
        success: function (callData, textStatus) {
            console.log("Session accessToken updated")
            litSSO.accessToken = accessToken
        },
        error: function (jqXHR, textStatus, errorThrown) {
            alert("Your website session has expired and will now be reset.")
            console.log("Session update failed: " + jqXHR.responseText)
            location.assign(logoutUri + "?redirectUri=" + encodeURIComponent(location.href.replace(window.location.origin, "")));
        }
    });
}

function getRedirectUri(location, fallback) {
    const urlParams = new URLSearchParams(location);
    const uriUrlParam = urlParams.get('uri');
    if (uriUrlParam)
        return encodeURIComponent(uriUrlParam);
    else
        return encodeURIComponent(fallback);
}

function isSignInPage() {
    return document.querySelector('meta[name="pbContext"]').content.indexOf("customPage:string:/sign-in") > -1;
}

function displayAuthenticatedMessage() {
    if (isSignInPage()) {
        var div = document.getElementById('authMsg');
        if ("" === "PersonUser") {
            div.innerHTML += "You are already signed in to " + window.location.origin.replace("https://", "").replace("www.", "") + ". If you would like to sign in with a different email address, please use the form below.";
        } else {
            div.innerHTML = '';
        }
    }
}</script>

                    
                
            </div>
        </div><iframe name="trustarc_notice" id="trustarcNoticeFrame" title="Trustarc Cross-Domain Consent Frame" src="https://consent.trustarc.com/get?name=crossdomain.html&amp;domain=nejm.com" style="display: none;"></iframe><script src="https://consent.trustarc.com/asset/notice.js/v/v1.7-1576" async="async" crossorigin="" importance="high" nonce="94d6c9e08714a4d7-GRU"></script>
        


        
        

            <script src="/products/mms-nextgen/mms/releasedAssets/js/build.lazyload.bundle-c8c4e7d20884f81951fb.js" nonce="94d6c9e08714a4d7-GRU"></script>

        <script src="/products/mms-nextgen/mms/releasedAssets/js/main.bundle-3819a02ec7bc2aca01ec.js" nonce="94d6c9e08714a4d7-GRU"></script>
        


<div id="adModal" tabindex="-1" aria-labelledby="exampleModalCenterTitle" class="ng-modal modal" style="display: none;" aria-hidden="true">
    <div role="document" class="ng-modal_dialog modal-dialog modal-dialog-centered ad-promoLayer">
        <div class="ng-modal_content modal-content p-0">
            <div class="ng-modal_body modal-body m-0">
                <div class="ng-modal_header modal-header">
                    <button type="button" data-dismiss="modal" aria-label="Close" class="ng-modal_close close"><span aria-hidden="true"><span class="icon-component "><svg aria-hidden="true"><use xlink:href="/specs/products/mms-nextgen/mms/releasedAssets/icons/icons.spritemap.svg#close"></use></svg></span></span>
                    </button>
                </div>

            </div>
        </div>
    </div>
</div>
<script type="text/javascript" src="/wro/1125813~product.js" nonce="94d6c9e08714a4d7-GRU"></script>








<input id="showLayers" type="hidden" value="true">

    <!-- placeholder id=null, description=ad-layer-config -->
    <!-- placeholder id=null, description=ad-lauchLayer-1 -->
    <!-- placeholder id=null, description=ad-layer-promo-1 -->

    <input id="firstAd" type="hidden" value="">
    <input id="secondAd" type="hidden" value="">

    
    
    

    
    
    <input id="IsInstitution" type="hidden" value="false">
    <input id="IsSubscriber" type="hidden" value="true">
    <input id="CustomerId" type="hidden" value="">


<script type="text/javascript" nonce="94d6c9e08714a4d7-GRU">
  jQuery.extend(jQuery.mmsLayers.config, {
    rules: [{
      "name": "Launch Layer Ad",
      "frequency": 30,
      "showOnPage": 5,
      "enabled": false,
      "cookieName": "MarketingLaunchLayer",
      "styleClass": "launchLayer"
    },
    {
      "name": "Promo Layer Ad",
      "frequency": 14,
      "enabled": true,
      "cookieName": "PromoLayer",
      "styleClass": "promoLayer"
    },
    {
      "name": "Interstitial Ad",
      "frequency": 7,
      "enabled": false,
      "cookieName": "InterstitialAd"
    },
    {
      "name": "Iperceptions - Ion Layer Ad",
      "showOnPage": 1,
      "enabled": false,
      "test": false,
      "cookieName":"Iperceptions"
    }]
 });
</script>

















    <script type="text/javascript" nonce="94d6c9e08714a4d7-GRU">
        $(document).ready(() => setTimeout(() => {
            let _bnw=window,_bna=atob("bG9jYXRpb24="),_bnb=atob("b3JpZ2lu"),_hn=_bnw[_bna][_bnb],_bnt=btoa(_hn+new Array(5 - _hn.length % 4).join(" "));
            $.get("/resource/lodash?t="+_bnt);
        },4000));
    </script>












    

    
    

    
    
    
    
        
            
                <script type="text/javascript" src="/wro/1125813~article-metrics.js" nonce="94d6c9e08714a4d7-GRU"></script>
            
            
            
        
    




<script type="text/javascript" src="/wro/1125813~full-text-analytics.js" nonce="94d6c9e08714a4d7-GRU"></script>


    


            <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94d6c9e06eb1a4d7',t:'MTc0OTUzNjY5Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94d6c9e06eb1a4d7&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;f55e150c7a5f4a4ab9ef82f4a1c9c43c&quot;}" crossorigin="anonymous"></script><div style="display:none;" id="signInEmbedded" class="ucc-fullpage-signin ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Sign In</h1>
  </div>    
  <div class="capture_signin">
    {* #signInForm *}
    <div class="ucc-form-inner-wrapper">
      {* signInEmailAddress *}
      {* currentPassword *}
      <div style="padding-top:10px;">
          <div class="capture_form_item capture_form_rememberme">
          <label class="ucc-form-checkbox">                
            <input checked="checked" id="ucc-remember-me-cb-embedded" name="ucc-remember-me-cb-embedded" type="checkbox" value="true">
            <span>Remember Me</span>
          </label>                           
          </div>
          <div class="capture_form_item capture_form_forgotpwd">
            <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
          </div>
      </div>
      <div class="capture_form_item">      
        <button id="ucc-sign-in-submit-embedded" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
      </div>
      <div class="capture_form_item capture_form_footer">
        <div class="ucc-no-acct-msg">Don't have an account?</div>
        <div class="ucc-no-acct-msg-2">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
          <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
        </div>
      </div>
      <div class="capture_form_item capture_form_submit">
        
      </div>      
    </div>
    {* /signInForm *}
  </div>
</div><div style="display:none;" id="forgotPassword" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Forgot Password</h1>
  </div>   
  <div class="ucc-form-inner-wrapper">
  <p style="color:black">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
  </div> 
  <div class="capture_forgotpassword">
    {* #forgotPasswordForm *}      
      <div class="ucc-form-inner-wrapper">
        {* forgotPasswordEmailAddress *}
        {* captcha *}
        <div class="capture_form_item" style="padding-top: 20px;">        
          <input id="ucc-widget-forgotpwd-submit" value="Continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
        </div>
      </div>
    {* /forgotPasswordForm *}
  </div>
  </div><div style="display:none;" id="forgotPasswordSuccess" class="ucc-widgets-nejm-next">
  <div class="capture_header">
    <h1>Create New Password</h1>
  </div>    
  <div class="capture_forgotpassword">
      <div class="ucc-form-inner-wrapper">
        <p style="padding-top: 30px; padding-bottom: 30px;">We've sent an email with instructions to create a new password. Your existing password has not been changed.</p>        
        <div class="capture_form_item">      
          <button class="capture_btn capture_primary capture-full-width-btn" onclick="janrain.capture.ui.modal.close()">CLOSE</button>
        </div>
      </div>
  </div>
  </div><div style="display:none;" id="resetPassword" class="ucc-widgets-nejm-next">
      <div class="row">      
        <div class="col-md-8 col-md-offset-2 reset-pwd-info"><p>To reset your password, enter a new password twice and click the 'Reset Password' button.</p></div>
      </div>
      <div class="col-md-4 col-md-offset-4">
        {* #changePasswordFormNoAuth *}
          {* newPassword *}
          {* newPasswordConfirm *}     
          <div class="capture_form_item">
            <input value="RESET PASSWORD" type="submit" class="capture_btn capture_primary capture-full-width-btn">
          </div>
          {* /changePasswordFormNoAuth *}
      </div>
    </div><div style="display:none;" id="resetPasswordSuccess">
        <div class="reset-pwd-info">
          <div class="reset-pwd-success-welcome"></div>
          <p class="reset-pwd-success-msg">Your password has been reset. You will need to <a href="/signin" onclick="mmsWidgets.signIn(event)">sign in</a> again using your new password to access site content and features.</p>
          <p class="reset-pwd-success-nav"></p>
        </div>      
    </div><div style="display:none;" id="resetPasswordRequestCode" class="ucc-widgets-nejm-next">
        {* #resetPasswordForm *}
        <div class="capture_form_error">The link that you followed to reset your password has expired.</div>
          <div class="col-md-8 col-md-offset-2">
            <p class="reset-pwd-info">Enter the email address associated with your account then click Continue. We will email you a link to a page where you can easily create a new password.</p>
          </div>
          <div class="col-md-4 col-md-offset-4">
            {* signInEmailAddress *}
            <div class="capture_form_item">
              <input value="continue" type="submit" class="capture_btn capture_primary capture-full-width-btn">
            </div>
          </div>
        {* /resetPasswordForm *}
    </div><div style="display:none;" id="resetPasswordRequestCodeSuccess">
      <div class="reset-pwd-info">
        <p>If the address matches an existing account, you will receive an email with instructions to reset your password.</p>
        <p class="reset-pwd-success-nav"></p>
      </div>
  </div>

        
        
    

<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">â</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">Moreâ¦</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><cis-dhajybqxalfy></cis-dhajybqxalfy><script type="text/javascript" src="https://api.altmetric.com/v1/internal-556fdf0f/doi/10.1056/nejmoa2119658?callback=_altmetric.embed_callback&amp;domain=www.nejm.org&amp;cache_until=3-10"></script><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="janrainEngageEmbed" style="display: none;"><div class="janrainContent" style="width: 380px !important; height: 156px !important; padding-left: 5px !important; padding-right: 5px !important; box-sizing: content-box !important; background-color: rgb(255, 255, 255) !important; border: 1px solid rgb(192, 192, 192) !important; border-radius: 10px !important; overflow: hidden !important; position: relative !important;"><div id="janrainView"><div class="janrainHeader" style="background-color: rgb(255, 255, 255) !important; font-size: 14px !important; color: rgb(102, 102, 102) !important; position: relative !important; height: 20px !important; left: -5px !important; padding: 5px 5px 0px !important; white-space: nowrap !important; width: 380px !important; z-index: 100 !important; border-radius: 10px 10px 0px 0px !important; text-align: left !important;"><div style="padding-left: 1px !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important;">Sign in using your account with</div></div><div id="janrainProviderPages" style="padding-top: 5px; left: 5px; position: absolute;"><div class="janrainPage" pageindex="0"><ul class="providers" id="janrainProviders_0" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-aol" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="1" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-aol" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-aol" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">AOL</span></a></li><li id="janrain-openid" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="3" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-openid" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-openid" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">OpenID</span></a></li></ul><ul class="providers" id="janrainProviders_1" style="float: left !important; list-style-type: none !important; margin: 0px !important; padding: 0px !important;"><li id="janrain-yahoo" role="button" style="list-style: none !important; height: 30px !important; width: 185px !important; margin-top: 0px !important; margin-right: 5px !important; margin-bottom: 5px !important; position: relative !important; border: 1px solid rgb(204, 204, 204) !important; border-radius: 5px !important; cursor: pointer !important; white-space: nowrap !important; overflow: hidden !important; background-image: -webkit-linear-gradient(bottom, rgb(238, 238, 238), rgb(255, 255, 255)) !important;"><a tabindex="2" href="javascript:void(0);" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; font-size: 12px !important; line-height: 14px !important; margin-left: auto !important; margin-right: auto !important; text-decoration: none !important; display: block !important; padding-left: 5px !important; padding-right: 5px !important; text-align: left !important; width: auto !important;"><span class="janrain-provider-icon-24 janrain-provider-icon-yahoo" style="margin-top: 3px !important; background-color: transparent !important;"></span><span class="janrain-provider-text-color-yahoo" style="font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; cursor: pointer !important; margin-left: 7px !important; text-align: left !important; margin-top: 9px !important; vertical-align: top !important; display: inline-block !important;">Yahoo!</span></a></li></ul></div></div><div style="background-color: rgb(255, 255, 255) !important; width: 380px !important; height: 10px !important; position: absolute !important; left: 0px !important; padding-left: 5px !important; padding-right: 5px !important; padding-bottom: 5px !important; bottom: 0px !important; font-size: 10px !important; text-align: left !important; color: rgb(102, 102, 102) !important; font-family: Helvetica, &quot;lucida grande&quot;, Verdana, sans-serif !important; border-radius: 0px 0px 10px 10px !important;"><div style="padding-left: 1px !important;"><a href="http://janrain.com/products/engage/social-login?utm_source=mms.rpxnow.com&amp;utm_medium=Partner&amp;utm_campaign=attribution" target="_blank">Social Login by Janrain</a></div></div></div></div></div><iframe name="captureIFrame_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" data-transactionid="m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" id="captureIFrame_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" src="about:blank" class="" data-captureiframeloadeventbound="yes" style="display: none;"></iframe><div id="janrainModalOverlay" style="inset: 0px; position: fixed; background-color: rgb(0, 0, 0); opacity: 0.4; display: none; z-index: 1000;"></div><div id="janrainModal" style="width: 380px; height: 131px; position: absolute; z-index: 1000; display: none;"><a href="#" class="janrain_modal_closebutton" style="position: absolute; cursor: pointer; z-index: 1000;">X</a><div style="display: block;" id="signIn" class="ucc-widgets-nejm-next janrain-capture-ui capture-ui-content capture_screen_container" data-capturescreenname="signIn" data-captureventadded="true">
    <div class="capture_header">
      <h1>Sign In</h1>
    </div>    
    <div class="capture_signin">
      <form id="capture_signIn_signInForm" name="signInForm" data-capturefield="signInForm" action="https://mms.us.janraincapture.com/widget/traditional_signin.jsonp" class="capture_form capture_signInForm" method="POST" novalidate="novalidate" data-transactionid="m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" target="captureIFrame_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" accept-charset="UTF-8" next="{&quot;noop&quot;:&quot;&quot;}"><div id="capture_signIn_signInForm_defaultSavedProfileMessage"></div><div id="capture_signIn_signInForm_errorMessages"></div><input id="capture_signIn_utf8" data-capturefield="undefined" value="â" type="hidden" class="capture_utf8" name="utf8"><input id="capture_signIn_screen_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" data-capturefield="undefined" value="signIn" type="hidden" class="capture_screen_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" name="capture_screen"><input id="capture_signIn_js_version_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" data-capturefield="undefined" value="d445bf4" type="hidden" class="capture_js_version_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" name="js_version"><input id="capture_signIn_transactionId_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" data-capturefield="undefined" value="m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" type="hidden" class="capture_transactionId_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" name="capture_transactionId"><input id="capture_signIn_form_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" data-capturefield="undefined" value="signInForm" type="hidden" class="capture_form_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" name="form"><input id="capture_signIn_flow_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" data-capturefield="undefined" value="standard" type="hidden" class="capture_flow_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" name="flow"><input id="capture_signIn_client_id_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" data-capturefield="undefined" value="qsra7g4d6jwdsgn3zbe6udp6r6278mr9" type="hidden" class="capture_client_id_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" name="client_id"><input id="capture_signIn_redirect_uri_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" data-capturefield="undefined" value="https://www.nejm.org" type="hidden" class="capture_redirect_uri_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" name="redirect_uri"><input id="capture_signIn_response_type_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" data-capturefield="undefined" value="code" type="hidden" class="capture_response_type_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" name="response_type"><input id="capture_signIn_flow_version_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" data-capturefield="undefined" value="20240514181256512029" type="hidden" class="capture_flow_version_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" name="flow_version"><input id="capture_signIn_settings_version_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" data-capturefield="undefined" value="" type="hidden" class="capture_settings_version_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" name="settings_version"><input id="capture_signIn_locale_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" data-capturefield="undefined" value="en-US" type="hidden" class="capture_locale_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" name="locale"><input id="capture_signIn_recaptcha_version_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" data-capturefield="undefined" value="2" type="hidden" class="capture_recaptcha_version_m126ws5zeq61b0ixayi3yak6gmggt0z6ozxrv6ju" name="recaptchaVersion">
      <div class="ucc-form-inner-wrapper">
        <div id="capture_signIn_form_item_signInEmailAddress" class="capture_form_item capture_email capture_form_item_signInEmailAddress" data-capturefield="undefined"><label for="capture_signIn_signInEmailAddress">Email Address</label><input id="capture_signIn_signInEmailAddress" data-capturefield="signInEmailAddress" value="" type="email" class="capture_signInEmailAddress capture_required capture_text_input" placeholder="Email Address" name="signInEmailAddress"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="signInEmailAddress">Validating</div><div class="capture_tip_error" data-elementname="signInEmailAddress"></div></div>
        <div id="capture_signIn_form_item_currentPassword" class="capture_form_item capture_password capture_form_item_currentPassword" data-capturefield="undefined"><label for="capture_signIn_currentPassword">Password</label><input id="capture_signIn_currentPassword" data-capturefield="currentPassword" value="" type="password" class="capture_currentPassword capture_required capture_text_input" placeholder="Password" name="currentPassword"><div class="capture_tip" style="display:none;"></div><div class="capture_tip_validating" data-elementname="currentPassword">Validating</div><div class="capture_tip_error" data-elementname="currentPassword"></div></div>
        <div style="padding-top:10px;">
            <div class="capture_form_item capture_form_rememberme">
                <label class="ucc-form-checkbox">                
                    <input checked="checked" id="ucc-remember-me-cb" name="ucc-remember-me-cb" type="checkbox" value="true">
                    <span>Remember Me</span>
                </label>          
            </div>
            <div class="capture_form_item capture_form_forgotpwd">
              <a role="button" class="ucc-anchor-button" data-capturescreen="forgotPassword">Forgot your password?</a>
            </div>
        </div>
        <div class="capture_form_item">
          <button id="ucc-sign-in-submit" class="capture_primary capture-full-width-btn" type="submit">Sign In</button>
        </div>
       
        <div class="capture_form_item">
          <div class="ucc-no-acct-msg">Don't have an account?</div>
          <div class="ucc-no-acct-msg-2" id="signInModalCreateAccountLink">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event); mmsWidgets.showRegAuto(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

          <div class="ucc-no-acct-msg-2" id="signInModalCloseLink" style="display:none">
          <a role="button" class="ucc-anchor-button" onclick="mmsWidgets.closeSignIn(event);">Create Account</a>
            <span></span><a href="https://store.nejm.org/nejm?promo=ONF4NRS1">Subscribe</a>
          </div>

        </div>
     
        <div class="capture_form_item capture_form_submit">
          
        </div>      
      </div>
      </form>
    </div>
  </div></div></body></html>